
<html lang="en"     class="pb-page"  data-request-id="5bc1d9ca-f865-4ad3-b81b-f612134fd0e1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b01253"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase" /></meta><meta name="dc.Creator" content="Hui-Li  Ng" /></meta><meta name="dc.Creator" content="Xiang  Ma" /></meta><meta name="dc.Creator" content="Eng-Hui  Chew" /></meta><meta name="dc.Creator" content="Wai-Keung  Chui" /></meta><meta name="dc.Description" content="The dihydrofolate reductase (DHFR) and thioredoxin reductase (TrxR) enzymes are involved in the process of tumor cell growth and survival. The 4,6-diamino-1,2-dihydro-1,3,5-triazine scaffold is wel..." /></meta><meta name="Description" content="The dihydrofolate reductase (DHFR) and thioredoxin reductase (TrxR) enzymes are involved in the process of tumor cell growth and survival. The 4,6-diamino-1,2-dihydro-1,3,5-triazine scaffold is wel..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 24, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01253" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01253" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01253" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01253" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01253" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0010.jpeg" /></meta><meta property="og:description" content="The dihydrofolate reductase (DHFR) and thioredoxin reductase (TrxR) enzymes are involved in the process of tumor cell growth and survival. The 4,6-diamino-1,2-dihydro-1,3,5-triazine scaffold is well-established as a useful scaffold for DHFR inhibition, while chalcones have been reported to be inhibitors of TrxR. In this study, 15 novel compounds designed by the structural combination of the 4,6-diamino-1,2-dihydro-1,3,5-triazine and chalcone scaffolds via a diether linker were successfully synthesized and characterized. All of the compounds demonstrated dual inhibition against DHFR and TrxR when they were assessed by in vitro enzyme assays. The compounds also exhibited antiproliferative activity against the MCF-7 and HCT116 cells. The more potent analogs 14 and 15 were found to inhibit cellular DHFR and TrxR activities in HCT116 cells. Therefore, this study provided compelling evidence that 14 and 15 could exert their anticancer property via multitarget inhibition at the cellular level." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01253"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01253">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01253&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01253&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01253&amp;href=/doi/10.1021/acs.jmedchem.6b01253" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1734-1745</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01115" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01254" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui-Li++Ng">Hui-Li Ng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol "><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiang++Ma">Xiang Ma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eng-Hui++Chew">Eng-Hui Chew</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wai-Keung++Chui">Wai-Keung Chui</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-2568-6021" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, 117543, Singapore</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China</span></div><div class="corresp-info"><strong>*</strong>E.-H.C.: e-mail, <a href="/cdn-cgi/l/email-protection#b3c3dbd2d0d6dbf3ddc6c09dd6d7c69dc0d4"><span class="__cf_email__" data-cfemail="b8c8d0d9dbddd0f8d6cdcb96dddccd96cbdf">[emailÂ protected]</span></a>; phone, +65 65161955; fax, +65 67791554.</div><div class="corresp-info"><strong>*</strong>W.-K.C.: e-mail, <a href="/cdn-cgi/l/email-protection#33435b52504458735d46401d5657461d4054"><span class="__cf_email__" data-cfemail="fa8a929b998d91ba948f89d49f9e8fd4899d">[emailÂ protected]</span></a>; phone, +65 65162933; fax, +65 67791554.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01253&amp;href=/doi/10.1021%2Facs.jmedchem.6b01253" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1734â1745</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 8, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 August 2016</li><li><span class="item_label"><b>Published</b> online</span>24 February 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01253" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01253</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1734%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHui-Li%2BNg%252C%2BXiang%2BMa%252C%2BEng-Hui%2BChew%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D5%26contentID%3Dacs.jmedchem.6b01253%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BCoupled%2BBioactive%2BScaffolds%2Bas%2BPotential%2BAnticancer%2BAgents%2Bfor%2BDual%2BTargeting%2Bof%2BDihydrofolate%2BReductase%2Band%2BThioredoxin%2BReductase%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1745%26publicationDate%3DMarch%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01253"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1793</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01253" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hui-Li&quot;,&quot;last_name&quot;:&quot;Ng&quot;},{&quot;first_name&quot;:&quot;Xiang&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Eng-Hui&quot;,&quot;last_name&quot;:&quot;Chew&quot;},{&quot;first_name&quot;:&quot;Wai-Keung&quot;,&quot;last_name&quot;:&quot;Chui&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;1734-1745&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01253&quot;},&quot;abstract&quot;:&quot;The dihydrofolate reductase (DHFR) and thioredoxin reductase (TrxR) enzymes are involved in the process of tumor cell growth and survival. The 4,6-diamino-1,2-dihydro-1,3,5-triazine scaffold is well-established as a useful scaffold for DHFR inhibition, while chalcones have been reported to be inhibitors of TrxR. In this study, 15 novel compounds designed by the structural combination of the 4,6-diamino-1,2-dihydro-1,3,5-triazine and chalcone scaffolds via a diether linker were successfully synthesized and characterized. All of the compounds demonstrated dual inhibition against DHFR and TrxR when they were assessed by in vitro enzyme assays. The compounds also exhibited antiproliferative activity against the MCF-7 and HCT116 cells. The more potent analogs 14 and 15 were found to inhibit cellular DHFR and TrxR activities in HCT116 cells. Therefore, this study provided compelling evidence that 14 and 15 could exert their anticancer property via multitarget inhibition at the cellular level.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01253&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01253" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01253&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01253" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01253&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01253" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01253&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01253&amp;href=/doi/10.1021/acs.jmedchem.6b01253" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01253" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01253" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01253%26sid%3Dliteratum%253Aachs%26pmid%3D28177228%26genre%3Darticle%26aulast%3DNg%26date%3D2017%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BCoupled%2BBioactive%2BScaffolds%2Bas%2BPotential%2BAnticancer%2BAgents%2Bfor%2BDual%2BTargeting%2Bof%2BDihydrofolate%2BReductase%2Band%2BThioredoxin%2BReductase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D5%26spage%3D1734%26epage%3D1745%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/jmcmar.2017.60.issue-5/20170309/jmcmar.2017.60.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The dihydrofolate reductase (DHFR) and thioredoxin reductase (TrxR) enzymes are involved in the process of tumor cell growth and survival. The 4,6-diamino-1,2-dihydro-1,3,5-triazine scaffold is well-established as a useful scaffold for DHFR inhibition, while chalcones have been reported to be inhibitors of TrxR. In this study, 15 novel compounds designed by the structural combination of the 4,6-diamino-1,2-dihydro-1,3,5-triazine and chalcone scaffolds via a diether linker were successfully synthesized and characterized. All of the compounds demonstrated dual inhibition against DHFR and TrxR when they were assessed by in vitro enzyme assays. The compounds also exhibited antiproliferative activity against the MCF-7 and HCT116 cells. The more potent analogs <b>14</b> and <b>15</b> were found to inhibit cellular DHFR and TrxR activities in HCT116 cells. Therefore, this study provided compelling evidence that <b>14</b> and <b>15</b> could exert their anticancer property via multitarget inhibition at the cellular level.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Combination chemotherapeutic regimens aiming at multiple molecular targets are commonly used in the treatment of cancer to improve efficacy, decrease toxicity, and prevent the development of drug resistance.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> An alternative strategy that is gaining interest in drug discovery is the development of a single chemical entity that contains a combination of pharmacophores that are capable of modulating multiple targets simultaneously. This strategy of using a single multitargeted agent named as a âdesigned multiple ligandâ bears the advantages of circumventing the problems of complicated pharmacokinetic and pharmacodynamics (PK/PD) relationships and drugâdrug interactions associated with combination therapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Dihydrofolate reductase (DHFR) has long been recognized as a target for the treatment of certain cancers. DHFR is an essential enzyme component of the folate pathway that catalyzes the reduction of dihydrofolic acid (DHF) to tetrahydrofolic acid (THF). THF and its derivatives are cofactors in a number of one-carbon transfer reactions leading to the synthesis of several nucleic acids and amino acids.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The well-known DHFR inhibitor, methotrexate (MTX), has been used for the treatment of cancer for more than 60 years. MTX is transported into cells by the reduced folate carrier (RFC).<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> MTX is then intracellularly polyglutamylated by folylpolyglutamate synthetase (FPGS), leading to its intracellular accumulation.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> However, emergence of acquired resistance to MTX through a reduction in its active transport, a decrease in its polyglutamylation, overexpression of DHFR, or mutations in the <i>DHFR</i> gene has limited MTXâs uses in the clinical setting.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> 4,6-Diamino-1,2-dihydro-1,3,5-triazines are lipophilic DHFR inhibitors that have previously demonstrated antiproliferative activity on cancer cells.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> These compounds cross the cell membrane via passive diffusion and are not polyglutamylated like MTX. Hence, they are unaffected by drug resistance arising from an impaired active transport mediated by RFC or a decrease in polyglutamylation due to low levels of FPGS.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Previously, our laboratory has reported the synthesis and antiproliferative activity of <b>17</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), a 4,6-diamino-1,2-dihydro-1,3,5-triazine, which is a spiro analogue of the DHFR inhibitor WR99210.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a><b>17</b> was found to possess strong in vitro DHFR inhibition with an IC<sub>50</sub> value of 2.3 nM against bovine DHFR.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Therefore, <b>17</b> forms the lead for the design of the new compounds in this study.</div><div class="NLM_p">More recently, thioredoxin reductase (TrxR) has been recognized as an attractive target for anticancer drug development. Together with its substrate thioredoxin (Trx), TrxR maintains redox homeostasis in cells, preventing oxidative damage and mutation.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Both Trx and TrxR have been reported to be overexpressed in numerous cancer cells and observed to be associated with poor prognosis and resistance to chemotherapy.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> The validity of TrxR as a target for anticancer treatment has been demonstrated by experiments showing that knockdown of TrxR in cancer cells brings about reversal of tumor phenotype, as well as inhibition of DNA replication and cancer cell growth.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> The nucleophilic selenocysteine (Sec) residue located on the flexible C-terminal active site of mammalian TrxR makes it a target for many electrophilic compounds.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a></div><div class="NLM_p">Chalcones are naturally occurring compounds that have been reported to exert anticancer activity through a number of mechanisms including inhibition of tubulin polymerization,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> blockade of the nuclear factor ÎºB (NF-ÎºB) signaling pathway,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> as well as inhibition of receptor tyrosine kinases such as epidermal growth factor receptor (EGFR)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and vascular endothelial growth factor receptor 2 (VEGFR-2).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Chalcones have recently been reported to be selective, irreversible inhibitors of TrxR that demonstrated antiproliferative activity against selected human cancer cell lines, with the Î±,Î²-unsaturated carbonyl moiety of chalcones postulated to react with the Sec residue of the TrxR enzyme via Michael addition reaction to form covalent adducts.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a></div><div class="NLM_p">On the basis of the prior knowledge that DHFR and TrxR are valid molecular targets for anticancer therapies, our laboratory has been focusing on exploiting the combination of DHFR-inhibiting 4,6-diamino-1,2-dihydro-1,3,5-triazine and TrxR-inhibiting chalcone pharmacophoric scaffolds to produce novel single molecules that would elicit antiproliferative effects on cancer cells at least partly through simultaneous inhibition of DHFR and TrxR. In a previous study, we reported the synthesis of four dihydrotriazineâchalcone compounds (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A) that were designed based on merging the bioactive scaffolds.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> These compounds were found to display growth inhibitory effects like their parent dihydrotriazine component but lack cytotoxicity that is characteristic of their parent chalcone component. Moreover, the growth inhibitory activities failed to correlate with their in vitro DHFR and TrxR inhibitory activities, which underscored the suboptimal structural design of combining the two pharmacophores in a single chemical compound using the merging approach. In this study, we report the design and synthesis of 15 dual-target inhibitors of DHFR and TrxR containing the bioactive 4,6-diamino-1,2-dihydro-1,3,5-triazine and chalcone scaffolds linked by flexible diether linkers of varying lengths (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). This work has led to the identification of <b>14</b> and <b>15</b> as the compounds having the greatest cytotoxic activities against human-derived HCT116 colorectal and MCF-7 breast carcinoma cells. The cytotoxic effect is correlated to strong inhibitory activities against DHFR and TrxR. Therefore, the results provided evidence to support the design strategy of including a flexible linker between the bioactive scaffolds, which has likely facilitated their optimal interaction with the targets.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of (A) dihydrotriazineâchalcone compounds <b>6a</b>, <b>6b</b>, <b>11a</b>, and <b>11b</b> (synthesis reported in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>) and (B) linked dihydrotriazineâchalcone compounds <b>1</b>â<b>15</b> containing diether linkers of varying lengths.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of Compounds</h3><div class="NLM_p">Compounds <b>1</b>â<b>15</b> were prepared by independent synthesis of the dihydrotriazine ring and chalcone, followed by a convergent fragment coupling step (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). First, 4,6-diamino-1-hydroxy-1,2-dihydro-1,3,5-triazine hydrochlorides (<b>21</b>) were obtained as previously reported<a onclick="showRef(event, 'ref8 ref29'); return false;" href="javascript:void(0);" class="ref ref8 ref29">(8, 29)</a> through the synthesis of 4,6-diamino-<i>N</i>-benzyloxy-1,2-dihydro-1,3,5-triazine hydrochloride (<b>20</b>) from refluxing <i>O</i>-benzylhydroxylamine hydrochloride (<b>19</b>), cyanoguanidine, and a ketone in the presence of concentrated hydrochloric acid. This was followed by the reduction of the benzyloxydihydrotriazine hydrochloride (<b>20</b>) using hydrogen gas in the presence of the catalyst platinum(IV) oxide (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (A) 4,6-Diamino-1-hydroxy-1,2-dihydro-1,3,5-triazine Hydrochlorides,<sup>a</sup> (B) Bromoalkoxychalcones,<sup>b</sup>  and (C) <b>1</b>â<b>15</b><sup>c</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents and conditions for (A): (a) EtOH, conc HCl; (b) H<sub>2</sub> (1 atm), 50% aq EtOH, PtO<sub>2</sub>.</p><p><span class="fn-label">Scheme b</span>Reagents and conditions for (B): (a) NaOH, EtOH, H<sub>2</sub>O, rt; (b) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux.</p><p class="last"><span class="fn-label">Scheme c</span>Reagents and conditions for (C): (a) NaOH, MeOH, reflux; (b) bromoalkoxychalcone, DMF, rt; (c) conc HCl, pH 1.</p></p></figure><div class="NLM_p">At the same time, hydroxy-substituted chalcones (<b>26</b>, <b>27</b>) were prepared from the sodium hydroxide-catalyzed ClaisenâSchmidt condensation reaction between acetophenone (<b>25</b>) or hydroxy-substituted acetophenone (<b>22</b>) and benzaldehyde (<b>23</b>) or hydroxy-substituted benzaldehyde (<b>24</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B). The reaction was quenched by the addition of water and neutralization of the reaction mixture using a 2 N HCl solution. The obtained hydroxy-substituted chalcones (<b>26</b>, <b>27</b>) were then alkylated with suitable dibromoalkanes in the presence of potassium carbonate to yield bromoalkoxychalcones (<b>28</b>, <b>29</b>) using a method adapted from that reported by Sodani et al.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Excess dibromoalkane was used in a molar ratio of 3:1 (dibromoalkane to chalcone) to decrease the formation of the disubstituted byproduct produced by the reaction of two chalcone molecules with one molecule of dibromoalkane. In addition, a dropping funnel was used to add the hydroxy-substituted chalcones (<b>26</b>, <b>27</b>) slowly into the reaction mixture to ensure that the dibromoalkanes were constantly in excess during the reaction. When the reaction was complete (as determined by TLC), acetone and excess dibromoalkane were removed under vacuum, and the residue was washed with cold water and stirred well. The solid residue was filtered and washed with dilute NaOH solution, followed by water. The residue was then dissolved in boiling ethanol and filtered hot to remove any disubstituted byproduct present, which would have been insoluble in ethanol. The filtrate was collected and ethanol was removed under vacuum to yield the solid bromoalkoxychalcones (<b>28</b>, <b>29</b>).</div><div class="NLM_p">Finally, the two fragments were coupled via Williamson etherification (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C). Sodium hydroxide was used to deprotonate the <i>N</i>-hydroxy group of the 4,6-diamino-1-hydroxy-1,2-dihydro-1,3,5-triazine hydrochloride (<b>21</b>). After the deprotonation, methanol was removed and DMF was used for the S<sub>N</sub>2 substitution reaction. Bromoalkoxychalcone (<b>28</b>, <b>29</b>) was added together with DMF, and the mixture was stirred overnight at room temperature. For spiropentyl compounds <b>13</b>, <b>14</b>, and <b>15</b>, potassium carbonate was also added to the reaction mixture to increase the yield of the target compounds. Finally, the pH of the reaction mixture was adjusted to pH 1 to obtain the target compounds <b>1</b>â<b>15</b> as hydrochloride salts. The solid products were purified by recrystallization to obtain clean compounds at 4â50% yields. The compounds <b>16</b>, <b>6h</b>, and <b>18</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) were also synthesized for biological evaluation alongside <b>1</b>â<b>15</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_001.pdf" class="ext-link">Supporting Information, Figures S1âS3</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of <b>16</b>, <b>17</b>, <b>6h</b>, <b>18</b>, and MTX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Evaluation of in Vitro DHFR and TrxR Inhibitory Activities of Compounds <b>1</b>â<b>15</b></h3><div class="NLM_p">Compounds <b>1</b>â<b>15</b> were evaluated for DHFR inhibitory activity using recombinant human DHFR, and the obtained IC<sub>50</sub> values are shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. The DHFR IC<sub>50</sub> values of <b>16</b>, <b>17</b>, <b>6h</b>, <b>18</b>, and MTX were also evaluated and presented for comparison. All of the synthesized compounds <b>1</b>â<b>15</b> showed potent DHFR inhibitory activity with IC<sub>50</sub> values in the nanomolar range of concentrations. These values were comparable to that of the 4,6-diamino-1,2-dihydro-1,3,5-triazines <b>16</b> and <b>17</b>. Most of the compounds also exhibited DHFR inhibitory efficacy comparable to MTX, especially compounds bearing linkers containing three or four carbon atoms (<b>5</b>â<b>12</b>, <b>14</b>, <b>15</b>). As expected, the chalcone compound <b>18</b> did not possess DHFR inhibitory effect. In general, DHFR inhibitory activity improved with increasing linker length from two to four carbon atoms with inhibitory activity against the enzyme significantly augmented by 1.5- to 18-fold as the linker length increased from two to three carbon atoms. When linker length was further increased from three to four carbon atoms, DHFR inhibitory activity of the compounds bearing four-carbon linkers was either improved by around 2-fold (for <b>9</b> and <b>10</b>) or similar (for <b>11</b> and <b>12</b>) when compared to the corresponding compounds bearing three-carbon linkers (<b>5</b>â<b>8</b>). <b>13</b>, <b>14</b>, and <b>15</b> bearing the cyclopentyl substituent at R<sup>1</sup> and R<sup>2</sup> of the triazine moiety had produced stronger DHFR inhibition than their corresponding compounds (<b>2</b>, <b>6</b>, <b>10</b>) bearing the dimethyl substituent. No consistent trend in correlation was observed between DHFR inhibitory activity and the position of attachment of the linker to the chalcone moiety.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities of Compounds on Recombinant Human DHFR and Rat Liver TrxR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">attachment to linker</th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">ring</th><th class="colsep0 rowsep0" align="center">position</th><th class="colsep0 rowsep0" align="center">DHFR IC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center">TrxR IC<sub>50</sub> (30Â min) (Î¼M)</th><th class="colsep0 rowsep0" align="center">TrxR IC<sub>50</sub> (60Â min) (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.0141Â Â±Â 0.0022</td><td class="colsep0 rowsep0" align="left">43.3Â Â±Â 10.9</td><td class="colsep0 rowsep0" align="left">20.4Â Â±Â 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0356Â Â±Â 0.0026</td><td class="colsep0 rowsep0" align="left">10.8Â Â±Â 2.7</td><td class="colsep0 rowsep0" align="left">6.9Â Â±Â 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.0534Â Â±Â 0.0014</td><td class="colsep0 rowsep0" align="left">29.8Â Â±Â 5.0</td><td class="colsep0 rowsep0" align="left">21.1Â Â±Â 8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0592Â Â±Â 0.0141</td><td class="colsep0 rowsep0" align="left">5.7Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="left">4.0Â Â±Â 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.0092Â Â±Â 0.0010</td><td class="colsep0 rowsep0" align="left">49.0Â Â±Â 15.0</td><td class="colsep0 rowsep0" align="left">32.4Â Â±Â 7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0090Â Â±Â 0.0012</td><td class="colsep0 rowsep0" align="left">10.8Â Â±Â 2.2</td><td class="colsep0 rowsep0" align="left">8.2Â Â±Â 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.0064Â Â±Â 0.0003</td><td class="colsep0 rowsep0" align="left">35.9Â Â±Â 5.4</td><td class="colsep0 rowsep0" align="left">25.7Â Â±Â 4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0032Â Â±Â 0.0003</td><td class="colsep0 rowsep0" align="left">4.1Â Â±Â 1.5</td><td class="colsep0 rowsep0" align="left">2.8Â Â±Â 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.0034Â Â±Â 0.0004</td><td class="colsep0 rowsep0" align="left">44.5Â Â±Â 9.1</td><td class="colsep0 rowsep0" align="left">27.0Â Â±Â 4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0042Â Â±Â 0.0002</td><td class="colsep0 rowsep0" align="left">11.2Â Â±Â 1.3</td><td class="colsep0 rowsep0" align="left">6.7Â Â±Â 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.0040Â Â±Â 0.0005</td><td class="colsep0 rowsep0" align="left">31.6Â Â±Â 10.1</td><td class="colsep0 rowsep0" align="left">21.1Â Â±Â 7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0048Â Â±Â 0.0012</td><td class="colsep0 rowsep0" align="left">6.0Â Â±Â 1.2</td><td class="colsep0 rowsep0" align="left">3.8Â Â±Â 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" colspan="2" align="left">-(CH<sub>2</sub>)<sub>4</sub>-</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0131Â Â±Â 0.0023</td><td class="colsep0 rowsep0" align="left">8.0Â Â±Â 1.6</td><td class="colsep0 rowsep0" align="left">4.6Â Â±Â 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" colspan="2" align="left">-(CH<sub>2</sub>)<sub>4</sub>-</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0061Â Â±Â 0.0021</td><td class="colsep0 rowsep0" align="left">7.5Â Â±Â 0.9</td><td class="colsep0 rowsep0" align="left">4.6Â Â±Â 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" colspan="2" align="left">-(CH<sub>2</sub>)<sub>4</sub>-</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.0026Â Â±Â 0.0008</td><td class="colsep0 rowsep0" align="left">9.2Â Â±Â 1.2</td><td class="colsep0 rowsep0" align="left">5.9Â Â±Â 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.0053Â Â±Â 0.0012</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.0199Â Â±Â 0.0061</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.0039Â Â±Â 0.0008</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">46.4Â Â±Â 9.9</td><td class="colsep0 rowsep0" align="left">26.7Â Â±Â 4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MTX</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.0079Â Â±Â 0.0002</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data reported are mean values taken from three independent experiments and standard deviation. ND: not detected.</p></div></div></div><div class="NLM_p">The compounds were also evaluated for in vitro inhibitory activity against the rat TrxR by incubating with the enzyme for 30 and 60 min separately, and the IC<sub>50</sub> values obtained are presented in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> as well. Compounds <b>1</b>â<b>15</b> exhibited in vitro TrxR inhibition in the micromolar range of concentrations for both time points. The compounds were either as potent as or more potent than the unsubstituted chalcone <b>18</b>. The experiment design also confirmed that the presence of the Î±,Î²-unsaturated carbonyl moiety was crucial for TrxR inhibitory activity, as demonstrated by the lack of activity in <b>6h</b> which did not contain the enone moiety (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). As expected, the 4,6-diamino-1,2-dihydro-1,3,5-triazines <b>16</b> and <b>17</b> did not inhibit TrxR. These observations are essential to demonstrate that the dual enzymatic inhibitory action is primarily due to the presence of the two pharmacophores in the single molecule.</div><div class="NLM_p last">The position of attachment of the linker to the chalcone moiety was observed to be a crucial factor influencing TrxR inhibitory activity. It was observed that the TrxR inhibitory efficacy followed a decreasing trend with the following analogs: attachment of linker to 3-position of ring B > 3-position of ring A > 4-position of ring B > 4-position of ring A. A possible explanation for this observation could be the electronic effect of the alkoxy linker. Attachment of the alkoxy linker to the meta-position of the phenyl ring gave rise to an inductive electron-withdrawing effect, while attachment to the para-position produced a mesomeric electron donating effect. The inductive electron-withdrawing effect of the alkoxy linker at the meta-position intensified the Î´+ charge on the Î²-carbon atom of the Î±,Î²-unsaturated carbonyl moiety, thereby potentially increasing its propensity to react with nucleophiles such as the Sec residue in the C-terminal active site of the TrxR enzyme. Since ring B of the chalcone is closer to the Î²-carbon atom, this electron-withdrawing effect is stronger when the alkoxy linker is attached to the 3-position of ring B than to ring A, hence giving rise to analogs possessing stronger TrxR inhibitory activity. Notably, the length of the diether linker and the alkyl substituent at R<sup>1</sup> and R<sup>2</sup> did not affect TrxR inhibitory activity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Evaluation of Antiproliferative Activity against Human-Derived Cancer Cell Lines</h3><div class="NLM_p">Since the results from the in vitro enzyme activity assays provided strong evidence that compounds <b>1</b>â<b>15</b> were inhibitors of both DHFR and TrxR, the compounds were then evaluated for antiproliferative activity against the human HCT116 colorectal and MCF-7 breast cancer cell lines. These two cell lines are known to be sensitive to MTX with IC<sub>50</sub> values in the nanomolar range.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In addition, chalcones have previously been shown to inhibit TrxR in these two cell lines, resulting in cell death.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The GI<sub>50</sub> values (concentration of drug at which 50% of growth inhibition was achieved) and LC<sub>50</sub> values (concentration at which 50% of cells were killed) of the compounds, as determined from 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability assays, are shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferative Activity of Compounds against HCT116 and MCF-7 Cells<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center">antiproliferative activity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">attachment to linker</th><th class="rowsep1 colsep0" colspan="2" align="center">HCT116 cells</th><th class="rowsep1 colsep0" colspan="2" align="center">MCF-7 cells</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">ring</th><th class="colsep0 rowsep0" align="center">position</th><th class="colsep0 rowsep0" align="center">GI<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center">LC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center">GI<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center">LC<sub>50</sub> (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.572Â Â±Â 0.144</td><td class="colsep0 rowsep0" align="left">50.1Â Â±Â 2.5</td><td class="colsep0 rowsep0" align="left">0.584Â Â±Â 0.141</td><td class="colsep0 rowsep0" align="left">40.1Â Â±Â 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.170Â Â±Â 0.036</td><td class="colsep0 rowsep0" align="left">49.9Â Â±Â 5.6</td><td class="colsep0 rowsep0" align="left">0.719Â Â±Â 0.063</td><td class="colsep0 rowsep0" align="left">40.7Â Â±Â 7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.706Â Â±Â 0.142</td><td class="colsep0 rowsep0" align="left">81.9Â Â±Â 10.1</td><td class="colsep0 rowsep0" align="left">0.512Â Â±Â 0.101</td><td class="colsep0 rowsep0" align="left">47.7Â Â±Â 8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.145Â Â±Â 0.036</td><td class="colsep0 rowsep0" align="left">52.2Â Â±Â 2.2</td><td class="colsep0 rowsep0" align="left">0.623Â Â±Â 0.138</td><td class="colsep0 rowsep0" align="left">38.8Â Â±Â 8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.016Â Â±Â 0.004</td><td class="colsep0 rowsep0" align="left">55.2Â Â±Â 3.5</td><td class="colsep0 rowsep0" align="left">0.085Â Â±Â 0.020</td><td class="colsep0 rowsep0" align="left">34.0Â Â±Â 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.011Â Â±Â 0.004</td><td class="colsep0 rowsep0" align="left">42.7Â Â±Â 3.2</td><td class="colsep0 rowsep0" align="left">0.076Â Â±Â 0.029</td><td class="colsep0 rowsep0" align="left">20.2Â Â±Â 4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.035Â Â±Â 0.010</td><td class="colsep0 rowsep0" align="left">39.0Â Â±Â 3.1</td><td class="colsep0 rowsep0" align="left">0.062Â Â±Â 0.013</td><td class="colsep0 rowsep0" align="left">35.3Â Â±Â 4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.011Â Â±Â 0.001</td><td class="colsep0 rowsep0" align="left">48.2Â Â±Â 18.4</td><td class="colsep0 rowsep0" align="left">0.013Â Â±Â 0.004</td><td class="colsep0 rowsep0" align="left">29.8Â Â±Â 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.039Â Â±Â 0.009</td><td class="colsep0 rowsep0" align="left">24.0Â Â±Â 4.9</td><td class="colsep0 rowsep0" align="left">0.087Â Â±Â 0.013</td><td class="colsep0 rowsep0" align="left">14.2Â Â±Â 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.051Â Â±Â 0.008</td><td class="colsep0 rowsep0" align="left">30.3Â Â±Â 6.0</td><td class="colsep0 rowsep0" align="left">0.122Â Â±Â 0.009</td><td class="colsep0 rowsep0" align="left">11.3Â Â±Â 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.026Â Â±Â 0.008</td><td class="colsep0 rowsep0" align="left">42.9Â Â±Â 3.7</td><td class="colsep0 rowsep0" align="left">0.141Â Â±Â 0.033</td><td class="colsep0 rowsep0" align="left">14.8Â Â±Â 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.034Â Â±Â 0.011</td><td class="colsep0 rowsep0" align="left">34.7Â Â±Â 5.8</td><td class="colsep0 rowsep0" align="left">0.086Â Â±Â 0.016</td><td class="colsep0 rowsep0" align="left">15.5Â Â±Â 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" colspan="2" align="left">-(CH<sub>2</sub>)<sub>4</sub>-</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.260Â Â±Â 0.069</td><td class="colsep0 rowsep0" align="left">24.1Â Â±Â 2.1</td><td class="colsep0 rowsep0" align="left">0.770Â Â±Â 0.156</td><td class="colsep0 rowsep0" align="left">16.1Â Â±Â 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" colspan="2" align="left">-(CH<sub>2</sub>)<sub>4</sub>-</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.026Â Â±Â 0.007</td><td class="colsep0 rowsep0" align="left">14.1Â Â±Â 1.0</td><td class="colsep0 rowsep0" align="left">0.080Â Â±Â 0.025</td><td class="colsep0 rowsep0" align="left">11.2Â Â±Â 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" colspan="2" align="left">-(CH<sub>2</sub>)<sub>4</sub>-</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.116Â Â±Â 0.014</td><td class="colsep0 rowsep0" align="left">13.5Â Â±Â 0.9</td><td class="colsep0 rowsep0" align="left">0.127Â Â±Â 0.010</td><td class="colsep0 rowsep0" align="left">9.7Â Â±Â 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.036Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.107Â Â±Â 0.006</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.021Â Â±Â 0.007</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.077Â Â±Â 0.025</td><td class="colsep0 rowsep0" align="left">90.8Â Â±Â 18.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.010Â Â±Â 0.001</td><td class="colsep0 rowsep0" align="left">34.2Â Â±Â 3.5</td><td class="colsep0 rowsep0" align="left">0.036Â Â±Â 0.006</td><td class="colsep0 rowsep0" align="left">25.9Â Â±Â 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">15.7Â Â±Â 2.2</td><td class="colsep0 rowsep0" align="left">22.5Â Â±Â 1.5</td><td class="colsep0 rowsep0" align="left">12.4Â Â±Â 2.0</td><td class="colsep0 rowsep0" align="left">30.7Â Â±Â 5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MTX</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.015Â Â±Â 0.001</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.024Â Â±Â 0.007</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data reported are mean values taken from three independent experiments with their respective standard deviation.</p></div></div></div><div class="NLM_p"><b>1</b>â<b>15</b> exhibited a biphasic doseâresponse curve (doseâresponse curves of <b>14</b> and <b>15</b> for MCF-7 and HCT116 cells are presented in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A and <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B respectively), causing growth inhibition of cancer cells at low concentrations with GI<sub>50</sub> values ranging from 0.011 to 2.18 Î¼M and causing cell kill at higher concentrations with LC<sub>50</sub> values ranging from 9.7 to 81.9 Î¼M. In general, the growth inhibitory effects of the target compounds were affected by the length of the diether linker. Compounds with a linker length of three carbon atoms possessed the strongest growth inhibitory activities (based on GI<sub>50</sub> values shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Upon comparison with their in vitro DHFR inhibitory activities, the increase in growth inhibitory effect when linker length was increased from two to three carbon atoms was consistent with a gain in DHFR inhibitory efficacies. However, when linker length was further increased from three to four carbon atoms, a mild decrease in growth inhibitory effects was observed despite a marginal gain in in vitro DHFR inhibitory activity. This marginal reduction in growth inhibitory activity could be due to a slight decrease in permeability of the compounds into the cells as the molecular weight increased, approaching 500 g/mol.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative doseâresponse curves of <b>14</b>, <b>15</b>, <b>17</b>, and <b>18</b> against (A) MCF-7 cells and (B) HCT116 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Replacement of the dimethyl substituent at R<sup>1</sup> and R<sup>2</sup> with the cyclopentyl substituent resulted in no difference in growth inhibitory activity against MCF-7 cells but weaker growth inhibitory activity against HCT116 cells. The drop in growth inhibitory effects of the compounds with cyclopentyl substituent (<b>13</b>, <b>14</b>, and <b>15</b>) could be due to decreased permeability of the compounds into the cells as their molecular weight increased, approaching 500 g/mol. Cell kill was observed to improve with increasing lipophilicity of the compounds, as evident from the decrease in LC<sub>50</sub> values of the test compounds as linker length increased from two to four carbon atoms. Replacement of the dimethyl substituent at R<sup>1</sup> and R<sup>2</sup> with the bulkier cyclopentyl substituent also resulted in decreased LC<sub>50</sub> values. As discussed earlier, the in vitro TrxR IC<sub>50</sub> values of <b>1</b>â<b>15</b> were observed to be in the micromolar range of concentrations, which coincided with their micromolar LC<sub>50</sub> values obtained from the MTT viability assay. Hence, it was deduced that TrxR inhibition contributed to cell kill. However, the trend in LC<sub>50</sub> values did not correspond well with the trend of in vitro TrxR inhibitory activity. Furthermore, compound <b>6h</b> that lacks the Î±,Î²-unsaturated carbonyl moiety essential for TrxR inhibitory activity also displayed cytotoxicity that was comparable to that of <b>6</b>, suggesting that besides TrxR inhibition, the cytotoxic activities of the compounds could be attributed to additional mechanisms. This finding was unexpected, since we had found that 1,3-diphenylpropan-2-one, a compound similar to chalcone <b>18</b> but lacking the Î±,Î²-unsaturation at the carbonyl moiety, did not display cytotoxic activity and in vitro TrxR inhibitory activity (results not shown). The key structureâactivity relationships for the antiproliferative activity of compounds <b>1</b>â<b>15</b> are summarized in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Key structureâactivity relationships of <b>1</b>â<b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Evaluation of Selected Compounds on DHFR Activity in Cells</h3><div class="NLM_p"><b>14</b> and <b>15</b> were selected as lead compounds for evaluation of their inhibitory effects on cellular DHFR and TrxR activities based on the fact they possessed the greatest cytotoxic effects and exhibited strong in vitro DHFR and TrxR inhibitory activities. Together, <b>6</b> and <b>10</b>, which are structurally similar to <b>14</b> and <b>15</b>, respectively (bearing the dimethyl substituent at R<sup>1</sup> and R<sup>2</sup> instead of the cyclopentyl substituent in <b>14</b> and <b>15</b>), 4,6-diamino-1,2-dihydro-1,3,5-triazines <b>16</b> and <b>17</b>, as well as the chalcone compound <b>18</b>, were also selected for biological evaluation for cellular DHFR and TrxR inhibitory activities.</div><div class="NLM_p">The cell-based DHFR assay was modified from an in-house protocol developed by Sigma-Aldrich Co. for assessing in vitro activity of DHFR enzyme.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> At growth inhibitory concentrations of 1 nM to 1 Î¼M, <b>6</b>, <b>10</b>, <b>14</b>, and <b>15</b> caused a dose-dependent decrease in DHFR activity in HCT116 cells (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). <b>6</b> brought about the strongest decline in cellular DHFR activity, followed by <b>14</b>, <b>10</b>, and last, <b>15</b>. This trend of cellular DHFR inhibition in HCT116 cells corresponded well with the trend in GI<sub>50</sub> values of the compounds against MCF-7 and HCT116 cells, where the recorded GI<sub>50</sub> values were also in the order of <b>6</b> < <b>14</b> < <b>10</b> < <b>15</b>. Hence, it was concluded that the growth inhibitory activities of the compounds were attributed to their DHFR inhibitory activities. As expected, the 4,6-diamino-1,2-dihydro-1,3,5-triazines <b>16</b> and <b>17</b> also effected a dose-dependent decrease in cellular DHFR activity whereas the chalcone compound <b>18</b> did not inhibit cellular DHFR (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of selected dihydrotriazineâchalcone compounds on DHFR activity in HCT116 cells. DHFR activity in lysates of HCT116 cells treated with <b>6</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b> at (A) concentrations of 0.001â1 Î¼M and (B) 40â70 Î¼M for 16 h was determined and expressed as a percentage of DHFR activity in DMSO-treated cells. Each point represents the average value from three independent experiments. (C) The lysates mentioned in (B) were analyzed by Western blotting for detection of levels of DHFR. Western blot images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">At cytotoxic concentrations of 40â70 Î¼M, the activity of cellular DHFR in HCT116 cells was completely inhibited by <b>6</b>, <b>10</b>, <b>14</b>, and <b>15</b>, as well as the 4,6-diamino-1,2-dihydro-1,3,5-triazines <b>16</b> and <b>17</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). Western blot analyses revealed that protein levels of DHFR were higher in cells treated with <b>14</b> and <b>15</b> than those observed in DMSO-treated cells (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C), indicating that the drop in cellular DHFR activity was mediated by <b>14</b> and <b>15</b> inhibiting DHFR and not due to a downregulation of DHFR protein levels. The upregulation of DHFR levels might be a cellular prosurvival mechanism triggered in response to the cell death inducing effects of high doses of <b>14</b> and <b>15</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Evaluation of Selected Compounds on TrxR Activity in Cells</h3><div class="NLM_p">At growth inhibitory concentrations of 1 nM to 1 Î¼M, all four of the linked dihydrotriazineâchalcone compounds failed to cause significant TrxR inhibition in HCT116 cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). The results were in agreement with the in vitro TrxR IC<sub>50</sub> values being greater than 1 Î¼M for all compounds tested against rat liver TrxR. On the other hand, at cytotoxic concentrations of 40â70 Î¼M, <b>6</b>, <b>10</b>, <b>14</b>, and <b>15</b> brought about a dose-dependent decrease in cellular TrxR activity. <b>15</b> possessed the greatest cellular TrxR inhibitory activity, followed by <b>14</b>, <b>10</b>, and last, <b>6</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). This trend of cellular TrxR inhibition corresponded well with the trend in LC<sub>50</sub> values of the compounds against MCF-7 and HCT116 cells, where the recorded LC<sub>50</sub> values were also in the order of <b>15</b> < <b>14</b> < <b>10</b> < <b>6</b>. The results had therefore indicated that inhibition of cellular TrxR could have at least played a role in causing cell death. Of note, chalcone-containing <b>10</b>, <b>14</b>, and <b>15</b> produced stronger cellular TrxR inhibition than the parent chalcone compound <b>18</b>, while the 4,6-diamino-1,2-dihydro-1,3,5-triazines <b>16</b> and <b>17</b> expectedly did not inhibit cellular TrxR activity even at high concentrations.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of selected dihydrotriazineâchalcone compounds on TrxR activity in HCT116 cells. TrxR activity in lysates of HCT116 cells treated with <b>6</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b> at (A) concentrations of 0.001â1 Î¼M and (B) 40â70 Î¼M for 16 h was determined and expressed as a percentage of TrxR activity in DMSO-treated cells. Each point represents the average value from three independent experiments. (C) The lysates mentioned in (B) were analyzed by Western blotting for detection of levels of TrxR. Western blot images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">When the aforementioned lysates of HCT116 cells treated with lead compounds <b>14</b> and <b>15</b> were analyzed by Western blotting, protein levels of TrxR were observed to be comparable to the levels expressed in DMSO control cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). This demonstrated that the observed dose-dependent decrease in cellular TrxR activity was due to inhibition of the enzyme and not due to downregulation of the enzymeâs protein levels.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The previous attempt to design dihydrotriazineâchalcone compounds by merging the DHFR-inhibiting 4,6-diamino-1,2-dihydro-1,3,5-triazine and TrxR-inhibiting chalcone scaffolds had yielded single molecules that failed to possess potent cytotoxicity,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> suggesting a suboptimal structural design in hybridizing the two pharmacophores into a single chemical entity. In this study, stemming from the hypothesis that a flexible linker would enable better interaction of the scaffolds with the targets, 15 compounds having a diether linker between the two scaffolds were synthesized and evaluated for their antiproliferative and enzyme inhibitory activities. Among the compounds, <b>14</b> and <b>15</b> were identified to possess the greatest cytotoxic activities against HCT116 and MCF-7 cancer cell lines that were correlated to strong in vitro inhibitory activities against recombinant human DHFR and rat TrxR enzymes. In addition, cellular DHFR and TrxR activities in lysates of HCT116 cells treated with growth inhibitory and cytotoxic doses of <b>14</b> and <b>15</b> respectively were significantly reduced. Considering the consistent results obtained from the cell-free and cell-based assays, it is therefore proposed that the strategy of combining the dihydrotriazine and chalcone chemical scaffolds via diether linker has generated novel single molecules that exert antiproliferative effects on cancer cells at least partly through targeting DHFR and TrxR.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p last">All reagents were purchased from Sigma-Aldrich, Tokyo Chemical Industry, Alfa Aesar, or Merck and were used directly without any purification. Thin layer chromatography (TLC) was performed using silica gel coated aluminum plates with fluorescent indicator and visualized with ultraviolet light at 254 nm. Melting points were determined using a Gallenkamp melting point apparatus and were uncorrected. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker Ultrashield 400 Plus NMR spectrometer. Chemical shift values (Î´) were expressed as parts per million (ppm) relative to tetramethylsilane as the internal standard. Electrospray ionization mass spectrometry (ESI-MS) was recorded on an AB SCIEX API 2000 Q Trap mass spectrometer. High performance liquid chromatography (HPLC) was performed for purity checking using Agilent 1100 series HPLC on a Lichrosorb 10 RP-18 250 mm Ã 4.0 mm, 10 Î¼m column with gradient elution (gradient of 50% acetonitrile and 0.1% TFA to 100% acetonitrile over 20 min, followed by maintenance of 100% acetonitrile for 5 min). All the final compounds were found to be pure up to 95% or higher.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedure for the Synthesis of <b>1</b>â<b>12</b></h3><div class="NLM_p last">4,6-Diamino-1-hydro-1,2-dihydro-1,3,5-triazine hydrochloride and NaOH (1 mol equiv) were dissolved in methanol (8 to 20 mL) and refluxed for 30 min. After the mixture was cooled to room temperature, methanol was removed under vacuum. The remaining white solid was dissolved in <i>N</i>,<i>N</i>-dimethylformamide (2â5 mL), and bromoalkoxy-substituted chalcone (1 mol equiv) was added. The reaction mixture was stirred overnight at room temperature. After completion of the reaction, the pH of the solution was adjusted to pH 1 using concentrated HCl. Water (approximately 50 mL) was added to the mixture. If the product precipitated out as a solid, the solid was collected by filtration and washed with water and ethyl acetate or dichloromethane. If a sticky substance was formed, the substance was washed with ethyl acetate to remove excess unreacted bromoalkoxy-substituted chalcone. If the product dissolved in water, brine was added to the solution and the product was extracted with ethyl acetate. The ethyl acetate solution was refrigerated to allow precipitation of the desired product. The collected products were then purified by recrystallization with ethanol/dilute HCl.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (2<i>E</i>)-1-{4-[2-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)ethoxy]phenyl}-3-phenylprop-2-en-1-one Hydrochloride (<b>1</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.58 g, 3 mmol) and (2<i>E</i>)-1-[4-(2-bromoethoxy)phenyl]-3-phenylprop-2-en-1-one (0.99 g, 3 mmol), <b>1</b> was obtained as a yellow solid, 0.32 g, yield 23.9%. Mp: 188â190 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.07 (s, 1H, NH), 8.70 (s, 1H, NH), 8.18 (d, 2H, <i>J</i> = 9.2 Hz), 8.09 (s, 1H, NH), 7.92â7.71 (m, 4H), 7.79 (br s, 1H, NH), 7.50â7.49 (m, 3H), 7.16 (d, 2H, <i>J</i> = 8.8 Hz), 7.12 (br s, 1H, NH), 4.42 (br s, 2H), 4.36â4.35 (m, 2H), 1.58 (br s, 3H), 1.35 (br s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 187.3, 162.0, 161.3, 156.2, 143.2, 134.7, 130.9, 130.7, 130.4, 128.8, 128.7, 121.9, 114.5, 75.9, 72.3, 65.4. Purity: 97.9%, HPLC <i>t</i><sub>R</sub> = 5.24 min. ESI-MS <i>m</i>/<i>z</i> 408.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (2<i>E</i>)-1-{3-[2-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)ethoxy]phenyl}-3-phenylprop-2-en-1-one Hydrochloride (<b>2</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.39 g, 2 mmol) and (2<i>E</i>)-1-[3-(2-bromoethoxy)phenyl]-3-phenylprop-2-en-1-one (0.66 g, 2 mmol), <b>2</b> was obtained as a pale yellow solid, 0.13 g, yield 14.3%. Mp: 132â134 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.02 (s, 1H, NH), 8.71 (s, 1H, NH), 8.06 (s, 1H, NH), 7.90â7.86 (m, 3H), 7.82â7.74 (m, 2H), 7.63â7.62 (m, 1H), 7.56 (t, 1H, <i>J</i> = 7.8 Hz), 7.51â7.49 (m, 3H), 7.31â7.29 (m, 1H), 7.08 (br s, 1H, NH), 4.40 (br s, 2H), 4.35â4.34 (m, 2H), 1.58 (br s, 3H), 1.34 (br s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 188.8, 161.3, 158.4, 156.2, 144.1, 139.0, 134.5, 130.6, 130.0, 128.9, 128.8, 122.0, 121.5, 119.8, 113.5, 76.1, 72.3, 65.4. Purity: 96.7%, HPLC <i>t</i><sub>R</sub> = 5.61 min. ESI-MS <i>m</i>/<i>z</i> 408.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (2<i>E</i>)-3-{4-[2-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)ethoxy]phenyl}-1-phenylprop-2-en-1-one Hydrochloride (<b>3</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.58 g, 3 mmol) and (2<i>E</i>)-3-[4-(2-bromoethoxy)phenyl]-1-phenylprop-2-en-1-one (0.99 g, 3 mmol), <b>3</b> was obtained as a yellow solid, 0.47 g, yield 35.5%. Mp: 141â143 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.03 (s, 1H, NH), 8.70 (s, 1H, NH), 8.14â8.12 (m, 2H), 8.07 (s, 1H, NH), 7.87 (d, 2H, <i>J</i> = 8.8 Hz), 7.82â7.66 (m, 3H), 7.75 (br s, 1H, NH), 7.59 (t, 2H, <i>J</i> = 7.4 Hz), 7.10 (br s, 1H, NH), 7.07 (d, 2H, <i>J</i> = 8.8 Hz), 4.37 (br s, 2H), 4.32 (br s, 2H), 1.56 (br s, 3H), 1.35 (br s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 189.0, 161.3, 160.1, 156.2, 143.8, 137.7, 132.9, 130.8, 128.7, 128.3, 127.6, 119.8, 114.9, 75.9, 72.3, 65.3. Purity: 98.5%, HPLC <i>t</i><sub>R</sub> = 5.21 min. ESI-MS <i>m</i>/<i>z</i> 408.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (2<i>E</i>)-3-{3-[2-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)ethoxy]phenyl}-1-phenylprop-2-en-1-one Hydrochloride (<b>4</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.39g, 2 mmol) and (2<i>E</i>)-3-[3-(2-bromoethoxy)phenyl]-1-phenylprop-2-en-1-one (0.66 g, 2 mmol), <b>4</b> was obtained as a yellow solid, 0.45 g, yield 50.4%. Mp: 139â141 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.20 (s, 1H, NH), 8.73 (s, 1H, NH), 8.15â8.13 (m, 2H), 8.06 (s, 1H, NH), 7.90 (d, 1H, <i>J</i> = 15.6 Hz), 7.78 (br s, 1H, NH), 7.75â7.70 (m, 2H), 7.64â7.60 (m, 2H), 7.50â7.42 (m, 3H), 7.18 (br s, 1H, NH), 7.10 (dd, 1H, <i>J</i> = 8.0, 1.6), 4.39 (br s, 2H), 4.31 (br s, 2H), 1.59 (br s, 3H), 1.35 (br s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 189.2, 161.4, 158.4, 156.2, 143.8, 137.4, 136.1, 133.1, 130.0, 128.7, 128.5, 122.4, 122.1, 117.2, 113.9, 76.1, 72.3, 65.2. Purity: 98.0%, HPLC <i>t</i><sub>R</sub> = 5.64 min. ESI-MS <i>m</i>/<i>z</i> 408.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (2<i>E</i>)-1-{4-[3-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)propoxy]phenyl}-3-phenylprop-2-en-1-one Hydrochloride (<b>5</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.97 g, 5 mmol) and (2<i>E</i>)-1-[4-(3-bromopropoxy)phenyl]-3-phenylprop-2-en-1-one (1.73 g, 5 mmol), <b>5</b> was obtained as a yellow solid, 0.68 g, yield 29.8%. Mp: 196â198 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.95 (s, 1H, NH), 8.63 (s, 1H, NH), 8.17 (d, 2H, <i>J</i> = 8.8 Hz), 8.10 (s, 1H, NH), 7.91 (d, 1H, <i>J</i> = 15.6 Hz), 7.87â7.85 (m, 2H), 7.78 (br s, 1H, NH), 7.72 (d, 1H, <i>J</i> = 15.6 Hz), 7.50â7.48 (m, 3H), 7.13 (d, 2H, <i>J</i> = 8.8 Hz), 7.06 (br s, 1H, NH), 4.23 (t, 2H, <i>J</i> = 6.0 Hz), 4.13 (t, 2H, <i>J</i> = 5.8 Hz), 2.21 (br s, 2H), 1.42 (br s, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 187.3, 162.2, 161.1, 156.1, 143.1, 134.7, 130.9, 130.5, 130.3, 128.8, 128.7, 122.0, 114.4, 74.2, 72.2, 64.5, 26.9. Purity: 98.5%, HPLC <i>t</i><sub>R</sub> = 5.71 min. ESI-MS <i>m</i>/<i>z</i> 422.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (2<i>E</i>)-1-{3-[3-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)propoxy]phenyl}-3-phenylprop-2-en-1-one Hydrochloride (<b>6</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.58 g, 3 mmol) and (2<i>E</i>)-1-[3-(3-bromopropoxy)phenyl]-3-phenylprop-2-en-1-one (0.99 g, 3 mmol), <b>6</b> was obtained as a yellow solid, 0.31 g, yield 22.9%. Mp: 164â166 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.89 (s, 1H, NH), 8.62 (s, 1H, NH), 8.09 (s, 1H, NH), 7.89â7.85 (m, 3H), 7.79â7.73 (m, 2H), 7.68 (br s, 1H, NH), 7.60â7.50 (m, 5H), 7.29 (dd, 1H, <i>J</i> = 8.2, 2.2 Hz), 7.04 (br s, 1H, NH), 4.21 (t, 2H, <i>J</i> = 5.8 Hz), 4.15 (t, 2H, <i>J</i> = 5.8 Hz), 2.21 (br s, 2H), 1.43 (br s, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 188.8, 161.2, 158.6, 156.0, 144.1, 139.0, 134.5, 130.6, 130.0, 128.9, 128.8, 122.0, 121.2, 119.6, 113.5, 74.3, 72.3, 64.4, 27.0. Purity: 99.7%, HPLC <i>t</i><sub>R</sub> = 6.13 min. ESI-MS <i>m</i>/<i>z</i> 422.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (2<i>E</i>)-3-{4-[3-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)propoxy]phenyl}-1-phenylprop-2-en-1-one Hydrochloride (<b>7</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.77 g, 4 mmol) and (2<i>E</i>)-3-[4-(3-bromopropoxy)phenyl]-1-phenylprop-2-en-1-one (1.38 g, 4 mmol), <b>7</b> was obtained as a yellow solid, 0.92 g, yield 50.0%. Mp: 193â195 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.11 (s, 1H, NH), 8.63 (s, 1H, NH), 8.12â8.10 (m, 2H), 8.09 (s, 1H, NH), 7.84 (d, 2H, <i>J</i> = 8.8 Hz), 7.79â7.68 (m, 3H), 7.70 (br s, 1H, NH), 7.60 (t, 2H, 7.4 Hz), 7.14 (br s, 1H, NH), 7.06 (d, 2H, <i>J</i> = 8.8 Hz), 4.18 (t, 2H, <i>J</i> = 6.0 Hz), 4.13 (t, 2H, <i>J</i> = 5.8 Hz), 2.19 (br s, 2H), 1.43 (br s, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 189.0, 161.1, 160.4, 156.2, 143.9, 137.7, 132.8, 130.8, 128.6, 128.3, 127.4, 119.6, 114.8, 74.2, 72.1, 64.3, 26.9. Purity: 99.6%, HPLC <i>t</i><sub>R</sub> = 5.58 min. ESI-MS <i>m</i>/<i>z</i> 422.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (2<i>E</i>)-3-{3-[3-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)propoxy]phenyl}-1-phenylprop-2-en-1-one Hydrochloride (<b>8</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.39 g, 2 mmol) and (2<i>E</i>)-3-[3-(3-bromopropoxy)phenyl]-1-phenylprop-2-en-1-one (0.69 g, 2 mmol), <b>8</b> was obtained as yellow crystals, 0.095 g, yield 10.4%. Mp: 132 Â°C (decomposed). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.94 (s, 1H, NH), 8.63 (s, 1H, NH), 8.17â8.15 (m, 2H), 8.08 (s, 1H, NH), 7.95 (d, 1H, <i>J</i> = 15.6 Hz), 7.74â7.67 (m, 2H), 7.67 (br s, 1H, NH), 7.59 (t, 2H, <i>J</i> = 7.4 Hz), 7.50â7.46 (m, 2H), 7.39 (t, 1H, <i>J</i> = 7.8 Hz), 7.05 (dd, 1H, <i>J</i> = 8.0, 1.6 Hz), 7.04 (br s, 1H, NH), 4.18 (t, 2H, <i>J</i> = 6.2 Hz), 4.11 (t, 2H, <i>J</i> = 6.0 Hz), 2.19 (br s, 2H), 1.42 (br s, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 189.2, 161.2, 158.6, 156.1, 143.9, 137.4, 136.0, 133.1, 129.9, 128.7, 128.5, 122.3, 121.7, 117.1, 114.0, 74.3, 72.2, 64.2, 27.0. Purity: 99.9%, HPLC <i>t</i><sub>R</sub> = 5.77 min. ESI-MS <i>m</i>/<i>z</i> 422.3 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (2<i>E</i>)-1-{4-[4-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)butoxy]phenyl}-3-phenylprop-2-en-1-one Hydrochloride (<b>9</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.77 g, 4 mmol) and (2<i>E</i>)-1-[4-(4-bromobutoxy)phenyl]-3-phenylprop-2-en-1-one (1.44 g, 4 mmol), <b>9</b> was obtained as a pale yellow solid, 0.31 g, yield 16.5%. Mp: 196â198 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.00 (s, 1H, NH), 8.58 (s, 1H, NH), 8.17 (d, 2H, <i>J</i> = 9.2 Hz), 8.02 (s, 1H, NH), 7.95 (d, 1H, <i>J</i> = 15.6 Hz), 7.89â7.87 (m, 2H), 7.71 (d, 1H, <i>J</i> = 15.6 Hz), 7.76 (br s, 1H, NH), 7.47â7.45 (m, 3H), 7.10 (br s, 1H, NH), 7.09 (d, 2H, <i>J</i> = 8.8 Hz), 4.15â4.00 (m, 4H), 1.85 (br s, 4H), 1.44 (br s, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 187.3, 162.5, 161.1, 156.3, 143.0, 134.7, 130.9, 130.3, 130.3, 128.8, 128.7, 122.0, 114.4, 77.2, 72.1, 67.7, 24.9, 24.0. Purity: 99.7%, HPLC <i>t</i><sub>R</sub> = 6.25 min. ESI-MS <i>m</i>/<i>z</i> 436.5 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (2<i>E</i>)-1-{3-[4-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)butoxy]phenyl}-3-phenylprop-2-en-1-one Hydrochloride (<b>10</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.97 g, 5 mmol) and (<i>2E</i>)-1-[3-(4-bromobutoxy)phenyl]-3-phenylprop-2-en-1-one (1.80 g, 5 mmol), <b>10</b> was obtained as a white solid, 0.21 g, yield 8.7%. Mp: 192â194 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.00 (s, 1H, NH), 8.58 (s, 1H, NH), 8.02â7.46 (m, 10H), 7.67 (br s, 2H, NH), 7.25 (dd, 1H, <i>J</i> = 8.0, 2.0 Hz), 7.07 (br s, 1H, NH), 4.11â4.00 (m, 4H), 1.85 (br s, 4H), 1.44 (br s, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 188.9, 161.1, 158.8, 156.2, 144.0, 138.9, 134.5, 130.6, 129.9, 128.9, 128.8, 122.0, 121.0, 119.6, 113.5, 77.2, 72.1, 67.5, 25.0, 24.0. Purity: 99.1%, HPLC <i>t</i><sub>R</sub> = 6.62 min. ESI-MS <i>m</i>/<i>z</i> 436.4 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (2<i>E</i>)-3-{4-[4-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)butoxy]phenyl}-1-phenylprop-2-en-1-one Hydrochloride (<b>11</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.68 g, 3.5 mmol) and (2<i>E</i>)-3-[4-(4-bromobutoxy)phenyl]-1-phenylprop-2-en-1-one (1.26 g, 3.5 mmol), <b>11</b> was obtained as a yellow solid, 0.067 g, yield 4.1%. Mp: 194â196 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.07 (s, 1H, NH), 8.59 (s, 1H, NH), 8.15â8.13 (m, 2H), 8.03 (s, 1H, NH), 7.87â7.55 (m, 7H), 7.72 (br s, 1H, NH), 7.13 (br s, 1H, NH), 7.02 (d, 2H, <i>J</i> = 8.8 Hz), 4.08â3.99 (m, 4H), 1.84 (m, 4H), 1.44 (m, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 188.9, 161.2, 160.6, 156.1, 143.9, 137.7, 132.8, 130.7, 128.6, 128.3, 127.2, 119.4, 114.8, 77.2, 72.1, 67.5, 24.9, 24.0. Purity: 99.4%, HPLC <i>t</i><sub>R</sub> = 6.04 min. ESI-MS <i>m</i>/<i>z</i> 436.3 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (2<i>E</i>)-3-{3-[4-(4,6-Diamino-2,2-dimethyl-1,3,5-triazin-1(2<i>H</i>)-yloxy)butoxy]phenyl}-1-phenylprop-2-en-1-one Hydrochloride (<b>12</b>)</h3><div class="NLM_p last">From 4,6-diamino-1,2-dihydro-2,2-dimethyl[1,3,5]triazin-1-ol hydrochloride (0.77 g, 4 mmol) and (2<i>E</i>)-3-[3-(4-bromobutoxy)phenyl]-1-phenylprop-2-en-1-one (1.44 g, 4 mmol), <b>12</b> was obtained as a pale yellow solid, 0.18 g, yield 9.3%. Mp: 177â179 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.00 (s, 1H, NH), 8.59 (s, 1H, NH), 8.18â8.15 (m, 2H), 8.03 (s, 1H, NH), 7.95 (d, 1H, <i>J</i> = 15.6 Hz), 7.74â7.67 (m, 2H), 7,69 (br s, 1H, NH), 7.59 (t, 2H, <i>J</i> = 7.6 Hz), 7.49â7.44 (m, 2H), 7.37 (t, 1H, <i>J</i> = 8.0 Hz), 7.06 (br s, 1H, NH), 7.04 (dd, 1H, <i>J</i> = 8.2, 1.8 Hz), 4.10â4.00 (m, 4H), 1.84 (br s, 4H), 1.44 (br s, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 189.1, 161.2, 158.9, 156.2, 143.9, 137.4, 136.0, 133.1, 129.9, 128.7, 128.5, 122.3, 121.6, 117.0, 114.0, 77.2, 72.1, 67.4, 25.0, 24.0. Purity: 97.4%, HPLC <i>t</i><sub>R</sub> = 6.41 min. ESI-MS <i>m</i>/<i>z</i> 436.2 (M + 1)<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure for the Synthesis of <b>13</b>â<b>15</b></h3><div class="NLM_p last"><b>13</b>â<b>15</b> were synthesized using the same procedure as described in the general procedure for synthesis of <b>1</b>â<b>12</b> but with potassium carbonate (1 mol equiv) added to the reaction mixture (before stirring overnight) to increase the yield of product.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>E</i>)-1-(3-{2-[(7,9-Diamino-6,8,10-triazaspiro[4.5]deca-7,9-dien-6-yl)oxy]ethoxy}phenyl)-3-phenylprop-2-en-1-one Hydrochloride (<b>13</b>)</h3><div class="NLM_p last">From 7,9-diamino-6,8,10-triazaspiro[4.5]deca-7,9-dien-6-ol hydrochloride (0.44 g, 2 mmol) and (2<i>E</i>)-1-[3-(2-bromoethoxy)phenyl]-3-phenylprop-2-en-1-one (0.66 g, 2 mmol), <b>13</b> was obtained as an off-white solid, 0.36 g, yield 38.4%. Mp: 192â194 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.34 (s, 1H, NH), 8.73 (s, 1H, NH), 8.14 (s, 1H, NH), 7.94â7.74 (m, 5H), 7.65 (br s, 1H, NH), 7.63â7.47 (m, 5H), 7.26 (dd, 1H, <i>J</i> = 8.0, 2.0 Hz), 7.03 (br s, 1H, NH), 4.42 (br s, 2H), 4.32 (br s, 2H), 2.06 (br s, 2H), 1.76â1.66 (m, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 188.8, 162.1, 158.3, 156.6, 144.1, 139.0, 134.5, 130.6, 130.0, 128.9, 122.0, 121.4, 119.8, 113.4, 81.3, 76.2, 65.2, 33.3, 22.2. Purity: 96.4%, HPLC <i>t</i><sub>R</sub> = 6.45 min. ESI-MS <i>m</i>/<i>z</i> 434.5 (M + 1)<sup>+</sup>.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2<i>E</i>)-1-(3-{3-[(7,9-Diamino-6,8,10-triazaspiro[4.5]deca-7,9-dien-6-yl)oxy]propoxy}phenyl)-3-phenylprop-2-en-1-one Hydrochloride (<b>14</b>)</h3><div class="NLM_p last">From 7,9-diamino-6,8,10-triazaspiro[4.5]deca-7,9-dien-6-ol hydrochloride (0.66 g, 3 mmol) and (2<i>E</i>)-1-[3-(3-bromopropoxy)phenyl]-3-phenylprop-2-en-1-one (1.04 g, 3 mmol), <b>14</b> was obtained as an off-white solid, 0.35 g, yield 24.2%. Mp: 191â192 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.14 (s, 1H, NH), 8.65 (s, 1H, NH), 8.14, (s, 1H, NH), 7.95â7.89 (m, 3H), 7.80â7.73 (m, 2H), 7.63â7.62 (m, 1H), 7.75 (br s, 1H, NH), 7.53â7.47 (m, 4H), 7.27 (dd, 1H, <i>J</i> = 8.0, 2.2 Hz), 6.92 (br s, 1H, NH), 4.19 (t, 2H, <i>J</i> = 6.0 Hz), 4.12 (t, 2H, <i>J</i> = 5.8 Hz), 2.21â2.19 (m, 2H), 2.00 (br s, 2H), 1.74â1.70 (m, 2H), 1.57â1.51 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 188.8, 161.9, 158.6, 156.5, 144.1, 138.9, 134.5, 130.6, 129.9, 128.9, 128.8, 122.0, 121.2, 119.5, 113.5, 81.1, 74.2, 64.2, 33.2, 26.9, 22.0. Purity: 99.9%, HPLC <i>t</i><sub>R</sub> = 6.74 min. ESI-MS <i>m</i>/<i>z</i> 448.5 (M + 1)<sup>+</sup>.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (2<i>E</i>)-1-(3-{4-[(7,9-Diamino-6,8,10-triazaspiro[4.5]deca-7,9-dien-6-yl)oxy]butyloxy}phenyl)-3-phenylprop-2-en-1-one Hydrochloride (<b>15</b>)</h3><div class="NLM_p last">From 7,9-diamino-6,8,10-triazaspiro[4.5]deca-7,9-dien-6-ol hydrochloride (1.10 g, 5 mmol) and (2<i>E</i>)-1-[3-(4-bromobutoxy)phenyl]-3-phenylprop-2-en-1-one (1.80 g, 5 mmol), <b>15</b> was obtained as an off-white solid, 0.78 g, yield 31.4%. Mp: 186â187 Â°C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.25 (s, 1H, NH), 8.61 (s, 1H, NH), 8.06 (s, 1H, NH), 7.94â7.89 (m, 3H), 7.79â7.73 (m, 2H), 7.71 (br s, 1H, NH), 7.61â7.60 (m, 1H), 7.52â7.47 (m, 4H), 7.25 (dd, 1H, <i>J</i> = 8.0, 2.0 Hz), 6.98 (br s, 1H, NH), 4.13â4.10 (m, 2H), 4.02â3.99 (m, 2H), 2.01 (br s, 2H), 1.88â1.69 (m, 10H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 188.9, 161.9, 158.8, 156.6, 144.0, 138.9, 134.5, 130.6, 129.9, 128.9, 128.8, 122.0, 121.0, 119.6, 113.5, 81.1, 77.3, 67.5, 33.4, 24.9, 24.0, 22.2. Purity: 95.3%, HPLC <i>t</i><sub>R</sub> = 7.59 min. ESI-MS <i>m</i>/<i>z</i> 462.5 (M + 1)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Chemicals, Reagents, and Cell Culture</h3><div class="NLM_p">Stock solutions of the compounds were prepared by dissolving the compounds in DMSO (final concentration 50 mM) and stored at â20 Â°C. DMSO, DHF, NADPH, recombinant human DHFR, thioredoxin reductase from rat liver, 5,5â²-dithiobis(2-nitrobenzoic acid) (DTNB), guanidine HCl, and insulin from bovine pancreas were purchased from Sigma-Aldrich (St. Louis, MO). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was obtained from Duchefa Biochemie (Haarlem, The Netherlands). MTX and ribonuclease A were purchased from MP Biomedicals (Santa Ana, CA). Protease inhibitor cocktail tablets were purchased from Roche Diagnostics (Mannheim, Germany). Recombinant human Trx was obtained from IMCO Corporation (Stockholm, Sweden). DHFR antibody (AB54612) was purchased from Abcam (Cambridge, U.K.), while TrxR (sc-18220) and Î²-actin (sc-47778) antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Horseradish peroxidase (HRP) conjugated secondary antibodies were from Thermo Scientific (Rockford, IL) or Santa Cruz Biotechnology Inc.</div><div class="NLM_p last">Human-derived HCT116 colorectal and MCF-7 breast carcinoma cells (ATCC, Rockville, MD) were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (HyClone Laboratories, Logan, UT), 100 units/mL penicillin, and 100 Î¼g/mL streptomycin and incubated at 37 Â°C in a humidified atmosphere of 95% air and 5% CO<sub>2</sub>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In Vitro DHFR Inhibition Assay</h3><div class="NLM_p last">The assay was performed at room temperature using a Hitachi U-1900 UV/visible spectrophotometer. In a 1 mL quartz cuvette containing a solution of 50 Î¼M dihydrofolate (DHF), 1.5 Ã 10<sup>â3</sup> units of recombinant human DHFR and various concentrations of the test compounds in 0.15 M phosphate buffer (pH 7), NADPH (final concentration 60 Î¼M) was added to initiate the enzymatic reaction. The rate of NADPH consumption during the conversion of DHF to THF was monitored by taking absorbance readings at 340 nm every 30 s over 6 min. A graph of absorbance readings versus time was plotted, and the slope of the graph represents the rate of reaction. The percentage inhibition at each concentration of inhibitor was calculated using the following formulas:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/jm-2016-01253b_m001.gif" alt="" /></img></span><span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/jm-2016-01253b_m002.gif" alt="" /></img></span>where Slope<sub>compound</sub> is the slope of the graph for solutions containing DHFR, test compound, NADPH, and DHF; Slope<sub>control</sub> is the slope of the graph for solutions containing DHFR, NADPH, and DHF; and Slope<sub>blank</sub> is the slope of the graph for solutions containing NADPH and DHF only. Graphs of percentage inhibition against logarithmic concentration were plotted for each compound, and IC<sub>50</sub> values were calculated using GraphPad Prism, version 5.01.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> In Vitro TrxR Inhibition Assay (DTNB Reduction Assay)</h3><div class="NLM_p last">In 96-well plates, a range of concentrations of the test compounds in DMSO stock solutions were incubated with 2.1 units/mL of TrxR from rat liver and 200 Î¼M NADPH in a volume of 100 Î¼L of 50 mM Tris-HCl and 1 mM EDTA, pH 7.5 (TE buffer), at room temperature for 30 or 60 min. A volume of 100 Î¼L of TE buffer containing 5 mM DTNB and 200 Î¼M NADPH was added to initiate the reaction, where the increase in TNB absorbance at 412 nm was measured over the initial 2 min with a Molecular Devices VersaMax microplate reader. Maximal velocity (<i>V</i><sub>max</sub>) values were obtained from the linear portion of the absorbance over time curve. TrxR activity was calculated as a percentage of enzyme activity compared to that of vehicle-treated sample using the following formula:<span class="NLM_disp-formula" id="ueq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/jm-2016-01253b_m003.gif" alt="" /></img></span>Graphs of percentage activity against logarithmic concentration were plotted for each compound, and IC<sub>50</sub> values were calculated using GraphPad Prism, version 5.01.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Cell Viability Assay</h3><div class="NLM_p">Cells were seeded at a density of 1.0 Ã 10<sup>4</sup> per well into 96-well plates and allowed to adhere overnight before introduction of test compounds. Serial dilutions of the compounds were prepared in medium from DMSO stock solutions immediately before each assay. At the time of compound addition (<i>T</i><sub>0</sub>) and after 72 h of incubation with the compounds, cell viability was determined by MTT assay. Briefly, MTT was added into each well at a final concentration of 400 Î¼g/mL and the plates were incubated at 37 Â°C for 4 h. The MTT-containing medium was aspirated, and the insoluble formazan product was solubilized by addition of 150 Î¼L of DMSO/glycine buffer, pH 10.5 (ratio 4:1). Absorbance at 550 nm was measured using a Molecular Devices VersaMax microplate reader.</div><div class="NLM_p last">To obtain GI<sub>50</sub> and LC<sub>50</sub> values, the absorbance readings were plotted against logarithmic concentration on GraphPad Prism, version 5.01. GI<sub>50</sub> and LC<sub>50</sub> values were interpolated from the graphs as concentrations corresponding to the following absorbance values:<span class="NLM_disp-formula" id="ueq4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/jm-2016-01253b_m004.gif" alt="" /></img></span><span class="NLM_disp-formula" id="ueq5"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/jm-2016-01253b_m005.gif" alt="" /></img></span></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Preparation of Cell Lysates and Western Blot Analysis</h3><div class="NLM_p last">HCT116 cells were plated onto 100 mm culture plates at 1.5 Ã 10<sup>6</sup> cells per plate and incubated for 48 h to allow exponential growth before treatment with selected test compounds for 16 h. Following drug treatment, adherent and floating cells were pooled, pelleted, washed once in ice-cold PBS and lysed in Triton X-100 lysis buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2.5 mM EGTA, 2.5 mM EDTA, 20 mM NaF, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 10 mM sodium pyrophosphate, 20 mM sodium Î²-glycerophosphate, 0.5% Triton X-100) containing freshly added protease inhibitor cocktail. Prior to use for determination of DHFR or TrxR activity or Western blot analysis, the lysates were precleared by centrifugation and protein concentrations were determined using the Bradford assay (Bio-Rad Laboratories, Hercules, CA) as described in the manufacturerâs manual. For Western blot analysis, equal amounts of protein in lysate samples were separated by SDSâPAGE and resolved proteins were electroblotted onto nitrocellulose membranes. The blots were probed with a primary antibody followed by a secondary HRP-conjugated antibody and then developed using enhanced chemiluminescence system [Western Lightning, PerkinElmer (Boston, MA) or SuperSignal West Femto, Thermo Scientific (Rockford, IL)]. All Western blots shown are representative of three independent experiments.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Determination of DHFR Activity in HCT116 Cell Lysates</h3><div class="NLM_p last">In 96-well plates, each cell lysate sample containing 400 Î¼g of protein was mixed in a final volume of 200 Î¼L of PBS containing 50 Î¼M DHF and 200 Î¼M NADPH. Controls containing all the reagents with additional 1 Î¼M methotrexate were set up alongside. The decrease in absorbance at 340 nm was measured at room temperature over 15 min with a Molecular Devices VersaMax microplate reader. DHFR activity was calculated as percentage activity of untreated cells using the following formula:<span class="NLM_disp-formula" id="ueq6"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/jm-2016-01253b_m006.gif" alt="" /></img></span></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Determination of TrxR Activity in HCT116 Cell Lysates</h3><div class="NLM_p last">TrxR activity in cell lysates was measured using a published end point insulin assay method.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In 96-well plates, each cell lysate sample containing 25 Î¼g of protein was incubated in a reaction volume of 50 Î¼L containing 85 mM HEPES (pH 7.6), 0.3 mM insulin, 660 Î¼M NADPH, 3 mM EDTA, and 10 Î¼M human Trx for 40 min at room temperature. Controls containing cell lysate and all the reagents except human Trx were set up alongside. The reaction was quenched by addition of 200 Î¼L of 1 mM DTNB and 240 Î¼M NADPH in 6 M guanidine hydrochloride and 200 mM Tris-HCl solution (pH 8.0). The amount of free thiols generated from insulin reduction was determined by DTNB reduction measured at 412 nm with a Molecular Devices VersaMax microplate reader. TrxR activity was represented as the absorbance at 412 nm minus that of the corresponding control.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01253">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01253" class="ext-link">10.1021/acs.jmedchem.6b01253</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis and characterization of <b>18</b>, <b>16</b>, and <b>6h</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_001.pdf">jm6b01253_si_001.pdf (169.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_002.csv">jm6b01253_si_002.csv (2.8 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01253" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eng-Hui Chew</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Science, National
University of Singapore, 18 Science Drive 4, 117543, Singapore</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#77071f1614121f3719020459121302590410"><span class="__cf_email__" data-cfemail="33435b5250565b735d46401d5657461d4054">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wai-Keung Chui</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Science, National
University of Singapore, 18 Science Drive 4, 117543, Singapore</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2568-6021" title="Orcid link">http://orcid.org/0000-0003-2568-6021</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#74041c1517031f341a01075a1110015a0713"><span class="__cf_email__" data-cfemail="3c4c545d5f4b577c52494f12595849124f5b">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui-Li Ng</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Science, National
University of Singapore, 18 Science Drive 4, 117543, Singapore</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiang Ma</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Tongji Medical College, Huazhong
University of Science and Technology, Wuhan, Hubei 430030, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript and declare that they have no conflict of interest.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3728-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the following research grants: National University of Singapore Academic Research Fund Tier 1 R-148-000-153-112 to W.-K.C., National Medical Research Council Grant NMRC/NIG/0050/2009 and National University of Singapore Academic Research Fund Tier 1 R-148-000-184-112 to E.-H.C.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> Abbreviations Used</h2><tr><td class="NLM_term">DHF</td><td class="NLM_def"><p class="first last">dihydrofolate</p></td></tr><tr><td class="NLM_term">DHFR</td><td class="NLM_def"><p class="first last">dihydrofolate reductase</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol tetraacetic acid</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">MTX</td><td class="NLM_def"><p class="first last">methotrexate</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>2</td><td class="NLM_def"><p class="first last">bimolecular nucleophilic substitution</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">Trx</td><td class="NLM_def"><p class="first last">thioredoxin</p></td></tr><tr><td class="NLM_term">TrxR</td><td class="NLM_def"><p class="first last">thioredoxin reductase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Chou, T. C.</span><span> </span><span class="NLM_article-title">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span><span class="refDoi">Â DOI: 10.1124/pr.58.3.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1124%2Fpr.58.3.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=16968952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=621-681&author=T.+C.+Chou&title=Theoretical+basis%2C+experimental+design%2C+and+computerized+simulation+of+synergism+and+antagonism+in+drug+combination+studies&doi=10.1124%2Fpr.58.3.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-681</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The median-effect equation derived from the mass-action law principle at equil. steady state via math. induction and deduction for different reaction sequences and mechanisms and different types of inhibition has been shown to be the unified theory for the Michaelis-Menten equation, Hill equation, Henderson-Hasselbalch equation, and Scatchard equation.  It is shown that dose and effect are interchangeable via defined parameters.  This general equation for the single drug effect has been extended to the multiple drug effect equation for n drugs.  These equations provide the theor. basis for the combination index (CI)-isobologram equation that allows quant. detn. of drug interactions, where CI < 1, = 1, and > 1 indicate synergism, additive effect, and antagonism, resp.  Based on these algorithms, computer software has been developed to allow automated simulation of synergism and antagonism at all dose or effect levels.  It displays the dose-effect curve, median-effect plot, combination index plot, isobologram, dose-redn. index plot, and polygonogram for in vitro or in vivo studies.  This theor. development, exptl. design, and computerized data anal. have facilitated dose-effect anal. for single drug evaluation or carcinogen and radiation risk assessment, as well as for drug or other entity combinations in a vast field of disciplines of biomedical sciences.  In this review, selected examples of applications are given, and step-by-step examples of exptl. designs and real data anal. are also illustrated.  The merging of the mass-action law principle with math. induction-deduction has been proven to be a unique and effective scientific method for general theory development.  The median-effect principle and its mass-action law based computer software are gaining increased applications in biomedical sciences, from how to effectively evaluate a single compd. or entity to how to beneficially use multiple drugs or modalities in combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoToLhZ8Njyh7Vg90H21EOLACvtfcHk0ljLy8fxTYE9BA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL&md5=374c53e0772c679d1cdb08ff3112be90</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.10%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DTheoretical%2520basis%252C%2520experimental%2520design%252C%2520and%2520computerized%2520simulation%2520of%2520synergism%2520and%2520antagonism%2520in%2520drug%2520combination%2520studies%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D621%26epage%3D681%26doi%3D10.1124%2Fpr.58.3.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">â</span> <span class="NLM_lpage">6543</span><span class="refDoi">Â DOI: 10.1021/jm058225d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm&doi=10.1021%2Fjm058225d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lg5OENpBqYQyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543%26doi%3D10.1021%2Fjm058225d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">McGuire, J. J.</span><span> </span><span class="NLM_article-title">Anticancer antifolates: current status and future directions</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">â</span> <span class="NLM_lpage">2613</span><span class="refDoi">Â DOI: 10.2174/1381612033453712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.2174%2F1381612033453712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=14529544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=2593-2613&author=J.+J.+McGuire&title=Anticancer+antifolates%3A+current+status+and+future+directions&doi=10.2174%2F1381612033453712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer antifolates: Current status and future directions</span></div><div class="casAuthors">McGuire, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">2593-2613</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Antifolates are the oldest of the antimetabolite class of anticancer agents and were one of the first modern anticancer drugs.  The first clin. useful antifolate, described in 1947, was 2,4-diamino-pteroylglutamate (4-amino-folic acid; aminopterin; AMT) which yielded the first-ever remissions in childhood leukemia.  AMT was soon superseded by its 10-Me congener, methotrexate (MTX), based on toxicity considerations; MTX remains, with one limited exception, the only antifolate anticancer agent in clin. use to this date.  Because of the safety and utility of MTX, considerable effort has been invested in attempting to design more therapeutically selective antifolates or antifolates with a wider tumor spectrum.  Initially, the design was based on the burgeoning knowledge of folate-dependent pathways and the determinants of the mechanism of action of MTX.  These determinants include transport, the tight-binding inhibition of its target (the folate-dependent enzyme dihydrofolate reductase (DHFR)), and metab. of MTX to poly-Î³-glutamate (Glun) metabolites.  These early studies led to the development of other antifolate DHFR inhibitors of two types: (1) "classical" analogs that use the same cellular transport systems as MTX and are also metabolized to Glun; and (2) "nonclassical" (i.e., lipophilic) analogs that do not require transport systems and that are not metabolized to Glun.  Although several of these analogs have undergone clin. trial, none is proved superior to MTX.  Detailed examn. of the mechanisms of cytotoxicity and selectivity of MTX showed that inhibition of both dTMP synthesis and de novo purine synthesis, secondary to DHFR inhibition, led to DNA synthesis inhibition and subsequent cell death; inhibition of other folate-dependent pathways did not appear necessary for cell death.  Further studies showed that the contribution of inhibition of dTMP or purine synthesis to cell death varied in different cell types.  These data suggested that inhibition of one of these pathways individually might (at least in some cases) be therapeutically superior to the dual inhibition induced by MTX.  Thus in rational design and in structure-based design studies, two new classes of antifolate enzyme inhibitors were elaborated-direct inhibitors of thymidylate synthase (TMPS) and direct inhibitors of one or both of the two folate-dependent enzymes of de novo purine synthesis.  Members of each class included both classical and nonclassical types.  After preclin. evaluation, several of these have moved into clin. trials.  To date only one new TMPS inhibitor has successfully completed clin. trials and been approved for routine use; this drug, Tomudex (D1694, raltitrexed) is currently approved only in Europe and only for the treatment of colon cancer.  This still represents a step forward for antifolates, however, since MTX is well-known to be ineffective in colon cancer; thus Tomudex extends the tumor range of antifolates.  Antifolate development continues.  Based on the immense body of knowledge now extant on antifolates, specific aspects of the mechanism of action have been the focus.  Newer antifolates have been described that inhibit more than one pathway in folate metab., that have improved delivery, or that inhibit other targets in folate metab.  These new analogs are in various stages of preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGwUdwGzF0rVg90H21EOLACvtfcHk0lgsrT-SgbtlTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D&md5=3e9aef8e71a32144ad5bcb661df3fa47</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1381612033453712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033453712%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26atitle%3DAnticancer%2520antifolates%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D2593%26epage%3D2613%26doi%3D10.2174%2F1381612033453712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Visentin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, I. D.</span><span> </span><span class="NLM_article-title">The antifolates</span> <span class="citation_source-journal">Hematol. Oncol. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">â</span> <span class="NLM_lpage">648</span><span class="refDoi">Â DOI: 10.1016/j.hoc.2012.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.hoc.2012.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=22520983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A280%3ADC%252BC38rmslyiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=629-648&author=M.+Visentinauthor=R.+Zhaoauthor=I.+D.+Goldman&title=The+antifolates&doi=10.1016%2Fj.hoc.2012.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The antifolates</span></div><div class="casAuthors">Visentin Michele; Zhao Rongbao; Goldman I David</div><div class="citationInfo"><span class="NLM_cas:title">Hematology/oncology clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-48, ix</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article focuses on the cellular, biochemical, and molecular pharmacology of antifolates and how a basic understanding of the mechanism of action of methotrexate, its cytotoxic determinants, mechanisms of resistance, and transport into and out of cells has led to the development of a new generation of antifolates, a process that continues in the laboratory and in the clinics.  New approaches to folate-based cancer chemotherapy are described based on the targeted delivery of drugs to malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTs6Vk1KGWrT_h3YQQtAhNufW6udTcc2eaufaaXmHp_obntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rmslyiuw%253D%253D&md5=516c6432e647418b245aba234c1dd545</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.hoc.2012.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hoc.2012.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DVisentin%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DGoldman%26aufirst%3DI.%2BD.%26atitle%3DThe%2520antifolates%26jtitle%3DHematol.%2520Oncol.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D629%26epage%3D648%26doi%3D10.1016%2Fj.hoc.2012.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Gonen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assaraf, Y. G.</span><span> </span><span class="NLM_article-title">Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">â</span> <span class="NLM_lpage">210</span><span class="refDoi">Â DOI: 10.1016/j.drup.2012.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.drup.2012.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=22921318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWqsrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=183-210&author=N.+Gonenauthor=Y.+G.+Assaraf&title=Antifolates+in+cancer+therapy%3A+structure%2C+activity+and+mechanisms+of+drug+resistance&doi=10.1016%2Fj.drup.2012.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance</span></div><div class="casAuthors">Gonen, Nitzan; Assaraf, Yehuda G.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">183-210</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past 65 years, antifolates targeting folate metab. played a pivotal role in drug treatment of malignant, microbial, parasitic and chronic inflammatory diseases.  Drug discovery of novel antifolates with improved properties and superior activities remains an attractive strategy both in academia and in the pharmaceutical industry.  Among novel antifolates are pemetrexed which primarily targets thymidylate synthase as well as pralatrexate which blocks dihydrofolate reductase, and displays enhanced transport and cellular retention properties.  The present review describes the evolution and pharmacol. activity of antifolates and prospects for the development of the next generation antifolates.  Pre-clin. and clin. studies identified a plethora of mechanisms of antifolate resistance that are a primary hindrance to curative cancer chemotherapy; these are frequently assocd. with qual. and/or quant. alterations in influx and/or efflux transporters of antifolates and in folate-dependent enzymes.  Current advances including for example the deciphering of the dominant folate transporter proton-coupled folate transporter (PCFT/SLC46A1) facilitated the synthesis of exptl. antifolates aimed at selectively targeting solid tumor cells, which reside in an acidic microenvironment where PCFT supposedly functions optimally.  Moreover, drugs that are structurally and mechanistically distinct from folates were conjugated to folic acid (e.g.  Vintafolide/EC145, a folic acid desacetylvinblastine conjugate) to facilitate endocytosis via the folate receptor (FR) which is markedly overexpressed in various solid tumors.  In an alternative approach, novel antifolates selectively targeting the FR but not other folate transporters are being developed (e.g.  BGC 945). Hence, targeting mechanisms of antifolate-resistance could facilitate the development of rationally-based novel antifolates and strategies that overcome chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVjP1iploMdbVg90H21EOLACvtfcHk0lgsrT-SgbtlTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWqsrnO&md5=e9f7f1742c26c72a96a2fdeb2d118f1a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2012.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2012.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DGonen%26aufirst%3DN.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26atitle%3DAntifolates%2520in%2520cancer%2520therapy%253A%2520structure%252C%2520activity%2520and%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2012%26volume%3D15%26spage%3D183%26epage%3D210%26doi%3D10.1016%2Fj.drup.2012.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Silipo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansch, C.</span><span> </span><span class="NLM_article-title">Correlation analysis. Its application to the structure-activity relationship of triazines inhibiting dihydrofolate reductase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6849</span><span class="NLM_x">â</span> <span class="NLM_lpage">6861</span><span class="refDoi">Â DOI: 10.1021/ja00856a042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00856a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1975&pages=6849-6861&author=C.+Silipoauthor=C.+Hansch&title=Correlation+analysis.+Its+application+to+the+structure-activity+relationship+of+triazines+inhibiting+dihydrofolate+reductase&doi=10.1021%2Fja00856a042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja00856a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00856a042%26sid%3Dliteratum%253Aachs%26aulast%3DSilipo%26aufirst%3DC.%26aulast%3DHansch%26aufirst%3DC.%26atitle%3DCorrelation%2520analysis.%2520Its%2520application%2520to%2520the%2520structure-activity%2520relationship%2520of%2520triazines%2520inhibiting%2520dihydrofolate%2520reductase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1975%26volume%3D97%26spage%3D6849%26epage%3D6861%26doi%3D10.1021%2Fja00856a042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span> </span><span class="NLM_article-title">Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">â</span> <span class="NLM_lpage">743</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2009.11.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.bmc.2009.11.065" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=737-743&author=X.+Maauthor=W.+K.+Chui&title=Antifolate+and+antiproliferative+activity+of+6%2C8%2C10-triazaspiro%5B4.5%5Ddeca-6%2C8-dienes+and+1%2C3%2C5-triazaspiro%5B5.5%5Dundeca-1%2C3-dienes&doi=10.1016%2Fj.bmc.2009.11.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.11.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.11.065%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DChui%26aufirst%3DW.%2BK.%26atitle%3DAntifolate%2520and%2520antiproliferative%2520activity%2520of%25206%252C8%252C10-triazaspiro%255B4.5%255Ddeca-6%252C8-dienes%2520and%25201%252C3%252C5-triazaspiro%255B5.5%255Dundeca-1%252C3-dienes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D737%26epage%3D743%26doi%3D10.1016%2Fj.bmc.2009.11.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span> </span><span class="NLM_article-title">Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span><span class="refDoi">Â DOI: 10.1111/j.1747-0285.2009.00860.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1111%2Fj.1747-0285.2009.00860.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=19703036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=322-326&author=X.+Maauthor=R.+S.+Woonauthor=P.+C.+Hoauthor=W.+K.+Chui&title=Antiproliferative+activity+against+MCF-7+breast+cancer+cells+by+diamino-triazaspirodiene+antifolates&doi=10.1111%2Fj.1747-0285.2009.00860.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates</span></div><div class="casAuthors">Ma, Xiang; Woon, Renee Ser-Peng; Ho, Paul Chi-Lui; Chui, Wai-Keung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">322-326</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Two triazaspirodienes, having similar phenoxy propyloxy side chain, were identified as potent mammalian dihydrofolate reductase inhibitors; one having a 6,5-spiro bicyclic ring system (IC50 = 2.3 nM) and the other a 6,6-spiro bicyclic system (IC50 = 6.9 nM).  They also showed more than 50% antiproliferative activity against the MCF-7 breast cancer cells at 20 Î¼M.  This study demonstrated the potential lead of the diamino-triazaspirodienes in anticancer chemotherapeutic agents' discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2za1IvZ3J0rVg90H21EOLACvtfcHk0lhkD1saahOfmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7fP&md5=129ef2f8c2e5338337cda127cd7aa373</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00860.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00860.x%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWoon%26aufirst%3DR.%2BS.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DChui%26aufirst%3DW.%2BK.%26atitle%3DAntiproliferative%2520activity%2520against%2520MCF-7%2520breast%2520cancer%2520cells%2520by%2520diamino-triazaspirodiene%2520antifolates%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D322%26epage%3D326%26doi%3D10.1111%2Fj.1747-0285.2009.00860.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Berman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbel, L. M.</span><span> </span><span class="NLM_article-title">The renewed potential for folate antagonists in contemporary cancer chemotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">â</span> <span class="NLM_lpage">485</span><span class="refDoi">Â DOI: 10.1021/jm00106a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=479-485&author=E.+M.+Bermanauthor=L.+M.+Werbel&title=The+renewed+potential+for+folate+antagonists+in+contemporary+cancer+chemotherapy&doi=10.1021%2Fjm00106a001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a001%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DE.%2BM.%26aulast%3DWerbel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520renewed%2520potential%2520for%2520folate%2520antagonists%2520in%2520contemporary%2520cancer%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D479%26epage%3D485%26doi%3D10.1021%2Fjm00106a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hekmat-Nejad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span> </span><span class="NLM_article-title">Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase</span> <span class="citation_source-journal">Exp. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">â</span> <span class="NLM_lpage">228</span><span class="refDoi">Â DOI: 10.1006/expr.1997.4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1006%2Fexpr.1997.4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=9371087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADyaK2sXns1yisLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1997&pages=222-228&author=M.+Hekmat-Nejadauthor=P.+K.+Rathod&title=Plasmodium+falciparum%3A+kinetic+interactions+of+WR99210+with+pyrimethamine-sensitive+and+pyrimethamine-resistant+dihydrofolate+reductase&doi=10.1006%2Fexpr.1997.4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase</span></div><div class="casAuthors">Hekmat-Nejad, Mohammad; Rathod, Pradipsinh K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-228</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">With emerging drug resistance in Plasmodium falciparum, novel antifolates effective against pyrimethamine-resistant and cycloguanil-resistant dihydrofolate reductase (DHFR) are in demand.  Based on structural similarity to cycloguanil, it has been proposed that WR99210, and its metabolic precursor PS-15, exerts selective antimalarial activity by binding tightly to both drug-sensitive and drug-resistant DHFR.  In the present study, Linweaver-Burk plots and Ackermann-Potter plots reveal that both forms of malarial DHFR bind WR99210 at subnanomolar concns.  It is not necessary to invoke an alternate target for WR99210 in P. falciparum.  The present studies confirm that malarial DHFRs offer potential binding interactions in the folate-binding pocket distinct from those exploited by pyrimethamine and cycloguanil.  These kinetic studies also provide a useful framework for the design and interpretation of future structural studies on drug-resistant DHFR from P. falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQxLPKLNC_fbVg90H21EOLACvtfcHk0lhleCDf8xjbWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXns1yisLk%253D&md5=baf0657c6f8a49d5539de3abf8ec5d7a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fexpr.1997.4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexpr.1997.4228%26sid%3Dliteratum%253Aachs%26aulast%3DHekmat-Nejad%26aufirst%3DM.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26atitle%3DPlasmodium%2520falciparum%253A%2520kinetic%2520interactions%2520of%2520WR99210%2520with%2520pyrimethamine-sensitive%2520and%2520pyrimethamine-resistant%2520dihydrofolate%2520reductase%26jtitle%3DExp.%2520Parasitol.%26date%3D1997%26volume%3D87%26spage%3D222%26epage%3D228%26doi%3D10.1006%2Fexpr.1997.4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gromer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, K.</span><span> </span><span class="NLM_article-title">The thioredoxin system--from science to clinic</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span><span class="refDoi">Â DOI: 10.1002/med.10051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2Fmed.10051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=14595672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=40-89&author=S.+Gromerauthor=S.+Urigauthor=K.+Becker&title=The+thioredoxin+system%2D%2Dfrom+science+to+clinic&doi=10.1002%2Fmed.10051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The thioredoxin system-from science to clinic</span></div><div class="casAuthors">Gromer, Stephan; Urig, Sabine; Becker, Katja</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-89</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The thioredoxin system-formed by thioredoxin reductase and its characteristic substrate thioredoxin-is an important constituent of the intracellular redox milieu.  Interactions with many different metabolic pathways such as DNA-synthesis, selenium metab., and the antioxidative network as well as significant species differences render this system an attractive target for chemotherapeutic approaches in many fields of medicine-ranging from infectious diseases to cancer therapy.  In this review we will present and evaluate the preclin. and clin. results available today.  Current trends in drug development are emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp26-L03rXS3rVg90H21EOLACvtfcHk0lhleCDf8xjbWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVaiug%253D%253D&md5=e27dea66a4361510f1f6198b96ef7ca0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.10051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10051%26sid%3Dliteratum%253Aachs%26aulast%3DGromer%26aufirst%3DS.%26aulast%3DUrig%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DK.%26atitle%3DThe%2520thioredoxin%2520system--from%2520science%2520to%2520clinic%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2004%26volume%3D24%26spage%3D40%26epage%3D89%26doi%3D10.1002%2Fmed.10051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lillig, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span> </span><span class="NLM_article-title">Thioredoxin and related molecules--from biology to health and disease</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">â</span> <span class="NLM_lpage">47</span><span class="refDoi">Â DOI: 10.1089/ars.2007.9.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2007.9.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=17115886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Wqur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=25-47&author=C.+H.+Lilligauthor=A.+Holmgren&title=Thioredoxin+and+related+molecules%2D%2Dfrom+biology+to+health+and+disease&doi=10.1089%2Fars.2007.9.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin and Related Molecules-From Biology to Health and Disease</span></div><div class="casAuthors">Lillig, Christopher Horst; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-47</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Thioredoxin and glutaredoxin systems in mammalian cells utilize thiol and selenol groups to maintain a reducing intracellular redox state acting as antioxidants and reducing agents in redox signaling with oxidizing reactive oxygen species.  During the last decade, the functional roles of thioredoxin in particular have continued to expand, also including novel functions such as a secreted growth factor or a chemokine for immune cells.  The role of thioredoxin and glutaredoxin in antioxidant defense and the role of thioredoxin in controlling recruitment of inflammatory cells offer potential use in clin. therapy.  The fundamental differences between bacterial and mammalian thioredoxin reductases offer new principles for treatment of infections.  Clin. drugs already in use target the active site selenol in thioredoxin reductases, inducing cell death in tumor cells.  Thioredoxin and binding proteins (ASK1 and TBP2) appear to control apoptosis or metabolic states such as carbohydrate and lipid metab. related to diseases such as diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoJiYC7UOm_rVg90H21EOLACvtfcHk0lhleCDf8xjbWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Wqur3P&md5=a7fcdf1f3ab87149ad75acbf88a3e397</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.9.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.9.25%26sid%3Dliteratum%253Aachs%26aulast%3DLillig%26aufirst%3DC.%2BH.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520and%2520related%2520molecules--from%2520biology%2520to%2520health%2520and%2520disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D25%26epage%3D47%26doi%3D10.1089%2Fars.2007.9.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kahlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soini, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saily, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paakko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnula, V. L.</span><span> </span><span class="NLM_article-title">Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span><span class="refDoi">Â DOI: 10.1002/1097-0215(20010520)95:3<198::AID-IJC1034>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11307155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFOmtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2001&pages=198-204&author=K.+Kahlosauthor=Y.+Soiniauthor=M.+Sailyauthor=P.+Koistinenauthor=S.+Kakkoauthor=P.+Paakkoauthor=A.+Holmgrenauthor=V.+L.+Kinnula&title=Up-regulation+of+thioredoxin+and+thioredoxin+reductase+in+human+malignant+pleural+mesothelioma&doi=10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma</span></div><div class="casAuthors">Kahlos, Katriina; Soini, Ylermi; Saly, Marjaana; Koistinen, Pirjo; Kakko, Sakari; Paakko, Paavo; Holmgren, Arne; Kinnula, Vuokko L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Thioredoxin (Trx) with a redoxactive dithiol together with NADPH and thioredoxin reductase (TrxR) is a major disulfide reductase regulating cellular redox state and cell proliferation and possibly contributing to the drug resistance of malignant cells.  We assessed the Trx system in malignant pleural mesothelioma cell lines, in nonmalignant pleural mesothelium and in biopsies of malignant pleural mesothelioma.  The mRNA and immunoreactive proteins of Trx and cytosolic and mitochondrial TrxR were pos. in all 4 human mesothelioma cell lines investigated.  6 Cases of nonmalignant, histol. healthy pleural mesothelium showed no Trx or TrxR immunoreactivity, whereas immunohistochem. on 26 biopsies of human malignant pleural mesothelioma showed pos. Trx in all cases and pos. TrxR in 23 (88%) of the cases.  Moderate or strong immunoreactivity for Trx or TrxR was detected in 85% (22 cases) and 61% (14 cases) of the mesothelioma cases, resp.  Both Trx and TrxR staining patterns were mainly diffuse and cytoplasmic, but in 39% of the mesothelioma cases prominent nuclear staining could also be detected.  Although staining for Trx and TrxR was seen in tumor cells, no significant assocn. could be demonstrated between Trx or TrxR expression and tumor cell proliferation or apoptosis in the biopsies of mesothelioma.  There was no significant assocn. between the intensity of Trx or TrxR immunoreactivity and patient survival, which may possibly be related to moderate or intense Trx and TrxR reactivity in most of the cases.  Although the Trx system may have an important role in the drug resistance of malignant mesothelioma, these studies also suggest that multiple factors contribute to the promotion, cell proliferation and apoptosis of malignant mesothelioma cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXkQXhXLNdYrVg90H21EOLACvtfcHk0lhhcWyGW2k8pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFOmtro%253D&md5=0547dce693c45d98382fdd59cfc73f96</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0215%252820010520%252995%253A3%253C198%253A%253AAID-IJC1034%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DKahlos%26aufirst%3DK.%26aulast%3DSoini%26aufirst%3DY.%26aulast%3DSaily%26aufirst%3DM.%26aulast%3DKoistinen%26aufirst%3DP.%26aulast%3DKakko%26aufirst%3DS.%26aulast%3DPaakko%26aufirst%3DP.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DKinnula%26aufirst%3DV.%2BL.%26atitle%3DUp-regulation%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%2520in%2520human%2520malignant%2520pleural%2520mesothelioma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2001%26volume%3D95%26spage%3D198%26epage%3D204%26doi%3D10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Soini, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napankangas, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaarteenaho-Wiik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saily, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paaakko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnula, V. L.</span><span> </span><span class="NLM_article-title">Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">â</span> <span class="NLM_lpage">1757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11410516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltV2hs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1750-1757&author=Y.+Soiniauthor=K.+Kahlosauthor=U.+Napankangasauthor=R.+Kaarteenaho-Wiikauthor=M.+Sailyauthor=P.+Koistinenauthor=P.+Paaakkoauthor=A.+Holmgrenauthor=V.+L.+Kinnula&title=Widespread+expression+of+thioredoxin+and+thioredoxin+reductase+in+non-small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma</span></div><div class="casAuthors">Soini, Ylermi; Kahlos, Katriina; Napankangas, Ulla; Kaarteenaho-Wiik, Riitta; Saily, Marjaana; Koistinen, Pirjo; Paakko, Paavo; Holmgren, Arne; Kinnula, Vuokko L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1750-1757</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We investigated the expression of thioredoxin (Trx) and thioredoxin reductase (TrxR) in 89 non-small cell lung carcinomas.  Addnl., immortalized human bronchial epithelial cells (BEAS 2B) and 4 human lung carcinoma cells lines (A549, SK-MES-1, CALU-6, and A427) were studied by Western blot and reverse transcription-PCR for the synthesis of Trx and TrxR protein and mRNA expression in vitro.  The histol. samples were also studied for immunohistochem. p53 and proliferating cell nuclear antigen expression and apoptosis.  In non-neoplastic lung, Trx and TrxR expression was seen in bronchial epithelial cells and alveolar macrophages, metaplastic alveolar epithelial cells, and chondrocytes of the bronchus.  In non-small cell lung carcinomas, there was a widespread expression of Trx and TrxR with only 3 and 8 cases neg., resp.  Trx and TrxR expression was located in both cytoplasmic and nuclear compartments of the cells.  There was a statistical assocn. between cytoplasmic and nuclear Trx or TrxR expression.  Grade I-II tumors showed stronger cytoplasmic and nuclear Trx and TrxR immunoreactivity than grade III tumors.  No assocn. was found between p53 and proliferating cell nuclear antigen expression and Trx or TrxR immunoreactivity.  However, apoptosis was inversely assocd. with nuclear Trx and TrxR positivity.  In the cell lines studied, both non-neoplastic BEAS 2B cells and all of the carcinoma cell lines expressed Trx and TrxR proteins and mRNA.  The results show that these redox-regulating proteins are highly expressed in lung carcinomas taking part in activation of transcriptional factors and regulation of apoptosis in non-small cell lung carcinoma.  In high-grade tumors, Trx and TrxR expression is diminished, suggesting loss of redox regulation in tumors with low differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1WnmKXYgB47Vg90H21EOLACvtfcHk0lhhcWyGW2k8pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltV2hs7c%253D&md5=c71eef9a2a4b06cbe192a68b983d2962</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoini%26aufirst%3DY.%26aulast%3DKahlos%26aufirst%3DK.%26aulast%3DNapankangas%26aufirst%3DU.%26aulast%3DKaarteenaho-Wiik%26aufirst%3DR.%26aulast%3DSaily%26aufirst%3DM.%26aulast%3DKoistinen%26aufirst%3DP.%26aulast%3DPaaakko%26aufirst%3DP.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DKinnula%26aufirst%3DV.%2BL.%26atitle%3DWidespread%2520expression%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%2520in%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D1750%26epage%3D1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yodoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, S.</span><span> </span><span class="NLM_article-title">High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">8425</span><span class="NLM_x">â</span> <span class="NLM_lpage">8430</span><span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-05-0449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1158%2F1078-0432.CCR-05-0449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=16322305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KjsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=8425-8430&author=S.+J.+Kimauthor=Y.+Miyoshiauthor=T.+Taguchiauthor=Y.+Tamakiauthor=H.+Nakamuraauthor=J.+Yodoiauthor=K.+Katoauthor=S.+Noguchi&title=High+thioredoxin+expression+is+associated+with+resistance+to+docetaxel+in+primary+breast+cancer&doi=10.1158%2F1078-0432.CCR-05-0449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer</span></div><div class="casAuthors">Kim, Seung Jin; Miyoshi, Yasuo; Taguchi, Tetsuya; Tamaki, Yasuhiro; Nakamura, Hajime; Yodoi, Junji; Kato, Kikuya; Noguchi, Shinzaburo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8425-8430</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Thioredoxin overexpression is suggested to be assocd. with resistance to several chemotherapeutic agents in vitro.  In the present study, it has been studied whether or not high thioredoxin expression is assocd. with resistance to docetaxel therapy in breast cancer patients.  PATIENTS AND METHODS: Sixty-three primary breast cancer patients were treated with docetaxel (60 mg/m2, q3w) for four cycles in the neoadjuvant setting.  Expression of thioredoxin, estrogen receptor (ER), p53, BRCA-1, and Bcl-2 in tumor tissues obtained before docetaxel therapy was studied by immunohistochem. (thioredoxin, p53, BRCA-1, and Bcl-2) and enzyme immunoassay (ER), and relationship of expression of these biomarkers with a pathol. response was investigated.  RESULTS: There was no significant correlation between the expression of p53, BRCA-1, or Bcl-2 and a response to docetaxel.  However, tumors with high thioredoxin expression showed a significantly lower response rate (0%) than those with low thioredoxin expression (30.6%; P = 0.018) and ER-neg. tumors showed a significantly higher response rate (32.4%) than ER-pos. tumors (10.7%; P = 0.043).  Thioredoxin expression significantly increased after docetaxel therapy (mean, 56.1%) as compared with that before docetaxel therapy (mean, 28.6%; P < 0.0001) but there was no significant assocn. between the extent of increase in thioredoxin expression and response.  CONCLUSION: High thioredoxin expression in prechemotherapy tumor samples, but not the increase in thioredoxin expression induced by docetaxel, is assocd. with resistance to docetaxel in breast cancer.  Thioredoxin and ER might be clin. useful in the prediction of a response to docetaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoziL6cScTivLVg90H21EOLACvtfcHk0lhhcWyGW2k8pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KjsrbI&md5=b8c27b4cc53669c571c2514b3420b260</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0449%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DMiyoshi%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DT.%26aulast%3DTamaki%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DYodoi%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DS.%26atitle%3DHigh%2520thioredoxin%2520expression%2520is%2520associated%2520with%2520resistance%2520to%2520docetaxel%2520in%2520primary%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D8425%26epage%3D8430%26doi%3D10.1158%2F1078-0432.CCR-05-0449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Raffel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallegos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einspahr, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span><span class="refDoi">Â DOI: 10.1016/S0022-2143(03)00068-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2FS0022-2143%2803%2900068-4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2003&pages=46-51&author=J.+Raffelauthor=A.+K.+Bhattacharyyaauthor=A.+Gallegosauthor=H.+Cuiauthor=J.+G.+Einspahrauthor=D.+S.+Albertsauthor=G.+Powis&title=Increased+expression+of+thioredoxin-1+in+human+colorectal+cancer+is+associated+with+decreased+patient+survival&doi=10.1016%2FS0022-2143%2803%2900068-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0022-2143%2803%2900068-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2143%252803%252900068-4%26sid%3Dliteratum%253Aachs%26aulast%3DRaffel%26aufirst%3DJ.%26aulast%3DBhattacharyya%26aufirst%3DA.%2BK.%26aulast%3DGallegos%26aufirst%3DA.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DEinspahr%26aufirst%3DJ.%2BG.%26aulast%3DAlberts%26aufirst%3DD.%2BS.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DIncreased%2520expression%2520of%2520thioredoxin-1%2520in%2520human%2520colorectal%2520cancer%2520is%2520associated%2520with%2520decreased%2520patient%2520survival%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D2003%26volume%3D142%26spage%3D46%26epage%3D51%26doi%3D10.1016%2FS0022-2143%2803%2900068-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. B.</span><span> </span><span class="NLM_article-title">Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span><span class="refDoi">Â DOI: 10.1002/jcb.20585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2Fjcb.20585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=16088946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFSrt7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=653-664&author=L.+Ganauthor=X.+L.+Yangauthor=Q.+Liuauthor=H.+B.+Xu&title=Inhibitory+effects+of+thioredoxin+reductase+antisense+RNA+on+the+growth+of+human+hepatocellular+carcinoma+cells&doi=10.1002%2Fjcb.20585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells</span></div><div class="casAuthors">Gan, Lu; Yang, Xiang-Liang; Liu, Qiong; Xu, Hui-Bi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">653-664</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Thioredoxin reductase (TrxR) in conjunction with thioredoxin (Trx) is a ubiquitous intracellular oxidoreductase system with antioxidant and redox regulatory roles.  In some human tumors, the thioredoxin system is found overexpressed.  We have used an antisense approach to investigate whether inhibition of TrxR overexpression can suppress the growth of human hepatocellular carcinoma SMMC-7721 cells.  TrxR cDNA fragment was inserted in the antisense direction into pcDNA3.1/myc-His and SMMC-7721 cells were stably transfected with the plasmid construct.  The results showed that TrxR antisense RNA could significantly reduce TrxR mRNA level and activity, and suppress the growth of SMMC-7721 cells.  Cell-cycle anal. showed G2/M phase arrest in SMMC-7721 cells transfected with TrxR antisense plasmid.  TrxR antisense RNA could significantly increase p53 mRNA level and decrease Bcl-2 mRNA level by reverse transcriptase-polymerase chain reaction (RT-PCR).  Furthermore a significant decrease in human telomerase reverse transcriptase (hTERT) mRNA level was found in SMMC-7721 cells transfected with TrxR antisense plasmid.  Flow cytometry and telomere fluorescence in situ hybridization (Flow FISH) showed that TrxR antisense RNA could significantly reduce the telomere fluorescence in SMMC-7721 cells.  The results suggested that TrxR antisense RNA inhibited the growth of SMMC-7721 cells through an accumulation of cell cycle at G2/M phase, an increase in p53 mRNA level and a redn. in telomere fluorescence and Bcl-2, hTERT mRNA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq85PJvTr63qbVg90H21EOLACvtfcHk0ljoZQKtZwdDww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFSrt7jK&md5=06e95b2deceb25bd368ddf682e02932a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjcb.20585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.20585%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DH.%2BB.%26atitle%3DInhibitory%2520effects%2520of%2520thioredoxin%2520reductase%2520antisense%2520RNA%2520on%2520the%2520growth%2520of%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D96%26spage%3D653%26epage%3D664%26doi%3D10.1002%2Fjcb.20585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yoo, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladyshev, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, D. L.</span><span> </span><span class="NLM_article-title">Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">13005</span><span class="NLM_x">â</span> <span class="NLM_lpage">13008</span><span class="refDoi">Â DOI: 10.1074/jbc.C600012200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1074%2Fjbc.C600012200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=13005-13008&author=M.+H.+Yooauthor=X.+M.+Xuauthor=B.+A.+Carlsonauthor=V.+N.+Gladyshevauthor=D.+L.+Hatfield&title=Thioredoxin+reductase+1+deficiency+reverses+tumor+phenotype+and+tumorigenicity+of+lung+carcinoma+cells&doi=10.1074%2Fjbc.C600012200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C600012200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C600012200%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DM.%2BH.%26aulast%3DXu%26aufirst%3DX.%2BM.%26aulast%3DCarlson%26aufirst%3DB.%2BA.%26aulast%3DGladyshev%26aufirst%3DV.%2BN.%26aulast%3DHatfield%26aufirst%3DD.%2BL.%26atitle%3DThioredoxin%2520reductase%25201%2520deficiency%2520reverses%2520tumor%2520phenotype%2520and%2520tumorigenicity%2520of%2520lung%2520carcinoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D13005%26epage%3D13008%26doi%3D10.1074%2Fjbc.C600012200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yoo, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladyshev, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, D. L.</span><span> </span><span class="NLM_article-title">Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1112</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0001112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1371%2Fjournal.pone.0001112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=17971875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A280%3ADC%252BD2snkslWlug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=e1112&author=M.+H.+Yooauthor=X.+M.+Xuauthor=B.+A.+Carlsonauthor=A.+D.+Pattersonauthor=V.+N.+Gladyshevauthor=D.+L.+Hatfield&title=Targeting+thioredoxin+reductase+1+reduction+in+cancer+cells+inhibits+self-sufficient+growth+and+DNA+replication&doi=10.1371%2Fjournal.pone.0001112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication</span></div><div class="casAuthors">Yoo Min-Hyuk; Xu Xue-Ming; Carlson Bradley A; Patterson Andrew D; Gladyshev Vadim N; Hatfield Dolph L</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1112</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Thioredoxin reductase 1 (TR1) is a major redox regulator in mammalian cells.  As an important antioxidant selenoprotein, TR1 is thought to participate in cancer prevention, but is also known to be over-expressed in many cancer cells.  Numerous cancer drugs inhibit TR1, and this protein has been proposed as a target for cancer therapy.  We previously reported that reduction of TR1 levels in cancer cells reversed many malignant characteristics suggesting that deficiency in TR1 function is antitumorigenic.  The molecular basis for TR1's role in cancer development, however, is not understood.  Herein, we found that, among selenoproteins, TR1 is uniquely overexpressed in cancer cells and its knockdown in a mouse cancer cell line driven by oncogenic k-ras resulted in morphological changes characteristic of parental (normal) cells, without significant effect on cell growth under normal growth conditions.  When grown in serum-deficient medium, TR1 deficient cancer cells lose self-sufficiency of growth, manifest a defective progression in their S phase and a decreased expression of DNA polymerase alpha, an enzyme important in DNA replication.  These observations provide evidence that TR1 is critical for self-sufficiency in growth signals of malignant cells, that TR1 acts largely as a pro-cancer protein and it is indeed a primary target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqpqQICSqJPxBrI9DTGjC0fW6udTcc2eYLHxSJ2gcNkbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snkslWlug%253D%253D&md5=d2fd949e1f8182e351c81253f447ed76</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001112%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DM.%2BH.%26aulast%3DXu%26aufirst%3DX.%2BM.%26aulast%3DCarlson%26aufirst%3DB.%2BA.%26aulast%3DPatterson%26aufirst%3DA.%2BD.%26aulast%3DGladyshev%26aufirst%3DV.%2BN.%26aulast%3DHatfield%26aufirst%3DD.%2BL.%26atitle%3DTargeting%2520thioredoxin%2520reductase%25201%2520reduction%2520in%2520cancer%2520cells%2520inhibits%2520self-sufficient%2520growth%2520and%2520DNA%2520replication%26jtitle%3DPLoS%2520One%26date%3D2007%26volume%3D2%26spage%3De1112%26doi%3D10.1371%2Fjournal.pone.0001112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Papp, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, K. K.</span><span> </span><span class="NLM_article-title">From selenium to selenoproteins: synthesis, identity, and their role in human health</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">â</span> <span class="NLM_lpage">806</span><span class="refDoi">Â DOI: 10.1089/ars.2007.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2007.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=17508906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOiurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=775-806&author=L.+V.+Pappauthor=J.+Luauthor=A.+Holmgrenauthor=K.+K.+Khanna&title=From+selenium+to+selenoproteins%3A+synthesis%2C+identity%2C+and+their+role+in+human+health&doi=10.1089%2Fars.2007.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">From Selenium to Selenoproteins: Synthesis, Identity, and Their Role in Human Health</span></div><div class="casAuthors">Papp, Laura Vanda; Lu, Jun; Holmgren, Arne; Khanna, Kum Kum</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">775-806</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The requirement of the trace element selenium for life and its beneficial role in human health has been known for several decades.  This is attributed to low mol. wt. selenium compds., as well as to its presence within at least 25 proteins, named selenoproteins, in the form of the amino acid selenocysteine (Sec).  Incorporation of Sec into selenoproteins employs a unique mechanism that involves decoding of the UGA codon.  This process requires multiple features such as the selenocysteine insertion sequence (SECIS) element and several protein factors including a specific elongation factor EFSec and the SECIS binding protein 2, SBP2.  The function of most selenoproteins is currently unknown; however, thioredoxin reductases (TrxR), glutathione peroxidases (GPx) and thyroid hormone deiodinases (DIO) are well characterized selenoproteins involved in redox regulation of intracellular signaling, redox homeostasis and thyroid hormone metab.  Recent evidence points to a role for selenium compds. as well as selenoproteins in the prevention of some forms of cancer.  A no. of clin. trials are either underway or being planned to examine the effects of selenium on cancer incidence.  In this review we describe some of the recent progress in our understanding of the mechanism of selenoprotein synthesis, the role of selenoproteins in human health and disease and the therapeutic potential of some of these proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJFvjzN_YPHLVg90H21EOLACvtfcHk0liK77Joj0om5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOiurw%253D&md5=44b83993922e803499bd408e82452ccc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1528%26sid%3Dliteratum%253Aachs%26aulast%3DPapp%26aufirst%3DL.%2BV.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26atitle%3DFrom%2520selenium%2520to%2520selenoproteins%253A%2520synthesis%252C%2520identity%252C%2520and%2520their%2520role%2520in%2520human%2520health%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D775%26epage%3D806%26doi%3D10.1089%2Fars.2007.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span> </span><span class="NLM_article-title">Thioredoxin system in cell death progression</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1738</span><span class="NLM_x">â</span> <span class="NLM_lpage">1747</span><span class="refDoi">Â DOI: 10.1089/ars.2012.4650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2012.4650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=22530689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1738-1747&author=J.+Luauthor=A.+Holmgren&title=Thioredoxin+system+in+cell+death+progression&doi=10.1089%2Fars.2012.4650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin System in Cell Death Progression</span></div><div class="casAuthors">Lu, Jun; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1738-1747</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: The thioredoxin (Trx) system, comprising NADP, Trx reductase (TrxR), and Trx, is crit. for maintaining cellular redox balance and antioxidant function, including control of oxidative stress and cell death.  Recent Advances: Here, we focus on the research progress that is involved in the regulation of apoptosis by Trx systems.  In mammalian cells, cytosolic Trx1 and mitochondrial Trx2 systems are the major disulfide reductases supplying electrons to enzymes for cell proliferation and viability.  The reduced/dithiol form of Trxs binds to apoptosis signal-regulating kinase 1 (ASK1) and inhibits its activity to prevent stress- and cytokine-induced apoptosis.  When Trx is oxidized, it dissocs. from ASK1 and apoptosis is stimulated.  The binding of Trx by its inhibitor Trx interacting protein (TXNIP) also contributes to the apoptosis process by removing Trx from ASK1.  TrxRs are large homodimeric selenoproteins with an overall structure which is similar to that of glutathione reductase, and contain an active site GCUG in the C-terminus.  Crit. Issues and Future Directions: In the regulation of cell death processes, Trx redox state and TrxR activities are key factors that det. the cell fate.  The high reactivity of Sec in TrxRs and its accessible location make TrxR enzymes emerge as targets for pharmaceutic drugs.  TrxR inactivation by covalent modification does not only change the redox state and activity of Trx, but may also convert TrxR into a reactive oxygen species generator.  Numerous electrophilic compds. including some environmental toxins and pharmaceutical drugs inhibit TrxR.  We have classified these compds. into four types and propose some useful principles to understand the reaction mechanism of the TrxR inhibition by these compds.  Antioxid. Redox Signal. 17, 1738-1747.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG24Fxk1bz_7Vg90H21EOLACvtfcHk0liK77Joj0om5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FK&md5=7287bfc98f2c31e5bcb787f06088b344</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4650%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520system%2520in%2520cell%2520death%2520progression%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D17%26spage%3D1738%26epage%3D1747%26doi%3D10.1089%2Fars.2012.4650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ducki, S.</span><span> </span><span class="NLM_article-title">Antimitotic chalcones and related compounds as inhibitors of tubulin assembly</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">â</span> <span class="NLM_lpage">347</span><span class="refDoi">Â DOI: 10.2174/1871520610909030336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.2174%2F1871520610909030336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=19275525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Cgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=336-347&author=S.+Ducki&title=Antimitotic+chalcones+and+related+compounds+as+inhibitors+of+tubulin+assembly&doi=10.2174%2F1871520610909030336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antimitotic chalcones and related compounds as inhibitors of tubulin assembly</span></div><div class="casAuthors">Ducki, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">336-347</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of chalcones as antimitotic agents has led to the design of other analogs able to interact with tubulin and inhibit its assembly into microtubules.  This activity has also been assocd. with their anti-vascular activity.  This review focuses on the development of chalcones and related analogs as antimitotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4udbevzeoA7Vg90H21EOLACvtfcHk0liK77Joj0om5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Cgu7c%253D&md5=de9d119eedd2f60dc9f3f9783b3d6495</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1871520610909030336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520610909030336%26sid%3Dliteratum%253Aachs%26aulast%3DDucki%26aufirst%3DS.%26atitle%3DAntimitotic%2520chalcones%2520and%2520related%2520compounds%2520as%2520inhibitors%2520of%2520tubulin%2520assembly%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D336%26epage%3D347%26doi%3D10.2174%2F1871520610909030336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Srinivasan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span> </span><span class="NLM_article-title">Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3â²,4â²,5â²- tetramethoxychalcone and its analogues as potent nuclear factor ÎºB inhibitors and their anticancer activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7228</span><span class="NLM_x">â</span> <span class="NLM_lpage">7235</span><span class="refDoi">Â DOI: 10.1021/jm901278z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901278z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7228-7235&author=B.+Srinivasanauthor=T.+E.+Johnsonauthor=R.+Ladauthor=C.+Xing&title=Structure-activity+relationship+studies+of+chalcone+leading+to+3-hydroxy-4%2C3%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2-+tetramethoxychalcone+and+its+analogues+as+potent+nuclear+factor+%CE%BAB+inhibitors+and+their+anticancer+activities&doi=10.1021%2Fjm901278z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901278z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901278z%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DT.%2BE.%26aulast%3DLad%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DC.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520chalcone%2520leading%2520to%25203-hydroxy-4%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2-%2520tetramethoxychalcone%2520and%2520its%2520analogues%2520as%2520potent%2520nuclear%2520factor%2520%25CE%25BAB%2520inhibitors%2520and%2520their%2520anticancer%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7228%26epage%3D7235%26doi%3D10.1021%2Fjm901278z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yang, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, P.</span><span> </span><span class="NLM_article-title">Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1550</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span><span class="refDoi">Â DOI: 10.1016/S0167-4838(01)00276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2FS0167-4838%2801%2900276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11755203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWn" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1550&publication_year=2001&pages=144-152&author=E.+B.+Yangauthor=Y.+J.+Guoauthor=K.+Zhangauthor=Y.+Z.+Chenauthor=P.+Mack&title=Inhibition+of+epidermal+growth+factor+receptor+tyrosine+kinase+by+chalcone+derivatives&doi=10.1016%2FS0167-4838%2801%2900276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives</span></div><div class="casAuthors">Yang, Er Bin; Guo, Yong Jian; Zhang, Kai; Chen, Yu Zong; Mack, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1550</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our previous study, butein, a chalcone deriv., was found to be an inhibitor of tyrosine kinases and the inhibition was ATP-competitive.  In this work, chalcone and seven chalcone derivs. were used to analyze the relationship between the structure of these compds. and their inhibition of tyrosine kinase activity.  Three of chalcone derivs., including butein, marein and phloretin, were found to have an ability to inhibit the tyrosine kinase activity of epidermal growth factor receptor (EGFR) in vitro.  IC50 was 8 Î¼M for butein, 19 Î¼M for marein and 25 Î¼M for phloretin.  The structural characterizations of these inhibitors suggest that the hydroxylations at C4 and C4' of these mols. may be required for them to act as EGFR tyrosine kinase inhibitors.  The inhibition of EGF-induced EGFR tyrosine phosphorylation by butein was also obsd. in human hepatocellular carcinoma HepG2 cells, while marein and phloretin were inactive at the doses tested.  Mol. modeling suggests that butein, marein and phloretin can be docked into the ATP binding pocket of EGFR.  Hydrogen bonds and hydrophobic interaction appear to be important in the binding of these inhibitors to EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89d_JO0pHFrVg90H21EOLACvtfcHk0lh_XR8vnWbPig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWn&md5=d39a563357fef4312c025d2d24e958e9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2801%2900276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252801%252900276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DE.%2BB.%26aulast%3DGuo%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%2BZ.%26aulast%3DMack%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520by%2520chalcone%2520derivatives%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2001%26volume%3D1550%26spage%3D144%26epage%3D152%26doi%3D10.1016%2FS0167-4838%2801%2900276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rizvi, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, I.</span><span> </span><span class="NLM_article-title">Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">â</span> <span class="NLM_lpage">944</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.bmcl.2011.12.017" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=942-944&author=S.+U.+Rizviauthor=H.+L.+Siddiquiauthor=M.+Nisarauthor=N.+Khanauthor=I.+Khan&title=Discovery+and+molecular+docking+of+quinolyl-thienyl+chalcones+as+anti-angiogenic+agents+targeting+VEGFR-2+tyrosine+kinase&doi=10.1016%2Fj.bmcl.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRizvi%26aufirst%3DS.%2BU.%26aulast%3DSiddiqui%26aufirst%3DH.%2BL.%26aulast%3DNisar%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DI.%26atitle%3DDiscovery%2520and%2520molecular%2520docking%2520of%2520quinolyl-thienyl%2520chalcones%2520as%2520anti-angiogenic%2520agents%2520targeting%2520VEGFR-2%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D942%26epage%3D944%26doi%3D10.1016%2Fj.bmcl.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gan, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminska, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leow, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, E. H.</span><span> </span><span class="NLM_article-title">Identification of Michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activity</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">â</span> <span class="NLM_lpage">1165</span><span class="refDoi">Â DOI: 10.1089/ars.2012.4909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2012.4909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=23311917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWnt7jM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1149-1165&author=F.+F.+Ganauthor=K.+K.+Kaminskaauthor=H.+Yangauthor=C.+Y.+Liewauthor=P.+C.+Leowauthor=C.+L.+Soauthor=L.+N.+Tuauthor=A.+Royauthor=C.+W.+Yapauthor=T.+S.+Kangauthor=W.+K.+Chuiauthor=E.+H.+Chew&title=Identification+of+Michael+acceptor-centric+pharmacophores+with+substituents+that+yield+strong+thioredoxin+reductase+inhibitory+character+correlated+to+antiproliferative+activity&doi=10.1089%2Fars.2012.4909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Michael Acceptor-Centric Pharmacophores with Substituents That Yield Strong Thioredoxin Reductase Inhibitory Character Correlated to Antiproliferative Activity</span></div><div class="casAuthors">Gan, Fei-Fei; Kaminska, Kamila K.; Yang, Hong; Liew, Chin-Yee; Leow, Pay-Chin; So, Choon-Leng; Tu, Lan N. L.; Roy, Amrita; Yap, Chun-Wei; Kang, Tse-Siang; Chui, Wai-Keung; Chew, Eng-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1149-1165</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The role of thioredoxin reductase (TrxR) in tumorigenesis has made it an attractive anticancer target.  A systematic approach for development of novel compds. as TrxR inhibitors is currently lacking.  Structurally diversified TrxR inhibitors share in common electrophilic propensities for the sulfhydryl groups, among which include the Michael reaction acceptors contg. an Î±,Î²-unsatd. carbonyl moiety.  We aimed to identify features among structurally diversified Michael acceptor-based compds. that would yield a strong TrxR inhibitory character.  Results: Structurally dissimilar Michael acceptor-based natural compds. such as isobutylamides, zerumbone, and shogaols (SGs) were found to possess a poor TrxR inhibitory activity, indicating that a sole Michael acceptor moiety was insufficient to produce TrxR inhibition.  The 1,7-diphenyl-hept-3-en-5-one pharmacophore in 3-phenyl-3-SG, a novel SG analog that possessed comparable TrxR inhibitory and antiproliferative potencies as 6-SG, was modified to yield 1,5-diphenyl-pent-1-en-3-one (DPPen) and 1,3-diphenyl-pro-1-en-3-one (DPPro, also known as chalcone) pharmacophores.  These Michael acceptor-centric pharmacophores, when substituted with the hydroxyl and fluorine groups, gave rise to analogs displaying a TrxR inhibitory character pos. correlated to their antiproliferative potencies.  Lead analogs 2,2'-diOH-5,5'-diF-DPPen and 2-OH-5-F-DPPro yielded a half-maximal TrxR inhibitory concn. of 9.1 and 10.5 Î¼M, resp., after 1-h incubation with recombinant rat TrxR, with the C-terminal selenocysteine residue found to be targeted.  Innovation: Identification of Michael acceptor-centric pharmacophores among diversified compds. demonstrates that a systematic approach to discover and develop Michael acceptor-based TrxR inhibitors is feasible.  Conclusion: A strong TrxR inhibitory character correlated to the antiproliferative potency is attributed to structural features that include an Î±,Î²-unsatd. carbonyl moiety centered in a DPPen or DPPro pharmacophore bearing hydroxyl and fluorine substitutions.  Antioxid. Redox Signal. 19, 1149-1165.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMUhOi4aQFrbVg90H21EOLACvtfcHk0lh_XR8vnWbPig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWnt7jM&md5=8944147ca550e5c618f77898b65791b4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4909%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DF.%2BF.%26aulast%3DKaminska%26aufirst%3DK.%2BK.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiew%26aufirst%3DC.%2BY.%26aulast%3DLeow%26aufirst%3DP.%2BC.%26aulast%3DSo%26aufirst%3DC.%2BL.%26aulast%3DTu%26aufirst%3DL.%2BN.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DYap%26aufirst%3DC.%2BW.%26aulast%3DKang%26aufirst%3DT.%2BS.%26aulast%3DChui%26aufirst%3DW.%2BK.%26aulast%3DChew%26aufirst%3DE.%2BH.%26atitle%3DIdentification%2520of%2520Michael%2520acceptor-centric%2520pharmacophores%2520with%2520substituents%2520that%2520yield%2520strong%2520thioredoxin%2520reductase%2520inhibitory%2520character%2520correlated%2520to%2520antiproliferative%2520activity%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2013%26volume%3D19%26spage%3D1149%26epage%3D1165%26doi%3D10.1089%2Fars.2012.4909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span> </span><span class="NLM_article-title">Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1795</span><span class="NLM_x">â</span> <span class="NLM_lpage">1805</span><span class="refDoi">Â DOI: 10.1021/jm5016507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5016507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2nsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1795-1805&author=B.+Zhangauthor=D.+Duanauthor=C.+Geauthor=J.+Yaoauthor=Y.+Liuauthor=X.+Liauthor=J.+Fang&title=Synthesis+of+xanthohumol+analogues+and+discovery+of+potent+thioredoxin+reductase+inhibitor+as+potential+anticancer+agent&doi=10.1021%2Fjm5016507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Xanthohumol Analogues and Discovery of Potent Thioredoxin Reductase Inhibitor as Potential Anticancer Agent</span></div><div class="casAuthors">Zhang, Baoxin; Duan, Dongzhu; Ge, Chunpo; Yao, Juan; Liu, Yaping; Li, Xinming; Fang, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1795-1805</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The selenoprotein thioredoxin reductases (TrxRs) are attractive targets for anticancer drugs development.  Xanthohumol (Xn), a naturally occurring polyphenol chalcone from hops, has received increasing attention because of its multiple pharmacol. activities.  We synthesized Xn and 43 analogs and discovered that compd. I displayed the highest cytotoxicity toward HeLa cells (IC50 = 1.4 Î¼M).  Structure-activity relationship study indicates that the prenyl group is not necessary for cytotoxicity, and introducing electron-withdrawing group, esp. on the meta-position, is favored.  In addn., methylation of the phenoxyl groups generally improves the potency.  Mechanistic study revealed that I selectively inhibits TrxR and induces reactive oxygen species and apoptosis in HeLa cells.  Cells overexpressing TrxR are resistant to I insult, while knockdown of TrxR sensitizes cells to I treatment, highlighting the physiol. significance of targeting TrxR by I.  The clarification of the structural determinants for the potency would guide the design of novel potent mols. for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwf_JKL9qk0bVg90H21EOLACvtfcHk0lhaSJw9DchYxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2nsLo%253D&md5=87716d4991e9d31cb00189d02b4ad19b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm5016507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5016507%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DDuan%26aufirst%3DD.%26aulast%3DGe%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520xanthohumol%2520analogues%2520and%2520discovery%2520of%2520potent%2520thioredoxin%2520reductase%2520inhibitor%2520as%2520potential%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1795%26epage%3D1805%26doi%3D10.1021%2Fjm5016507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ng, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span> </span><span class="NLM_article-title">Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">74</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.ejmech.2016.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=26994844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFKlu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=63-74&author=H.+L.+Ngauthor=S.+Chenauthor=E.+H.+Chewauthor=W.+K.+Chui&title=Applying+the+designed+multiple+ligands+approach+to+inhibit+dihydrofolate+reductase+and+thioredoxin+reductase+for+anti-proliferative+activity&doi=10.1016%2Fj.ejmech.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity</span></div><div class="casAuthors">Ng, Hui-Li; Chen, Shangying; Chew, Eng-Hui; Chui, Wai-Keung</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-74</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of multi-targeting drugs is currently being explored as an attractive alternative to combination therapy, esp. for the treatment of complex diseases such as cancer.  Dihydrofolate reductase (DHFR) and thioredoxin reductase (TrxR) are enzymes belonging to two unrelated cellular pathways that are known to contribute towards cancer cell growth and survival.  In order to evaluate whether simultaneous inhibition of DHFR and TrxR by dihydrotriazines (DHFR-targeting) and chalcones (TrxR-targeting) may be beneficial, breast MCF-7 and colorectal HCT116 carcinoma cells were treated with combinations of selected dihydrotriazines and chalcones at a 1:1 M ratio.  Two combinations demonstrated synergy at low-to-moderate concns.  Based on this result, four merged dihydrotriazine-chalcone compds. were designed and synthesized.  Two compds., 11a [DHFR IC50 = 56.4 Î¼M, TrxR IC50 (60 min) = 12.6 Î¼M] and 11b [DHFR IC50 = 2.4 Î¼M, TrxR IC50 (60 min) = 10.1 Î¼M], demonstrated in vitro inhibition of DHFR and TrxR.  The compds. showed growth inhibitory activity against MCF-7 and HCT116 cells, but lacked cytotoxicity.  Mol. docking expts. showed 11b to possess rational binding modes to both the enzymes.  In conclusion, this study has not only identified the dihydrotriazine and chalcone scaffolds as good starting points for the development of dual inhibitors of DHFR and TrxR, but also demonstrated the synthetic feasibility of producing a chem. entity that could result in simultaneous inhibition of DHFR and TrxR.  Future efforts to improve the antiproliferative profiles of such compds. will look at alternative ways of integrating the two pharmacophoric scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTfuawRog-FrVg90H21EOLACvtfcHk0lhaSJw9DchYxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFKlu7Y%253D&md5=db0eda82fcec1659f32400c6c64c4b0f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DH.%2BL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChew%26aufirst%3DE.%2BH.%26aulast%3DChui%26aufirst%3DW.%2BK.%26atitle%3DApplying%2520the%2520designed%2520multiple%2520ligands%2520approach%2520to%2520inhibit%2520dihydrofolate%2520reductase%2520and%2520thioredoxin%2520reductase%2520for%2520anti-proliferative%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D63%26epage%3D74%26doi%3D10.1016%2Fj.ejmech.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Mamalis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outred, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, M.</span><span> </span><span class="NLM_article-title">770. Amino-oxy-derivatives. Part III. Dihydrotriazines and related heterocycles</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_fpage">3915</span><span class="NLM_x">â</span> <span class="NLM_lpage">3926</span><span class="refDoi">Â DOI: 10.1039/jr9620003915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1039%2Fjr9620003915" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1962&pages=3915-3926&author=P.+Mamalisauthor=J.+Greenauthor=D.+J.+Outredauthor=M.+Rix&title=770.+Amino-oxy-derivatives.+Part+III.+Dihydrotriazines+and+related+heterocycles&doi=10.1039%2Fjr9620003915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fjr9620003915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9620003915%26sid%3Dliteratum%253Aachs%26aulast%3DMamalis%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DOutred%26aufirst%3DD.%2BJ.%26aulast%3DRix%26aufirst%3DM.%26atitle%3D770.%2520Amino-oxy-derivatives.%2520Part%2520III.%2520Dihydrotriazines%2520and%2520related%2520heterocycles%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1962%26spage%3D3915%26epage%3D3926%26doi%3D10.1039%2Fjr9620003915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sodani, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, B. L.</span><span> </span><span class="NLM_article-title">Syntheses and Reactions of 4 â²-[(omega-Bromoalkyl)oxy]- and 4 â²,4 â´-(Polymethylenedoxy)-bis Substituted Chalcones</span> <span class="citation_source-journal">E-J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">â</span> <span class="NLM_lpage">769</span><span class="refDoi">Â DOI: 10.1155/2010/807059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1155%2F2010%2F807059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVCis7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=763-769&author=R.+S.+Sodaniauthor=P.+C.+Choudharyauthor=H.+O.+Sharmaauthor=B.+L.+Verma&title=Syntheses+and+Reactions+of+4+%E2%80%B2-%5B%28omega-Bromoalkyl%29oxy%5D-+and+4+%E2%80%B2%2C4+%E2%80%B4-%28Polymethylenedoxy%29-bis+Substituted+Chalcones&doi=10.1155%2F2010%2F807059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and reactions of 4'-[(Ï-bromoalkyl)oxy]- and 4',4'''-(polymethylenedioxy)-bis substituted chalcones</span></div><div class="casAuthors">Sodani, R. S.; Choudhary, Prakash C.; Sharma, Hari Om; Verma, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">E-Journal of Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">763-769</span>CODEN:
                <span class="NLM_cas:coden">ECJHAO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">WWW Publications</span>)
        </div><div class="casAbstract">Base-catalyzed condensation of 4-HOC6H4Ac with appropriate aldehydes gave 4'-hydroxychalcone and its 4-methoxy and 4-chloro deriv.  Subsequent reaction with 1 equiv. Î±,Ï-dibromoethane, -butane, or -hexane resulted in a mixt. of 4'-[(Ï-bromoalkyl)oxy]chalcones (sol. in EtOH) and 4',4'''-(polymethylenedioxy)bischalcones (insol. in EtOH).  The latter compds. were also synthesized by another route.  Thus, on treatment with Î±,Ï-dibromo alkanes in 2:1 molar ratio, 4-HOC6H4Ac was converted to 4',4'''-(polymethylenedioxy)diacetophenones, which on base-catalyzed condensation gave the target compds.  Reaction of 4d with phenols and thiophenols gave corresponding phenoxy- and thiophenoxy chalcones, whereas the bis-chalcones on treatment with N2H4Â·H2O furnished the corresponding bis-2-pyrazolines.  The structures of the compds. were confirmed by elemental anal. and spectra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQ7etIhM8CLVg90H21EOLACvtfcHk0liuV6iylpB7Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVCis7Y%253D&md5=b325bdf151569d1808dc06bd8ee2a6c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1155%2F2010%2F807059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2010%252F807059%26sid%3Dliteratum%253Aachs%26aulast%3DSodani%26aufirst%3DR.%2BS.%26aulast%3DChoudhary%26aufirst%3DP.%2BC.%26aulast%3DSharma%26aufirst%3DH.%2BO.%26aulast%3DVerma%26aufirst%3DB.%2BL.%26atitle%3DSyntheses%2520and%2520Reactions%2520of%25204%2520%25E2%2580%25B2-%255B%2528omega-Bromoalkyl%2529oxy%255D-%2520and%25204%2520%25E2%2580%25B2%252C4%2520%25E2%2580%25B4-%2528Polymethylenedoxy%2529-bis%2520Substituted%2520Chalcones%26jtitle%3DE-J.%2520Chem.%26date%3D2010%26volume%3D7%26spage%3D763%26epage%3D769%26doi%3D10.1155%2F2010%2F807059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span> </span><span class="NLM_article-title">The impact of p53 status on cellular sensitivity to antifolate drugs</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2114</span><span class="NLM_x">â</span> <span class="NLM_lpage">2123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11448931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslaksr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=2114-2123&author=X.+Luauthor=J.+Erringtonauthor=N.+J.+Curtinauthor=J.+Lunecauthor=D.+R.+Newell&title=The+impact+of+p53+status+on+cellular+sensitivity+to+antifolate+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of p53 status on cellular sensitivity to antifolate drugs</span></div><div class="casAuthors">Lu, Xiaohong; Errington, Julie; Curtin, Nicola J.; Lunec, John; Newell, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2114-2123</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The impact of p53 status on cellular sensitivity to antifolate drugs has been examd. in seven human cell lines (A549, MCF7, T-47D, CCRF-CEM, COR-L23, A2780, and HCT-116) and p53 nonfunctional counterparts of two of the cell lines (HCT-116/N7 and A2780/CP70).  P53 status was detd. by sequencing and functional assays.  The sensitivities of the cell lines to growth inhibition (sulforhodamine B assay) produced by four antifolate drugs (Alimta, methotrexate, raltitrexed, and lometrexol) were studied.  There was no clear relationship between functional p53 status and sensitivity to methotrexate or lometrexol, whereas a functional p53 status was possibly assocd. with resistance to Alimta- and raltitrexed-induced growth inhibition.  In contrast, in the two pairs of related human tumor cell lines (HCT-116 and HCT-116/N7 and A2780 and A2780/CP70) cells with functional p53 were more sensitive to Alimta- and raltitrexed-induced growth inhibition (P = 0.002).  Detailed studies were performed with the A2780 cell lines, and in the parental cells sensitivity to Alimta- and raltitrexed-induced cytotoxicity (clonogenic assay) was similar to the sensitivity detd. in the sulforhodamine B assay.  However, in A2780/CP70 cells, 1 Î¼M of drug resulted in only 40-60% growth inhibition yet â¥85% cytotoxicity.  After Alimta and raltitrexed exposure for â¤72 h, there were no differences between the A2780 and A278/CP70 cell lines in cell cycle phase distribution, abs. cell no., or the induction of apoptosis.  However, the cellular protein content of the A2780/CP70 cells was 3-6-fold higher than in A2780 cells after Alimta and raltitrexed treatment, suggesting that cells without functional p53 can maintain protein synthesis in the absence of cell division (unbalanced cell growth).  In conclusion, the apparent impact of functional p53 status on sensitivity to antifolate drugs may depend upon the phenotypic/genotypic background as well as the assay used to measure cellular sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1VUq3zl8vPbVg90H21EOLACvtfcHk0liiymhNSUpmsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslaksr8%253D&md5=b4ac9eb5f2da16ddde0748d80a7d874a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DErrington%26aufirst%3DJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DLunec%26aufirst%3DJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26atitle%3DThe%2520impact%2520of%2520p53%2520status%2520on%2520cellular%2520sensitivity%2520to%2520antifolate%2520drugs%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D2114%26epage%3D2123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>Dihydrofolate reductase assay kit: technical bulletin. <a href="http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Bulletin/cs0340bul.pdf" class="extLink">http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Bulletin/cs0340bul.pdf</a> (accessed July 6,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dihydrofolate+reductase+assay+kit%3A+technical+bulletin.+http%3A%2F%2Fwww.sigmaaldrich.com%2Fcontent%2Fdam%2Fsigma-aldrich%2Fdocs%2FSigma%2FBulletin%2Fcs0340bul.pdf+%28accessed+July+6%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">ArnÃ©r, E. S.; Holmgren, A.</span><span> </span><span class="NLM_article-title">Measurement of thioredoxin and thioredoxin reductase</span>.  <span class="citation_source-book">Current Protocols in Toxicology</span>; <span class="NLM_publisher-name">Wiley</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>Chapter 7, Unit 7.4, DOI: <span class="refDoi">Â DOI: 10.1002/0471140856.tx0704s05</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2F0471140856.tx0704s05" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=E.+S.+Arn%C3%A9r&author=A.+Holmgren&title=Current+Protocols+in+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2F0471140856.tx0704s05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471140856.tx0704s05%26sid%3Dliteratum%253Aachs%26aulast%3DArn%25C3%25A9r%26aufirst%3DE.%2BS.%26atitle%3DMeasurement%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%26btitle%3DCurrent%2520Protocols%2520in%2520Toxicology%26pub%3DWiley%26date%3D2003%26doi%3D10.1002%2F0471140856.tx0704s05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yuanwei Liang, Delong Zeng, Yuanyuan You, Bin Ma, Xiaoling Li, <span class="NLM_string-name hlFld-ContribAuthor">Tianfeng Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Dihydrofolate Reductase Inhibitors as X-ray Radiosensitizers to Reverse Radioresistance of Cervical Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 1421-1428. <a href="https://doi.org/10.1021/acsmedchemlett.0c00105" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00105%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesigning%252BDihydrofolate%252BReductase%252BInhibitors%252Bas%252BX-ray%252BRadiosensitizers%252Bto%252BReverse%252BRadioresistance%252Bof%252BCervical%252BCancer%26aulast%3DLiang%26aufirst%3DYuanwei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11032020%26date%3D17062020%26date%3D28062020%26date%3D17062020%26volume%3D11%26issue%3D7%26spage%3D1421%26epage%3D1428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ruijuan Liu, Danfeng Shi, Junmin Zhang, Xinming Li, Xiao Han, Xiaojun Yao, <span class="NLM_string-name hlFld-ContribAuthor">Jianguo Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Xanthatin Promotes Apoptosis via Inhibiting Thioredoxin Reductase and Eliciting Oxidative Stress. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (8)
                                     , 3285-3296. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00338" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00338%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DXanthatin%252BPromotes%252BApoptosis%252Bvia%252BInhibiting%252BThioredoxin%252BReductase%252Band%252BEliciting%252BOxidative%252BStress%26aulast%3DLiu%26aufirst%3DRuijuan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29032018%26date%3D25062018%26date%3D18062018%26date%3D05072018%26date%3D25062018%26volume%3D15%26issue%3D8%26spage%3D3285%26epage%3D3296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jagpreet Singh  Sidhu</span>, <span class="hlFld-ContribAuthor ">Navneet  Kaur</span>, <span class="hlFld-ContribAuthor ">Narinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Trends in small organic fluorescent scaffolds for detection of oxidoreductase. </span><span class="cited-content_cbyCitation_journal-name">Biosensors and Bioelectronics</span><span> <strong>2021,</strong> <em>191 </em>, 113441. <a href="https://doi.org/10.1016/j.bios.2021.113441" title="DOI URL">https://doi.org/10.1016/j.bios.2021.113441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bios.2021.113441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bios.2021.113441%26sid%3Dliteratum%253Aachs%26jtitle%3DBiosensors%2520and%2520Bioelectronics%26atitle%3DTrends%252Bin%252Bsmall%252Borganic%252Bfluorescent%252Bscaffolds%252Bfor%252Bdetection%252Bof%252Boxidoreductase%26aulast%3DSidhu%26aufirst%3DJagpreet%2BSingh%26date%3D2021%26volume%3D191%26spage%3D113441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Ji  Zhou</span>, <span class="hlFld-ContribAuthor ">Qing-Zhu  Fan</span>, <span class="hlFld-ContribAuthor ">Xiao-Mei  Lv</span>, <span class="hlFld-ContribAuthor ">Tian  Wang</span>, <span class="hlFld-ContribAuthor ">Fan  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Chen</span>, <span class="hlFld-ContribAuthor ">Sen-Yan  Hong</span>, <span class="hlFld-ContribAuthor ">Xiao-Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Bing-Song  Xu</span>, <span class="hlFld-ContribAuthor ">Lei  Hu</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Ye-Ming  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of hydroxytyrosol as thioredoxin reductase 1 inhibitor to induce apoptosis and G
              1
              /S cell cycle arrest in human colorectal cancer cells via ROS generation. </span><span class="cited-content_cbyCitation_journal-name">Experimental and Therapeutic Medicine</span><span> <strong>2021,</strong> <em>22 </em>
                                    (2)
                                     <a href="https://doi.org/10.3892/etm.2021.10261" title="DOI URL">https://doi.org/10.3892/etm.2021.10261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/etm.2021.10261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fetm.2021.10261%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520and%2520Therapeutic%2520Medicine%26atitle%3DDiscovery%252Bof%252Bhydroxytyrosol%252Bas%252Bthioredoxin%252Breductase%252B1%252Binhibitor%252Bto%252Binduce%252Bapoptosis%252Band%252BG%252B1%252B%25252FS%252Bcell%252Bcycle%252Barrest%252Bin%252Bhuman%252Bcolorectal%252Bcancer%252Bcells%252Bvia%252BROS%252Bgeneration%26aulast%3DZhang%26aufirst%3DSheng-Peng%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Juanjuan  Li</span>, <span class="hlFld-ContribAuthor ">Xinyue  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Fu</span>, <span class="hlFld-ContribAuthor ">Si  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Chalcone Derivatives: Role in Anticancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 894. <a href="https://doi.org/10.3390/biom11060894" title="DOI URL">https://doi.org/10.3390/biom11060894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11060894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11060894%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DChalcone%252BDerivatives%25253A%252BRole%252Bin%252BAnticancer%252BTherapy%26aulast%3DOuyang%26aufirst%3DYang%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evgeny  Chupakhin</span>, <span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Thioredoxin reductase inhibitors: updated patent review (2017-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>8 </em>, 1-14. <a href="https://doi.org/10.1080/13543776.2021.1899160" title="DOI URL">https://doi.org/10.1080/13543776.2021.1899160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1899160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1899160%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DThioredoxin%252Breductase%252Binhibitors%25253A%252Bupdated%252Bpatent%252Breview%252B%2525282017-present%252529%26aulast%3DChupakhin%26aufirst%3DEvgeny%26date%3D2021%26date%3D2021%26volume%3D8%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamal  Lasri</span>, <span class="hlFld-ContribAuthor ">Matti  Haukka</span>, <span class="hlFld-ContribAuthor ">Hessa H.  Al-Rasheed</span>, <span class="hlFld-ContribAuthor ">Nael  Abutaha</span>, <span class="hlFld-ContribAuthor ">Ayman  El-Faham</span>, <span class="hlFld-ContribAuthor ">Saied M.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Structure and In Vitro Anticancer Activity of Pd(II) Complex of Pyrazolyl-s-Triazine Ligand; A New Example of Metal-Mediated Hydrolysis of s-Triazine Pincer Ligand. </span><span class="cited-content_cbyCitation_journal-name">Crystals</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 119. <a href="https://doi.org/10.3390/cryst11020119" title="DOI URL">https://doi.org/10.3390/cryst11020119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cryst11020119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcryst11020119%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystals%26atitle%3DSynthesis%25252C%252BStructure%252Band%252BIn%252BVitro%252BAnticancer%252BActivity%252Bof%252BPd%252528II%252529%252BComplex%252Bof%252BPyrazolyl-s-Triazine%252BLigand%25253B%252BA%252BNew%252BExample%252Bof%252BMetal-Mediated%252BHydrolysis%252Bof%252Bs-Triazine%252BPincer%252BLigand%26aulast%3DLasri%26aufirst%3DJamal%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Zhu  Fan</span>, <span class="hlFld-ContribAuthor ">Ji  Zhou</span>, <span class="hlFld-ContribAuthor ">Yi-Bao  Zhu</span>, <span class="hlFld-ContribAuthor ">Lian-Jun  He</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Miao</span>, <span class="hlFld-ContribAuthor ">Sheng-Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104401. <a href="https://doi.org/10.1016/j.bioorg.2020.104401" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104401%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnovel%252Bindoleamine%252B2%25252C3-dioxigenase%252B1%252B%252528IDO1%252529%252Band%252Bthioredoxin%252Breductase%252B%252528TrxR%252529%252Bdual%252Binhibitor%26aulast%3DFan%26aufirst%3DQing-Zhu%26date%3D2020%26volume%3D105%26spage%3D104401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Yan</span>, <span class="hlFld-ContribAuthor ">Renchao  Ma</span>, <span class="hlFld-ContribAuthor ">Rener  Chen</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiming  Wang</span>, <span class="hlFld-ContribAuthor ">Yongmin  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,2-dihydro-1,3,5-triazine derivatives
              via
              Cu(
              ii
              )-catalyzed C(sp
              3
              )âH activation of
              N
              ,
              N
              -dimethylethanolamine with amidines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (74)
                                     , 10946-10949. <a href="https://doi.org/10.1039/D0CC03820B" title="DOI URL">https://doi.org/10.1039/D0CC03820B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC03820B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC03820B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSynthesis%252Bof%252B1%25252C2-dihydro-1%25252C3%25252C5-triazine%252Bderivatives%252Bvia%252BCu%252528%252Bii%252B%252529-catalyzed%252BC%252528sp%252B3%252B%252529%2525E2%252580%252593H%252Bactivation%252Bof%252BN%252B%25252C%252BN%252B-dimethylethanolamine%252Bwith%252Bamidines%26aulast%3DYan%26aufirst%3DMin%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D74%26spage%3D10946%26epage%3D10949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Gao</span>, <span class="hlFld-ContribAuthor ">Gang  Huang</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structureâactivity relationship. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (5)
                                     , 2049-2084. <a href="https://doi.org/10.1002/med.21698" title="DOI URL">https://doi.org/10.1002/med.21698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21698%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DChalcone%252Bhybrids%252Bas%252Bpotential%252Banticancer%252Bagents%25253A%252BCurrent%252Bdevelopment%25252C%252Bmechanism%252Bof%252Baction%25252C%252Band%252Bstructure%2525E2%252580%252590activity%252Brelationship%26aulast%3DGao%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D5%26spage%3D2049%26epage%3D2084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamal  Lasri</span>, <span class="hlFld-ContribAuthor ">Hessa H.  Al-Rasheed</span>, <span class="hlFld-ContribAuthor ">Ayman  El-Faham</span>, <span class="hlFld-ContribAuthor ">Matti  Haukka</span>, <span class="hlFld-ContribAuthor ">Nael  Abutaha</span>, <span class="hlFld-ContribAuthor ">Saied M.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structure and in vitro anticancer activity of Pd(II) complexes of mono- and bis-pyrazolyl-s-triazine ligands. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2020,</strong> <em>187 </em>, 114665. <a href="https://doi.org/10.1016/j.poly.2020.114665" title="DOI URL">https://doi.org/10.1016/j.poly.2020.114665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2020.114665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2020.114665%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DSynthesis%25252C%252Bstructure%252Band%252Bin%252Bvitro%252Banticancer%252Bactivity%252Bof%252BPd%252528II%252529%252Bcomplexes%252Bof%252Bmono-%252Band%252Bbis-pyrazolyl-s-triazine%252Bligands%26aulast%3DLasri%26aufirst%3DJamal%26date%3D2020%26volume%3D187%26spage%3D114665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hessa  H. Al Rasheed</span>, <span class="hlFld-ContribAuthor ">Azizah  M. Malebari</span>, <span class="hlFld-ContribAuthor ">Kholood  A. Dahlous</span>, <span class="hlFld-ContribAuthor ">Ayman  El-Faham</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (11)
                                     , 2708. <a href="https://doi.org/10.3390/molecules25112708" title="DOI URL">https://doi.org/10.3390/molecules25112708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25112708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25112708%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BNew%252BSeries%252Bof%252B1%25252C3-5-Triazine%252BHydrazone%252BDerivatives%252Bwith%252BPromising%252BAntiproliferative%252BActivity%26aulast%3DH.%2BAl%2BRasheed%26aufirst%3DHessa%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D11%26spage%3D2708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Germain  Homerin</span>, <span class="hlFld-ContribAuthor ">Adrian Sorin  Nica</span>, <span class="hlFld-ContribAuthor ">Amaury  Farce</span>, <span class="hlFld-ContribAuthor ">JoÃ«lle  Dubois</span>, <span class="hlFld-ContribAuthor ">Alina  Ghinet</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (11)
                                     , 127149. <a href="https://doi.org/10.1016/j.bmcl.2020.127149" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127149%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DUltrasounds-mediated%252B10-seconds%252Bsynthesis%252Bof%252Bchalcones%252Bas%252Bpotential%252Bfarnesyltransferase%252Binhibitors%26aulast%3DHomerin%26aufirst%3DGermain%26date%3D2020%26volume%3D30%26issue%3D11%26spage%3D127149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gunasekaran  Arun Kumar</span>, <span class="hlFld-ContribAuthor ">Ayyavu  Chandramohan</span>, <span class="hlFld-ContribAuthor ">Ponnaiah  Gomathi Priya</span>, <span class="hlFld-ContribAuthor ">Muthukaruppan  Alagar</span>. </span><span class="cited-content_cbyCitation_article-title">Acetophenone and thiophene sideâarm polyaryleneethynylene conjugated polymers for enrichment of electronic applications. </span><span class="cited-content_cbyCitation_journal-name">Polymer International</span><span> <strong>2020,</strong> <em>69 </em>
                                    (4)
                                     , 429-438. <a href="https://doi.org/10.1002/pi.5972" title="DOI URL">https://doi.org/10.1002/pi.5972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pi.5972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpi.5972%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymer%2520International%26atitle%3DAcetophenone%252Band%252Bthiophene%252Bside%2525E2%252580%252590arm%252Bpolyaryleneethynylene%252Bconjugated%252Bpolymers%252Bfor%252Benrichment%252Bof%252Belectronic%252Bapplications%26aulast%3DArun%2BKumar%26aufirst%3DGunasekaran%26date%3D2020%26date%3D2020%26volume%3D69%26issue%3D4%26spage%3D429%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno Junior  Neves</span>, <span class="hlFld-ContribAuthor ">Jonathan Paulo  Agnes</span>, <span class="hlFld-ContribAuthor ">Marcelo do Nascimento  Gomes</span>, <span class="hlFld-ContribAuthor ">Marcio Roberto  Henriques Donza</span>, <span class="hlFld-ContribAuthor ">RosÃ¢ngela Mayer  GonÃ§alves</span>, <span class="hlFld-ContribAuthor ">Marina  Delgobo</span>, <span class="hlFld-ContribAuthor ">Lauro  Ribeiro de Souza Neto</span>, <span class="hlFld-ContribAuthor ">Mario Roberto  Senger</span>, <span class="hlFld-ContribAuthor ">Floriano Paes  Silva-Junior</span>, <span class="hlFld-ContribAuthor ">Sabrina Baptista  Ferreira</span>, <span class="hlFld-ContribAuthor ">Alfeu  Zanotto-Filho</span>, <span class="hlFld-ContribAuthor ">Carolina Horta  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient identification of novel anti-glioma lead compounds by machine learning models. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 111981. <a href="https://doi.org/10.1016/j.ejmech.2019.111981" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111981%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEfficient%252Bidentification%252Bof%252Bnovel%252Banti-glioma%252Blead%252Bcompounds%252Bby%252Bmachine%252Blearning%252Bmodels%26aulast%3DNeves%26aufirst%3DBruno%2BJunior%26date%3D2020%26volume%3D189%26spage%3D111981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Wenda  Zhang</span>, <span class="hlFld-ContribAuthor ">Junqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Jianbo  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103530. <a href="https://doi.org/10.1016/j.bioorg.2019.103530" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103530%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioactivity%252Bevaluation%252Bof%252Bcoumarin-chalcone%252Bhybrids%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DWang%26aufirst%3DYu%26date%3D2020%26volume%3D95%26spage%3D103530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroshi  Nonaka</span>, <span class="hlFld-ContribAuthor ">Yuki  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Satoshi  Kuno</span>, <span class="hlFld-ContribAuthor ">Tomoki  Ota</span>, <span class="hlFld-ContribAuthor ">Kentaro  Mochidome</span>, <span class="hlFld-ContribAuthor ">Yutaro  Saito</span>, <span class="hlFld-ContribAuthor ">Fuminori  Sugihara</span>, <span class="hlFld-ContribAuthor ">Yoichi  Takakusagi</span>, <span class="hlFld-ContribAuthor ">Ichio  Aoki</span>, <span class="hlFld-ContribAuthor ">Satoru  Nagatoishi</span>, <span class="hlFld-ContribAuthor ">Kouhei  Tsumoto</span>, <span class="hlFld-ContribAuthor ">Shinsuke  Sando</span>. </span><span class="cited-content_cbyCitation_article-title">Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-08833-7" title="DOI URL">https://doi.org/10.1038/s41467-019-08833-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-08833-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-08833-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DDesign%252Bstrategy%252Bfor%252Bserine%252Bhydroxymethyltransferase%252Bprobes%252Bbased%252Bon%252Bretro-aldol-type%252Breaction%26aulast%3DNonaka%26aufirst%3DHiroshi%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruijuan  Liu</span>, <span class="hlFld-ContribAuthor ">Danfeng  Shi</span>, <span class="hlFld-ContribAuthor ">Junmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinming  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Han</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screening-guided discovery of thioredoxin reductase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2019,</strong> <em>370 </em>, 106-116. <a href="https://doi.org/10.1016/j.taap.2019.03.014" title="DOI URL">https://doi.org/10.1016/j.taap.2019.03.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2019.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2019.03.014%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DVirtual%252Bscreening-guided%252Bdiscovery%252Bof%252Bthioredoxin%252Breductase%252Binhibitors%26aulast%3DLiu%26aufirst%3DRuijuan%26date%3D2019%26volume%3D370%26spage%3D106%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Raimondi</span>, <span class="hlFld-ContribAuthor ">Ornella  Randazzo</span>, <span class="hlFld-ContribAuthor ">Mery  La Franca</span>, <span class="hlFld-ContribAuthor ">Giampaolo  Barone</span>, <span class="hlFld-ContribAuthor ">Elisa  Vignoni</span>, <span class="hlFld-ContribAuthor ">Daniela  Rossi</span>, <span class="hlFld-ContribAuthor ">Simona  Collina</span>. </span><span class="cited-content_cbyCitation_article-title">DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (6)
                                     , 1140. <a href="https://doi.org/10.3390/molecules24061140" title="DOI URL">https://doi.org/10.3390/molecules24061140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24061140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24061140%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDHFR%252BInhibitors%25253A%252BReading%252Bthe%252BPast%252Bfor%252BDiscovering%252BNovel%252BAnticancer%252BAgents%26aulast%3DRaimondi%26aufirst%3DMaria%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D6%26spage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thalia  Liargkova</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Eleftheriadis</span>, <span class="hlFld-ContribAuthor ">Frank  Dekker</span>, <span class="hlFld-ContribAuthor ">Efstathia  Voulgari</span>, <span class="hlFld-ContribAuthor ">Constantinos  Avgoustakis</span>, <span class="hlFld-ContribAuthor ">Marina  Sagnou</span>, <span class="hlFld-ContribAuthor ">Barbara  Mavroidi</span>, <span class="hlFld-ContribAuthor ">Maria  Pelecanou</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">Small Multitarget Molecules Incorporating the Enone Moiety. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (1)
                                     , 199. <a href="https://doi.org/10.3390/molecules24010199" title="DOI URL">https://doi.org/10.3390/molecules24010199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24010199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24010199%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSmall%252BMultitarget%252BMolecules%252BIncorporating%252Bthe%252BEnone%252BMoiety%26aulast%3DLiargkova%26aufirst%3DThalia%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D1%26spage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adnan  Ashraf</span>, <span class="hlFld-ContribAuthor ">Syeda Abida  Ejaz</span>, <span class="hlFld-ContribAuthor ">Shafiq Ur  Rahman</span>, <span class="hlFld-ContribAuthor ">Waseeq Ahmad  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Muhammad Nadeem  Arshad</span>, <span class="hlFld-ContribAuthor ">Joanna  Lecka</span>, <span class="hlFld-ContribAuthor ">Jean  SÃ©vigny</span>, <span class="hlFld-ContribAuthor ">Mohie E. Moustafa  Zayed</span>, <span class="hlFld-ContribAuthor ">Abdullah M.  Asiri</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Christian G.  Hartinger</span>, <span class="hlFld-ContribAuthor ">Muhammad  Hanif</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>159 </em>, 282-291. <a href="https://doi.org/10.1016/j.ejmech.2018.09.063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHybrid%252Bcompounds%252Bfrom%252Bchalcone%252Band%252B1%25252C2-benzothiazine%252Bpharmacophores%252Bas%252Bselective%252Binhibitors%252Bof%252Balkaline%252Bphosphatase%252Bisozymes%26aulast%3DAshraf%26aufirst%3DAdnan%26date%3D2018%26volume%3D159%26spage%3D282%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhawana  Kumari</span>, <span class="hlFld-ContribAuthor ">Kalpana  Chauhan</span>, <span class="hlFld-ContribAuthor ">Jalpa  Trivedi</span>, <span class="hlFld-ContribAuthor ">Varun  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Shamsher S.  Kanwar</span>, <span class="hlFld-ContribAuthor ">Yuba Raj  Pokharel</span>. </span><span class="cited-content_cbyCitation_article-title">Benzothiazole-Based-Bioconjugates with Improved Antimicrobial, Anticancer and Antioxidant Potential. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (40)
                                     , 11326-11332. <a href="https://doi.org/10.1002/slct.201801936" title="DOI URL">https://doi.org/10.1002/slct.201801936</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201801936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201801936%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DBenzothiazole-Based-Bioconjugates%252Bwith%252BImproved%252BAntimicrobial%25252C%252BAnticancer%252Band%252BAntioxidant%252BPotential%26aulast%3DKumari%26aufirst%3DBhawana%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D40%26spage%3D11326%26epage%3D11332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Lu</span>, <span class="hlFld-ContribAuthor ">Obinna N.  Obianom</span>, <span class="hlFld-ContribAuthor ">Yong  Ai</span>. </span><span class="cited-content_cbyCitation_article-title">Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer
              in vitro
              and
              in vivo. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 1722-1732. <a href="https://doi.org/10.1039/C8MD00284C" title="DOI URL">https://doi.org/10.1039/C8MD00284C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00284C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00284C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNovel%252Bhybrids%252Bderived%252Bfrom%252Baspirin%252Band%252Bchalcones%252Bpotently%252Bsuppress%252Bcolorectal%252Bcancer%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DLu%26aufirst%3DShan%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D10%26spage%3D1722%26epage%3D1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaobin  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Wen Jian  Tang</span>, <span class="hlFld-ContribAuthor ">Jing Bo  Shi</span>, <span class="hlFld-ContribAuthor ">Xin Hua  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel curcumin analogue hybrids: Synthesis and anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 493-509. <a href="https://doi.org/10.1016/j.ejmech.2018.07.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bcurcumin%252Banalogue%252Bhybrids%25253A%252BSynthesis%252Band%252Banticancer%252Bactivity%26aulast%3DWang%26aufirst%3DJie%2BQuan%26date%3D2018%26volume%3D156%26spage%3D493%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Devrim  GÃ¼zel BayÃ¼lken</span>, <span class="hlFld-ContribAuthor ">R. Beklem  BostancÄ±oÄlu</span>, <span class="hlFld-ContribAuthor ">A. Tansu  Koparal</span>, <span class="hlFld-ContribAuthor ">Berrin  Ayaz TÃ¼ylÃ¼</span>, <span class="hlFld-ContribAuthor ">Aydan  DaÄ</span>, <span class="hlFld-ContribAuthor ">Kadriye  Benkli</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of in vitro cytotoxic and genotoxic activities of some trimethoprim conjugates. </span><span class="cited-content_cbyCitation_journal-name">Cytotechnology</span><span> <strong>2018,</strong> <em>70 </em>
                                    (3)
                                     , 1051-1059. <a href="https://doi.org/10.1007/s10616-018-0187-7" title="DOI URL">https://doi.org/10.1007/s10616-018-0187-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10616-018-0187-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10616-018-0187-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCytotechnology%26atitle%3DAssessment%252Bof%252Bin%252Bvitro%252Bcytotoxic%252Band%252Bgenotoxic%252Bactivities%252Bof%252Bsome%252Btrimethoprim%252Bconjugates%26aulast%3DG%25C3%25BCzel%2BBay%25C3%25BClken%26aufirst%3DDevrim%26date%3D2018%26date%3D2018%26volume%3D70%26issue%3D3%26spage%3D1051%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei-Fei  Gan</span>, <span class="hlFld-ContribAuthor ">Ruirui  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui-Li  Ng</span>, <span class="hlFld-ContribAuthor ">Muthukumar  Karuppasamy</span>, <span class="hlFld-ContribAuthor ">Waygene  Seah</span>, <span class="hlFld-ContribAuthor ">Wei Hseun  Yeap</span>, <span class="hlFld-ContribAuthor ">Siew-Min  Ong</span>, <span class="hlFld-ContribAuthor ">Eva  Hadadi</span>, <span class="hlFld-ContribAuthor ">Siew-Cheng  Wong</span>, <span class="hlFld-ContribAuthor ">Wai-Keung  Chui</span>, <span class="hlFld-ContribAuthor ">Eng-Hui  Chew</span>. </span><span class="cited-content_cbyCitation_article-title">Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-ÎºB signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Food and Chemical Toxicology</span><span> <strong>2018,</strong> <em>116 </em>, 238-248. <a href="https://doi.org/10.1016/j.fct.2018.04.003" title="DOI URL">https://doi.org/10.1016/j.fct.2018.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fct.2018.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fct.2018.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520and%2520Chemical%2520Toxicology%26atitle%3DNovel%252Bdual-targeting%252Banti-proliferative%252Bdihydrotriazine-chalcone%252Bderivatives%252Bdisplay%252Bsuppression%252Bof%252Bcancer%252Bcell%252Binvasion%252Band%252Binflammation%252Bby%252Binhibiting%252Bthe%252BNF-%2525CE%2525BAB%252Bsignaling%252Bpathway%26aulast%3DGan%26aufirst%3DFei-Fei%26date%3D2018%26volume%3D116%26spage%3D238%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinming  Li</span>, <span class="hlFld-ContribAuthor ">Yanan  Hou</span>, <span class="hlFld-ContribAuthor ">Xianke  Meng</span>, <span class="hlFld-ContribAuthor ">Chunpo  Ge</span>, <span class="hlFld-ContribAuthor ">Huilong  Ma</span>, <span class="hlFld-ContribAuthor ">Jin  Li</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Activation of a Prodrug by Thioredoxin Reductase Providing a Strategy to Target Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (21)
                                     , 6141-6145. <a href="https://doi.org/10.1002/anie.201801058" title="DOI URL">https://doi.org/10.1002/anie.201801058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201801058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201801058%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSelective%252BActivation%252Bof%252Ba%252BProdrug%252Bby%252BThioredoxin%252BReductase%252BProviding%252Ba%252BStrategy%252Bto%252BTarget%252BCancer%252BCells%26aulast%3DLi%26aufirst%3DXinming%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D21%26spage%3D6141%26epage%3D6145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinming  Li</span>, <span class="hlFld-ContribAuthor ">Yanan  Hou</span>, <span class="hlFld-ContribAuthor ">Xianke  Meng</span>, <span class="hlFld-ContribAuthor ">Chunpo  Ge</span>, <span class="hlFld-ContribAuthor ">Huilong  Ma</span>, <span class="hlFld-ContribAuthor ">Jin  Li</span>, <span class="hlFld-ContribAuthor ">Jianguo  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Activation of a Prodrug by Thioredoxin Reductase Providing a Strategy to Target Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (21)
                                     , 6249-6253. <a href="https://doi.org/10.1002/ange.201801058" title="DOI URL">https://doi.org/10.1002/ange.201801058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201801058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201801058%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSelective%252BActivation%252Bof%252Ba%252BProdrug%252Bby%252BThioredoxin%252BReductase%252BProviding%252Ba%252BStrategy%252Bto%252BTarget%252BCancer%252BCells%26aulast%3DLi%26aufirst%3DXinming%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D21%26spage%3D6249%26epage%3D6253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Li</span>, <span class="hlFld-ContribAuthor ">Fang  Fang</span>, <span class="hlFld-ContribAuthor ">Yunqi  Liu</span>, <span class="hlFld-ContribAuthor ">Liangmin  Xue</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Chao  Tian</span>, <span class="hlFld-ContribAuthor ">Junyi  Liu</span>, <span class="hlFld-ContribAuthor ">Zhili  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of dihydrofolate reductase as antitumor agents: design, synthesis and biological evaluation of a series of novel nonclassical 6-substituted pyrido[3,2-d]pyrimidines with a three- to five-carbon bridge. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2674-2685. <a href="https://doi.org/10.1016/j.bmc.2018.04.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252Bdihydrofolate%252Breductase%252Bas%252Bantitumor%252Bagents%25253A%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bnonclassical%252B6-substituted%252Bpyrido%25255B3%25252C2-d%25255Dpyrimidines%252Bwith%252Ba%252Bthree-%252Bto%252Bfive-carbon%252Bbridge%26aulast%3DLi%26aufirst%3DHao%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2674%26epage%3D2685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  D'Errico</span>, <span class="hlFld-ContribAuthor ">Nicola  Borbone</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Piccialli</span>, <span class="hlFld-ContribAuthor ">Elena  Di Gennaro</span>, <span class="hlFld-ContribAuthor ">Andrea  Zotti</span>, <span class="hlFld-ContribAuthor ">Alfredo  Budillon</span>, <span class="hlFld-ContribAuthor ">Carlo  Vitagliano</span>, <span class="hlFld-ContribAuthor ">Ilaria  Piccialli</span>, <span class="hlFld-ContribAuthor ">Giorgia  Oliviero</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of the Antitumor Properties of a Small Collection of Pt
              II
              Complexes with 7-Deazaadenosine as Scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (33)
                                     , 4935-4947. <a href="https://doi.org/10.1002/ejoc.201700730" title="DOI URL">https://doi.org/10.1002/ejoc.201700730</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201700730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201700730%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252Bthe%252BAntitumor%252BProperties%252Bof%252Ba%252BSmall%252BCollection%252Bof%252BPt%252BII%252BComplexes%252Bwith%252B7-Deazaadenosine%252Bas%252BScaffold%26aulast%3DD%2527Errico%26aufirst%3DStefano%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D33%26spage%3D4935%26epage%3D4947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mudumala Veeranarayana  Reddy</span>, <span class="hlFld-ContribAuthor ">Kang Rok  Byeon</span>, <span class="hlFld-ContribAuthor ">Su Hong  Park</span>, <span class="hlFld-ContribAuthor ">Dong Wook  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Polyethylene glycol methacrylate-grafted dicationic imidazolium-based ionic liquid: Heterogeneous catalyst for the synthesis of aryl-benzo[4,5]imidazo[1,2- a ]pyrimidine amines under solvent-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (35)
                                     , 5289-5296. <a href="https://doi.org/10.1016/j.tet.2017.07.025" title="DOI URL">https://doi.org/10.1016/j.tet.2017.07.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.07.025%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DPolyethylene%252Bglycol%252Bmethacrylate-grafted%252Bdicationic%252Bimidazolium-based%252Bionic%252Bliquid%25253A%252BHeterogeneous%252Bcatalyst%252Bfor%252Bthe%252Bsynthesis%252Bof%252Baryl-benzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyrimidine%252Bamines%252Bunder%252Bsolvent-free%252Bconditions%26aulast%3DReddy%26aufirst%3DMudumala%2BVeeranarayana%26date%3D2017%26volume%3D73%26issue%3D35%26spage%3D5289%26epage%3D5296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Leone</span>, <span class="hlFld-ContribAuthor ">Maria Serena  Roca</span>, <span class="hlFld-ContribAuthor ">Chiara  Ciardiello</span>, <span class="hlFld-ContribAuthor ">Susan  Costantini</span>, <span class="hlFld-ContribAuthor ">Alfredo  Budillon</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2017,</strong> <em>2017 </em>, 1-18. <a href="https://doi.org/10.1155/2017/2597581" title="DOI URL">https://doi.org/10.1155/2017/2597581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2017/2597581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2017%2F2597581%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DOxidative%252BStress%252BGene%252BExpression%252BProfile%252BCorrelates%252Bwith%252BCancer%252BPatient%252BPoor%252BPrognosis%25253A%252BIdentification%252Bof%252BCrucial%252BPathways%252BMight%252BSelect%252BNovel%252BTherapeutic%252BApproaches%26aulast%3DLeone%26aufirst%3DAlessandra%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of (A) dihydrotriazineâchalcone compounds <b>6a</b>, <b>6b</b>, <b>11a</b>, and <b>11b</b> (synthesis reported in ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>) and (B) linked dihydrotriazineâchalcone compounds <b>1</b>â<b>15</b> containing diether linkers of varying lengths.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (A) 4,6-Diamino-1-hydroxy-1,2-dihydro-1,3,5-triazine Hydrochlorides,<sup>a</sup> (B) Bromoalkoxychalcones,<sup>b</sup>  and (C) <b>1</b>â<b>15</b><sup>c</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents and conditions for (A): (a) EtOH, conc HCl; (b) H<sub>2</sub> (1 atm), 50% aq EtOH, PtO<sub>2</sub>.</p><p><span class="fn-label">Scheme b</span>Reagents and conditions for (B): (a) NaOH, EtOH, H<sub>2</sub>O, rt; (b) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux.</p><p class="last"><span class="fn-label">Scheme c</span>Reagents and conditions for (C): (a) NaOH, MeOH, reflux; (b) bromoalkoxychalcone, DMF, rt; (c) conc HCl, pH 1.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of <b>16</b>, <b>17</b>, <b>6h</b>, <b>18</b>, and MTX.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative doseâresponse curves of <b>14</b>, <b>15</b>, <b>17</b>, and <b>18</b> against (A) MCF-7 cells and (B) HCT116 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Key structureâactivity relationships of <b>1</b>â<b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of selected dihydrotriazineâchalcone compounds on DHFR activity in HCT116 cells. DHFR activity in lysates of HCT116 cells treated with <b>6</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b> at (A) concentrations of 0.001â1 Î¼M and (B) 40â70 Î¼M for 16 h was determined and expressed as a percentage of DHFR activity in DMSO-treated cells. Each point represents the average value from three independent experiments. (C) The lysates mentioned in (B) were analyzed by Western blotting for detection of levels of DHFR. Western blot images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/medium/jm-2016-01253b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of selected dihydrotriazineâchalcone compounds on TrxR activity in HCT116 cells. TrxR activity in lysates of HCT116 cells treated with <b>6</b>, <b>10</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b> at (A) concentrations of 0.001â1 Î¼M and (B) 40â70 Î¼M for 16 h was determined and expressed as a percentage of TrxR activity in DMSO-treated cells. Each point represents the average value from three independent experiments. (C) The lysates mentioned in (B) were analyzed by Western blotting for detection of levels of TrxR. Western blot images are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01253/20170303/images/large/jm-2016-01253b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01253&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Chou, T. C.</span><span> </span><span class="NLM_article-title">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span><span class="refDoi">Â DOI: 10.1124/pr.58.3.10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1124%2Fpr.58.3.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=16968952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=621-681&author=T.+C.+Chou&title=Theoretical+basis%2C+experimental+design%2C+and+computerized+simulation+of+synergism+and+antagonism+in+drug+combination+studies&doi=10.1124%2Fpr.58.3.10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies</span></div><div class="casAuthors">Chou, Ting-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-681</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The median-effect equation derived from the mass-action law principle at equil. steady state via math. induction and deduction for different reaction sequences and mechanisms and different types of inhibition has been shown to be the unified theory for the Michaelis-Menten equation, Hill equation, Henderson-Hasselbalch equation, and Scatchard equation.  It is shown that dose and effect are interchangeable via defined parameters.  This general equation for the single drug effect has been extended to the multiple drug effect equation for n drugs.  These equations provide the theor. basis for the combination index (CI)-isobologram equation that allows quant. detn. of drug interactions, where CI < 1, = 1, and > 1 indicate synergism, additive effect, and antagonism, resp.  Based on these algorithms, computer software has been developed to allow automated simulation of synergism and antagonism at all dose or effect levels.  It displays the dose-effect curve, median-effect plot, combination index plot, isobologram, dose-redn. index plot, and polygonogram for in vitro or in vivo studies.  This theor. development, exptl. design, and computerized data anal. have facilitated dose-effect anal. for single drug evaluation or carcinogen and radiation risk assessment, as well as for drug or other entity combinations in a vast field of disciplines of biomedical sciences.  In this review, selected examples of applications are given, and step-by-step examples of exptl. designs and real data anal. are also illustrated.  The merging of the mass-action law principle with math. induction-deduction has been proven to be a unique and effective scientific method for general theory development.  The median-effect principle and its mass-action law based computer software are gaining increased applications in biomedical sciences, from how to effectively evaluate a single compd. or entity to how to beneficially use multiple drugs or modalities in combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoToLhZ8Njyh7Vg90H21EOLACvtfcHk0lgs0Vp_ezlmcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfL&md5=374c53e0772c679d1cdb08ff3112be90</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.10%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DTheoretical%2520basis%252C%2520experimental%2520design%252C%2520and%2520computerized%2520simulation%2520of%2520synergism%2520and%2520antagonism%2520in%2520drug%2520combination%2520studies%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D621%26epage%3D681%26doi%3D10.1124%2Fpr.58.3.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">â</span> <span class="NLM_lpage">6543</span><span class="refDoi">Â DOI: 10.1021/jm058225d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm&doi=10.1021%2Fjm058225d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lgs0Vp_ezlmcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543%26doi%3D10.1021%2Fjm058225d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">McGuire, J. J.</span><span> </span><span class="NLM_article-title">Anticancer antifolates: current status and future directions</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2593</span><span class="NLM_x">â</span> <span class="NLM_lpage">2613</span><span class="refDoi">Â DOI: 10.2174/1381612033453712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.2174%2F1381612033453712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=14529544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=2593-2613&author=J.+J.+McGuire&title=Anticancer+antifolates%3A+current+status+and+future+directions&doi=10.2174%2F1381612033453712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer antifolates: Current status and future directions</span></div><div class="casAuthors">McGuire, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">2593-2613</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Antifolates are the oldest of the antimetabolite class of anticancer agents and were one of the first modern anticancer drugs.  The first clin. useful antifolate, described in 1947, was 2,4-diamino-pteroylglutamate (4-amino-folic acid; aminopterin; AMT) which yielded the first-ever remissions in childhood leukemia.  AMT was soon superseded by its 10-Me congener, methotrexate (MTX), based on toxicity considerations; MTX remains, with one limited exception, the only antifolate anticancer agent in clin. use to this date.  Because of the safety and utility of MTX, considerable effort has been invested in attempting to design more therapeutically selective antifolates or antifolates with a wider tumor spectrum.  Initially, the design was based on the burgeoning knowledge of folate-dependent pathways and the determinants of the mechanism of action of MTX.  These determinants include transport, the tight-binding inhibition of its target (the folate-dependent enzyme dihydrofolate reductase (DHFR)), and metab. of MTX to poly-Î³-glutamate (Glun) metabolites.  These early studies led to the development of other antifolate DHFR inhibitors of two types: (1) "classical" analogs that use the same cellular transport systems as MTX and are also metabolized to Glun; and (2) "nonclassical" (i.e., lipophilic) analogs that do not require transport systems and that are not metabolized to Glun.  Although several of these analogs have undergone clin. trial, none is proved superior to MTX.  Detailed examn. of the mechanisms of cytotoxicity and selectivity of MTX showed that inhibition of both dTMP synthesis and de novo purine synthesis, secondary to DHFR inhibition, led to DNA synthesis inhibition and subsequent cell death; inhibition of other folate-dependent pathways did not appear necessary for cell death.  Further studies showed that the contribution of inhibition of dTMP or purine synthesis to cell death varied in different cell types.  These data suggested that inhibition of one of these pathways individually might (at least in some cases) be therapeutically superior to the dual inhibition induced by MTX.  Thus in rational design and in structure-based design studies, two new classes of antifolate enzyme inhibitors were elaborated-direct inhibitors of thymidylate synthase (TMPS) and direct inhibitors of one or both of the two folate-dependent enzymes of de novo purine synthesis.  Members of each class included both classical and nonclassical types.  After preclin. evaluation, several of these have moved into clin. trials.  To date only one new TMPS inhibitor has successfully completed clin. trials and been approved for routine use; this drug, Tomudex (D1694, raltitrexed) is currently approved only in Europe and only for the treatment of colon cancer.  This still represents a step forward for antifolates, however, since MTX is well-known to be ineffective in colon cancer; thus Tomudex extends the tumor range of antifolates.  Antifolate development continues.  Based on the immense body of knowledge now extant on antifolates, specific aspects of the mechanism of action have been the focus.  Newer antifolates have been described that inhibit more than one pathway in folate metab., that have improved delivery, or that inhibit other targets in folate metab.  These new analogs are in various stages of preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGwUdwGzF0rVg90H21EOLACvtfcHk0lh78A18B_NpOA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVCktLs%253D&md5=3e9aef8e71a32144ad5bcb661df3fa47</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1381612033453712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033453712%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26atitle%3DAnticancer%2520antifolates%253A%2520current%2520status%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D2593%26epage%3D2613%26doi%3D10.2174%2F1381612033453712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Visentin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, I. D.</span><span> </span><span class="NLM_article-title">The antifolates</span> <span class="citation_source-journal">Hematol. Oncol. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">â</span> <span class="NLM_lpage">648</span><span class="refDoi">Â DOI: 10.1016/j.hoc.2012.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.hoc.2012.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=22520983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A280%3ADC%252BC38rmslyiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=629-648&author=M.+Visentinauthor=R.+Zhaoauthor=I.+D.+Goldman&title=The+antifolates&doi=10.1016%2Fj.hoc.2012.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The antifolates</span></div><div class="casAuthors">Visentin Michele; Zhao Rongbao; Goldman I David</div><div class="citationInfo"><span class="NLM_cas:title">Hematology/oncology clinics of North America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-48, ix</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article focuses on the cellular, biochemical, and molecular pharmacology of antifolates and how a basic understanding of the mechanism of action of methotrexate, its cytotoxic determinants, mechanisms of resistance, and transport into and out of cells has led to the development of a new generation of antifolates, a process that continues in the laboratory and in the clinics.  New approaches to folate-based cancer chemotherapy are described based on the targeted delivery of drugs to malignant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTs6Vk1KGWrT_h3YQQtAhNufW6udTcc2eZqdADHYOuKfrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rmslyiuw%253D%253D&md5=516c6432e647418b245aba234c1dd545</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.hoc.2012.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hoc.2012.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DVisentin%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DGoldman%26aufirst%3DI.%2BD.%26atitle%3DThe%2520antifolates%26jtitle%3DHematol.%2520Oncol.%2520Clin.%2520North%2520Am.%26date%3D2012%26volume%3D26%26spage%3D629%26epage%3D648%26doi%3D10.1016%2Fj.hoc.2012.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Gonen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assaraf, Y. G.</span><span> </span><span class="NLM_article-title">Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">â</span> <span class="NLM_lpage">210</span><span class="refDoi">Â DOI: 10.1016/j.drup.2012.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.drup.2012.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=22921318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWqsrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=183-210&author=N.+Gonenauthor=Y.+G.+Assaraf&title=Antifolates+in+cancer+therapy%3A+structure%2C+activity+and+mechanisms+of+drug+resistance&doi=10.1016%2Fj.drup.2012.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance</span></div><div class="casAuthors">Gonen, Nitzan; Assaraf, Yehuda G.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">183-210</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In the past 65 years, antifolates targeting folate metab. played a pivotal role in drug treatment of malignant, microbial, parasitic and chronic inflammatory diseases.  Drug discovery of novel antifolates with improved properties and superior activities remains an attractive strategy both in academia and in the pharmaceutical industry.  Among novel antifolates are pemetrexed which primarily targets thymidylate synthase as well as pralatrexate which blocks dihydrofolate reductase, and displays enhanced transport and cellular retention properties.  The present review describes the evolution and pharmacol. activity of antifolates and prospects for the development of the next generation antifolates.  Pre-clin. and clin. studies identified a plethora of mechanisms of antifolate resistance that are a primary hindrance to curative cancer chemotherapy; these are frequently assocd. with qual. and/or quant. alterations in influx and/or efflux transporters of antifolates and in folate-dependent enzymes.  Current advances including for example the deciphering of the dominant folate transporter proton-coupled folate transporter (PCFT/SLC46A1) facilitated the synthesis of exptl. antifolates aimed at selectively targeting solid tumor cells, which reside in an acidic microenvironment where PCFT supposedly functions optimally.  Moreover, drugs that are structurally and mechanistically distinct from folates were conjugated to folic acid (e.g.  Vintafolide/EC145, a folic acid desacetylvinblastine conjugate) to facilitate endocytosis via the folate receptor (FR) which is markedly overexpressed in various solid tumors.  In an alternative approach, novel antifolates selectively targeting the FR but not other folate transporters are being developed (e.g.  BGC 945). Hence, targeting mechanisms of antifolate-resistance could facilitate the development of rationally-based novel antifolates and strategies that overcome chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVjP1iploMdbVg90H21EOLACvtfcHk0lh78A18B_NpOA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWqsrnO&md5=e9f7f1742c26c72a96a2fdeb2d118f1a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2012.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2012.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DGonen%26aufirst%3DN.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26atitle%3DAntifolates%2520in%2520cancer%2520therapy%253A%2520structure%252C%2520activity%2520and%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2012%26volume%3D15%26spage%3D183%26epage%3D210%26doi%3D10.1016%2Fj.drup.2012.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Silipo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansch, C.</span><span> </span><span class="NLM_article-title">Correlation analysis. Its application to the structure-activity relationship of triazines inhibiting dihydrofolate reductase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6849</span><span class="NLM_x">â</span> <span class="NLM_lpage">6861</span><span class="refDoi">Â DOI: 10.1021/ja00856a042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00856a042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1975&pages=6849-6861&author=C.+Silipoauthor=C.+Hansch&title=Correlation+analysis.+Its+application+to+the+structure-activity+relationship+of+triazines+inhibiting+dihydrofolate+reductase&doi=10.1021%2Fja00856a042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fja00856a042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00856a042%26sid%3Dliteratum%253Aachs%26aulast%3DSilipo%26aufirst%3DC.%26aulast%3DHansch%26aufirst%3DC.%26atitle%3DCorrelation%2520analysis.%2520Its%2520application%2520to%2520the%2520structure-activity%2520relationship%2520of%2520triazines%2520inhibiting%2520dihydrofolate%2520reductase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1975%26volume%3D97%26spage%3D6849%26epage%3D6861%26doi%3D10.1021%2Fja00856a042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span> </span><span class="NLM_article-title">Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">â</span> <span class="NLM_lpage">743</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2009.11.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.bmc.2009.11.065" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=737-743&author=X.+Maauthor=W.+K.+Chui&title=Antifolate+and+antiproliferative+activity+of+6%2C8%2C10-triazaspiro%5B4.5%5Ddeca-6%2C8-dienes+and+1%2C3%2C5-triazaspiro%5B5.5%5Dundeca-1%2C3-dienes&doi=10.1016%2Fj.bmc.2009.11.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.11.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.11.065%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DChui%26aufirst%3DW.%2BK.%26atitle%3DAntifolate%2520and%2520antiproliferative%2520activity%2520of%25206%252C8%252C10-triazaspiro%255B4.5%255Ddeca-6%252C8-dienes%2520and%25201%252C3%252C5-triazaspiro%255B5.5%255Dundeca-1%252C3-dienes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D737%26epage%3D743%26doi%3D10.1016%2Fj.bmc.2009.11.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woon, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span> </span><span class="NLM_article-title">Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span><span class="refDoi">Â DOI: 10.1111/j.1747-0285.2009.00860.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1111%2Fj.1747-0285.2009.00860.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=19703036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=322-326&author=X.+Maauthor=R.+S.+Woonauthor=P.+C.+Hoauthor=W.+K.+Chui&title=Antiproliferative+activity+against+MCF-7+breast+cancer+cells+by+diamino-triazaspirodiene+antifolates&doi=10.1111%2Fj.1747-0285.2009.00860.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates</span></div><div class="casAuthors">Ma, Xiang; Woon, Renee Ser-Peng; Ho, Paul Chi-Lui; Chui, Wai-Keung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">322-326</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Two triazaspirodienes, having similar phenoxy propyloxy side chain, were identified as potent mammalian dihydrofolate reductase inhibitors; one having a 6,5-spiro bicyclic ring system (IC50 = 2.3 nM) and the other a 6,6-spiro bicyclic system (IC50 = 6.9 nM).  They also showed more than 50% antiproliferative activity against the MCF-7 breast cancer cells at 20 Î¼M.  This study demonstrated the potential lead of the diamino-triazaspirodienes in anticancer chemotherapeutic agents' discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2za1IvZ3J0rVg90H21EOLACvtfcHk0lh7rTsenABm7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSgt7fP&md5=129ef2f8c2e5338337cda127cd7aa373</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00860.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00860.x%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWoon%26aufirst%3DR.%2BS.%26aulast%3DHo%26aufirst%3DP.%2BC.%26aulast%3DChui%26aufirst%3DW.%2BK.%26atitle%3DAntiproliferative%2520activity%2520against%2520MCF-7%2520breast%2520cancer%2520cells%2520by%2520diamino-triazaspirodiene%2520antifolates%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D322%26epage%3D326%26doi%3D10.1111%2Fj.1747-0285.2009.00860.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Berman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbel, L. M.</span><span> </span><span class="NLM_article-title">The renewed potential for folate antagonists in contemporary cancer chemotherapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">â</span> <span class="NLM_lpage">485</span><span class="refDoi">Â DOI: 10.1021/jm00106a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=479-485&author=E.+M.+Bermanauthor=L.+M.+Werbel&title=The+renewed+potential+for+folate+antagonists+in+contemporary+cancer+chemotherapy&doi=10.1021%2Fjm00106a001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a001%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DE.%2BM.%26aulast%3DWerbel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520renewed%2520potential%2520for%2520folate%2520antagonists%2520in%2520contemporary%2520cancer%2520chemotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D479%26epage%3D485%26doi%3D10.1021%2Fjm00106a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hekmat-Nejad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span> </span><span class="NLM_article-title">Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase</span> <span class="citation_source-journal">Exp. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">â</span> <span class="NLM_lpage">228</span><span class="refDoi">Â DOI: 10.1006/expr.1997.4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1006%2Fexpr.1997.4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=9371087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADyaK2sXns1yisLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1997&pages=222-228&author=M.+Hekmat-Nejadauthor=P.+K.+Rathod&title=Plasmodium+falciparum%3A+kinetic+interactions+of+WR99210+with+pyrimethamine-sensitive+and+pyrimethamine-resistant+dihydrofolate+reductase&doi=10.1006%2Fexpr.1997.4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase</span></div><div class="casAuthors">Hekmat-Nejad, Mohammad; Rathod, Pradipsinh K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-228</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">With emerging drug resistance in Plasmodium falciparum, novel antifolates effective against pyrimethamine-resistant and cycloguanil-resistant dihydrofolate reductase (DHFR) are in demand.  Based on structural similarity to cycloguanil, it has been proposed that WR99210, and its metabolic precursor PS-15, exerts selective antimalarial activity by binding tightly to both drug-sensitive and drug-resistant DHFR.  In the present study, Linweaver-Burk plots and Ackermann-Potter plots reveal that both forms of malarial DHFR bind WR99210 at subnanomolar concns.  It is not necessary to invoke an alternate target for WR99210 in P. falciparum.  The present studies confirm that malarial DHFRs offer potential binding interactions in the folate-binding pocket distinct from those exploited by pyrimethamine and cycloguanil.  These kinetic studies also provide a useful framework for the design and interpretation of future structural studies on drug-resistant DHFR from P. falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQxLPKLNC_fbVg90H21EOLACvtfcHk0lh7rTsenABm7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXns1yisLk%253D&md5=baf0657c6f8a49d5539de3abf8ec5d7a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fexpr.1997.4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexpr.1997.4228%26sid%3Dliteratum%253Aachs%26aulast%3DHekmat-Nejad%26aufirst%3DM.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26atitle%3DPlasmodium%2520falciparum%253A%2520kinetic%2520interactions%2520of%2520WR99210%2520with%2520pyrimethamine-sensitive%2520and%2520pyrimethamine-resistant%2520dihydrofolate%2520reductase%26jtitle%3DExp.%2520Parasitol.%26date%3D1997%26volume%3D87%26spage%3D222%26epage%3D228%26doi%3D10.1006%2Fexpr.1997.4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gromer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, K.</span><span> </span><span class="NLM_article-title">The thioredoxin system--from science to clinic</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span><span class="refDoi">Â DOI: 10.1002/med.10051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2Fmed.10051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=14595672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=40-89&author=S.+Gromerauthor=S.+Urigauthor=K.+Becker&title=The+thioredoxin+system%2D%2Dfrom+science+to+clinic&doi=10.1002%2Fmed.10051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The thioredoxin system-from science to clinic</span></div><div class="casAuthors">Gromer, Stephan; Urig, Sabine; Becker, Katja</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-89</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The thioredoxin system-formed by thioredoxin reductase and its characteristic substrate thioredoxin-is an important constituent of the intracellular redox milieu.  Interactions with many different metabolic pathways such as DNA-synthesis, selenium metab., and the antioxidative network as well as significant species differences render this system an attractive target for chemotherapeutic approaches in many fields of medicine-ranging from infectious diseases to cancer therapy.  In this review we will present and evaluate the preclin. and clin. results available today.  Current trends in drug development are emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp26-L03rXS3rVg90H21EOLACvtfcHk0lgh-i-13dBoPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVaiug%253D%253D&md5=e27dea66a4361510f1f6198b96ef7ca0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.10051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10051%26sid%3Dliteratum%253Aachs%26aulast%3DGromer%26aufirst%3DS.%26aulast%3DUrig%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DK.%26atitle%3DThe%2520thioredoxin%2520system--from%2520science%2520to%2520clinic%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2004%26volume%3D24%26spage%3D40%26epage%3D89%26doi%3D10.1002%2Fmed.10051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lillig, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span> </span><span class="NLM_article-title">Thioredoxin and related molecules--from biology to health and disease</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">â</span> <span class="NLM_lpage">47</span><span class="refDoi">Â DOI: 10.1089/ars.2007.9.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2007.9.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=17115886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Wqur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=25-47&author=C.+H.+Lilligauthor=A.+Holmgren&title=Thioredoxin+and+related+molecules%2D%2Dfrom+biology+to+health+and+disease&doi=10.1089%2Fars.2007.9.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin and Related Molecules-From Biology to Health and Disease</span></div><div class="casAuthors">Lillig, Christopher Horst; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-47</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Thioredoxin and glutaredoxin systems in mammalian cells utilize thiol and selenol groups to maintain a reducing intracellular redox state acting as antioxidants and reducing agents in redox signaling with oxidizing reactive oxygen species.  During the last decade, the functional roles of thioredoxin in particular have continued to expand, also including novel functions such as a secreted growth factor or a chemokine for immune cells.  The role of thioredoxin and glutaredoxin in antioxidant defense and the role of thioredoxin in controlling recruitment of inflammatory cells offer potential use in clin. therapy.  The fundamental differences between bacterial and mammalian thioredoxin reductases offer new principles for treatment of infections.  Clin. drugs already in use target the active site selenol in thioredoxin reductases, inducing cell death in tumor cells.  Thioredoxin and binding proteins (ASK1 and TBP2) appear to control apoptosis or metabolic states such as carbohydrate and lipid metab. related to diseases such as diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoJiYC7UOm_rVg90H21EOLACvtfcHk0lgh-i-13dBoPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Wqur3P&md5=a7fcdf1f3ab87149ad75acbf88a3e397</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.9.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.9.25%26sid%3Dliteratum%253Aachs%26aulast%3DLillig%26aufirst%3DC.%2BH.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520and%2520related%2520molecules--from%2520biology%2520to%2520health%2520and%2520disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D25%26epage%3D47%26doi%3D10.1089%2Fars.2007.9.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kahlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soini, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saily, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paakko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnula, V. L.</span><span> </span><span class="NLM_article-title">Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span><span class="refDoi">Â DOI: 10.1002/1097-0215(20010520)95:3<198::AID-IJC1034>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11307155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFOmtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2001&pages=198-204&author=K.+Kahlosauthor=Y.+Soiniauthor=M.+Sailyauthor=P.+Koistinenauthor=S.+Kakkoauthor=P.+Paakkoauthor=A.+Holmgrenauthor=V.+L.+Kinnula&title=Up-regulation+of+thioredoxin+and+thioredoxin+reductase+in+human+malignant+pleural+mesothelioma&doi=10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma</span></div><div class="casAuthors">Kahlos, Katriina; Soini, Ylermi; Saly, Marjaana; Koistinen, Pirjo; Kakko, Sakari; Paakko, Paavo; Holmgren, Arne; Kinnula, Vuokko L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Thioredoxin (Trx) with a redoxactive dithiol together with NADPH and thioredoxin reductase (TrxR) is a major disulfide reductase regulating cellular redox state and cell proliferation and possibly contributing to the drug resistance of malignant cells.  We assessed the Trx system in malignant pleural mesothelioma cell lines, in nonmalignant pleural mesothelium and in biopsies of malignant pleural mesothelioma.  The mRNA and immunoreactive proteins of Trx and cytosolic and mitochondrial TrxR were pos. in all 4 human mesothelioma cell lines investigated.  6 Cases of nonmalignant, histol. healthy pleural mesothelium showed no Trx or TrxR immunoreactivity, whereas immunohistochem. on 26 biopsies of human malignant pleural mesothelioma showed pos. Trx in all cases and pos. TrxR in 23 (88%) of the cases.  Moderate or strong immunoreactivity for Trx or TrxR was detected in 85% (22 cases) and 61% (14 cases) of the mesothelioma cases, resp.  Both Trx and TrxR staining patterns were mainly diffuse and cytoplasmic, but in 39% of the mesothelioma cases prominent nuclear staining could also be detected.  Although staining for Trx and TrxR was seen in tumor cells, no significant assocn. could be demonstrated between Trx or TrxR expression and tumor cell proliferation or apoptosis in the biopsies of mesothelioma.  There was no significant assocn. between the intensity of Trx or TrxR immunoreactivity and patient survival, which may possibly be related to moderate or intense Trx and TrxR reactivity in most of the cases.  Although the Trx system may have an important role in the drug resistance of malignant mesothelioma, these studies also suggest that multiple factors contribute to the promotion, cell proliferation and apoptosis of malignant mesothelioma cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXkQXhXLNdYrVg90H21EOLACvtfcHk0lgh-i-13dBoPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFOmtro%253D&md5=0547dce693c45d98382fdd59cfc73f96</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-0215%252820010520%252995%253A3%253C198%253A%253AAID-IJC1034%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DKahlos%26aufirst%3DK.%26aulast%3DSoini%26aufirst%3DY.%26aulast%3DSaily%26aufirst%3DM.%26aulast%3DKoistinen%26aufirst%3DP.%26aulast%3DKakko%26aufirst%3DS.%26aulast%3DPaakko%26aufirst%3DP.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DKinnula%26aufirst%3DV.%2BL.%26atitle%3DUp-regulation%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%2520in%2520human%2520malignant%2520pleural%2520mesothelioma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2001%26volume%3D95%26spage%3D198%26epage%3D204%26doi%3D10.1002%2F1097-0215%2820010520%2995%3A3%3C198%3A%3AAID-IJC1034%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Soini, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahlos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napankangas, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaarteenaho-Wiik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saily, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paaakko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnula, V. L.</span><span> </span><span class="NLM_article-title">Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">â</span> <span class="NLM_lpage">1757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11410516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltV2hs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=1750-1757&author=Y.+Soiniauthor=K.+Kahlosauthor=U.+Napankangasauthor=R.+Kaarteenaho-Wiikauthor=M.+Sailyauthor=P.+Koistinenauthor=P.+Paaakkoauthor=A.+Holmgrenauthor=V.+L.+Kinnula&title=Widespread+expression+of+thioredoxin+and+thioredoxin+reductase+in+non-small+cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma</span></div><div class="casAuthors">Soini, Ylermi; Kahlos, Katriina; Napankangas, Ulla; Kaarteenaho-Wiik, Riitta; Saily, Marjaana; Koistinen, Pirjo; Paakko, Paavo; Holmgren, Arne; Kinnula, Vuokko L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1750-1757</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We investigated the expression of thioredoxin (Trx) and thioredoxin reductase (TrxR) in 89 non-small cell lung carcinomas.  Addnl., immortalized human bronchial epithelial cells (BEAS 2B) and 4 human lung carcinoma cells lines (A549, SK-MES-1, CALU-6, and A427) were studied by Western blot and reverse transcription-PCR for the synthesis of Trx and TrxR protein and mRNA expression in vitro.  The histol. samples were also studied for immunohistochem. p53 and proliferating cell nuclear antigen expression and apoptosis.  In non-neoplastic lung, Trx and TrxR expression was seen in bronchial epithelial cells and alveolar macrophages, metaplastic alveolar epithelial cells, and chondrocytes of the bronchus.  In non-small cell lung carcinomas, there was a widespread expression of Trx and TrxR with only 3 and 8 cases neg., resp.  Trx and TrxR expression was located in both cytoplasmic and nuclear compartments of the cells.  There was a statistical assocn. between cytoplasmic and nuclear Trx or TrxR expression.  Grade I-II tumors showed stronger cytoplasmic and nuclear Trx and TrxR immunoreactivity than grade III tumors.  No assocn. was found between p53 and proliferating cell nuclear antigen expression and Trx or TrxR immunoreactivity.  However, apoptosis was inversely assocd. with nuclear Trx and TrxR positivity.  In the cell lines studied, both non-neoplastic BEAS 2B cells and all of the carcinoma cell lines expressed Trx and TrxR proteins and mRNA.  The results show that these redox-regulating proteins are highly expressed in lung carcinomas taking part in activation of transcriptional factors and regulation of apoptosis in non-small cell lung carcinoma.  In high-grade tumors, Trx and TrxR expression is diminished, suggesting loss of redox regulation in tumors with low differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1WnmKXYgB47Vg90H21EOLACvtfcHk0liC_SDDBynZig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltV2hs7c%253D&md5=c71eef9a2a4b06cbe192a68b983d2962</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoini%26aufirst%3DY.%26aulast%3DKahlos%26aufirst%3DK.%26aulast%3DNapankangas%26aufirst%3DU.%26aulast%3DKaarteenaho-Wiik%26aufirst%3DR.%26aulast%3DSaily%26aufirst%3DM.%26aulast%3DKoistinen%26aufirst%3DP.%26aulast%3DPaaakko%26aufirst%3DP.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DKinnula%26aufirst%3DV.%2BL.%26atitle%3DWidespread%2520expression%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%2520in%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D1750%26epage%3D1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yodoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, S.</span><span> </span><span class="NLM_article-title">High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">8425</span><span class="NLM_x">â</span> <span class="NLM_lpage">8430</span><span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-05-0449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1158%2F1078-0432.CCR-05-0449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=16322305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KjsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=8425-8430&author=S.+J.+Kimauthor=Y.+Miyoshiauthor=T.+Taguchiauthor=Y.+Tamakiauthor=H.+Nakamuraauthor=J.+Yodoiauthor=K.+Katoauthor=S.+Noguchi&title=High+thioredoxin+expression+is+associated+with+resistance+to+docetaxel+in+primary+breast+cancer&doi=10.1158%2F1078-0432.CCR-05-0449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer</span></div><div class="casAuthors">Kim, Seung Jin; Miyoshi, Yasuo; Taguchi, Tetsuya; Tamaki, Yasuhiro; Nakamura, Hajime; Yodoi, Junji; Kato, Kikuya; Noguchi, Shinzaburo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8425-8430</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Thioredoxin overexpression is suggested to be assocd. with resistance to several chemotherapeutic agents in vitro.  In the present study, it has been studied whether or not high thioredoxin expression is assocd. with resistance to docetaxel therapy in breast cancer patients.  PATIENTS AND METHODS: Sixty-three primary breast cancer patients were treated with docetaxel (60 mg/m2, q3w) for four cycles in the neoadjuvant setting.  Expression of thioredoxin, estrogen receptor (ER), p53, BRCA-1, and Bcl-2 in tumor tissues obtained before docetaxel therapy was studied by immunohistochem. (thioredoxin, p53, BRCA-1, and Bcl-2) and enzyme immunoassay (ER), and relationship of expression of these biomarkers with a pathol. response was investigated.  RESULTS: There was no significant correlation between the expression of p53, BRCA-1, or Bcl-2 and a response to docetaxel.  However, tumors with high thioredoxin expression showed a significantly lower response rate (0%) than those with low thioredoxin expression (30.6%; P = 0.018) and ER-neg. tumors showed a significantly higher response rate (32.4%) than ER-pos. tumors (10.7%; P = 0.043).  Thioredoxin expression significantly increased after docetaxel therapy (mean, 56.1%) as compared with that before docetaxel therapy (mean, 28.6%; P < 0.0001) but there was no significant assocn. between the extent of increase in thioredoxin expression and response.  CONCLUSION: High thioredoxin expression in prechemotherapy tumor samples, but not the increase in thioredoxin expression induced by docetaxel, is assocd. with resistance to docetaxel in breast cancer.  Thioredoxin and ER might be clin. useful in the prediction of a response to docetaxel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoziL6cScTivLVg90H21EOLACvtfcHk0liC_SDDBynZig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KjsrbI&md5=b8c27b4cc53669c571c2514b3420b260</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0449%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DMiyoshi%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DT.%26aulast%3DTamaki%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DYodoi%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DS.%26atitle%3DHigh%2520thioredoxin%2520expression%2520is%2520associated%2520with%2520resistance%2520to%2520docetaxel%2520in%2520primary%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D8425%26epage%3D8430%26doi%3D10.1158%2F1078-0432.CCR-05-0449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Raffel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallegos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einspahr, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span><span class="refDoi">Â DOI: 10.1016/S0022-2143(03)00068-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2FS0022-2143%2803%2900068-4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2003&pages=46-51&author=J.+Raffelauthor=A.+K.+Bhattacharyyaauthor=A.+Gallegosauthor=H.+Cuiauthor=J.+G.+Einspahrauthor=D.+S.+Albertsauthor=G.+Powis&title=Increased+expression+of+thioredoxin-1+in+human+colorectal+cancer+is+associated+with+decreased+patient+survival&doi=10.1016%2FS0022-2143%2803%2900068-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0022-2143%2803%2900068-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2143%252803%252900068-4%26sid%3Dliteratum%253Aachs%26aulast%3DRaffel%26aufirst%3DJ.%26aulast%3DBhattacharyya%26aufirst%3DA.%2BK.%26aulast%3DGallegos%26aufirst%3DA.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DEinspahr%26aufirst%3DJ.%2BG.%26aulast%3DAlberts%26aufirst%3DD.%2BS.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DIncreased%2520expression%2520of%2520thioredoxin-1%2520in%2520human%2520colorectal%2520cancer%2520is%2520associated%2520with%2520decreased%2520patient%2520survival%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D2003%26volume%3D142%26spage%3D46%26epage%3D51%26doi%3D10.1016%2FS0022-2143%2803%2900068-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. B.</span><span> </span><span class="NLM_article-title">Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span><span class="refDoi">Â DOI: 10.1002/jcb.20585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2Fjcb.20585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=16088946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFSrt7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=653-664&author=L.+Ganauthor=X.+L.+Yangauthor=Q.+Liuauthor=H.+B.+Xu&title=Inhibitory+effects+of+thioredoxin+reductase+antisense+RNA+on+the+growth+of+human+hepatocellular+carcinoma+cells&doi=10.1002%2Fjcb.20585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells</span></div><div class="casAuthors">Gan, Lu; Yang, Xiang-Liang; Liu, Qiong; Xu, Hui-Bi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">653-664</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Thioredoxin reductase (TrxR) in conjunction with thioredoxin (Trx) is a ubiquitous intracellular oxidoreductase system with antioxidant and redox regulatory roles.  In some human tumors, the thioredoxin system is found overexpressed.  We have used an antisense approach to investigate whether inhibition of TrxR overexpression can suppress the growth of human hepatocellular carcinoma SMMC-7721 cells.  TrxR cDNA fragment was inserted in the antisense direction into pcDNA3.1/myc-His and SMMC-7721 cells were stably transfected with the plasmid construct.  The results showed that TrxR antisense RNA could significantly reduce TrxR mRNA level and activity, and suppress the growth of SMMC-7721 cells.  Cell-cycle anal. showed G2/M phase arrest in SMMC-7721 cells transfected with TrxR antisense plasmid.  TrxR antisense RNA could significantly increase p53 mRNA level and decrease Bcl-2 mRNA level by reverse transcriptase-polymerase chain reaction (RT-PCR).  Furthermore a significant decrease in human telomerase reverse transcriptase (hTERT) mRNA level was found in SMMC-7721 cells transfected with TrxR antisense plasmid.  Flow cytometry and telomere fluorescence in situ hybridization (Flow FISH) showed that TrxR antisense RNA could significantly reduce the telomere fluorescence in SMMC-7721 cells.  The results suggested that TrxR antisense RNA inhibited the growth of SMMC-7721 cells through an accumulation of cell cycle at G2/M phase, an increase in p53 mRNA level and a redn. in telomere fluorescence and Bcl-2, hTERT mRNA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq85PJvTr63qbVg90H21EOLACvtfcHk0lhJtsoKW7FBiA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFSrt7jK&md5=06e95b2deceb25bd368ddf682e02932a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjcb.20585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.20585%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DH.%2BB.%26atitle%3DInhibitory%2520effects%2520of%2520thioredoxin%2520reductase%2520antisense%2520RNA%2520on%2520the%2520growth%2520of%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D96%26spage%3D653%26epage%3D664%26doi%3D10.1002%2Fjcb.20585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yoo, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladyshev, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, D. L.</span><span> </span><span class="NLM_article-title">Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">13005</span><span class="NLM_x">â</span> <span class="NLM_lpage">13008</span><span class="refDoi">Â DOI: 10.1074/jbc.C600012200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1074%2Fjbc.C600012200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=13005-13008&author=M.+H.+Yooauthor=X.+M.+Xuauthor=B.+A.+Carlsonauthor=V.+N.+Gladyshevauthor=D.+L.+Hatfield&title=Thioredoxin+reductase+1+deficiency+reverses+tumor+phenotype+and+tumorigenicity+of+lung+carcinoma+cells&doi=10.1074%2Fjbc.C600012200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C600012200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C600012200%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DM.%2BH.%26aulast%3DXu%26aufirst%3DX.%2BM.%26aulast%3DCarlson%26aufirst%3DB.%2BA.%26aulast%3DGladyshev%26aufirst%3DV.%2BN.%26aulast%3DHatfield%26aufirst%3DD.%2BL.%26atitle%3DThioredoxin%2520reductase%25201%2520deficiency%2520reverses%2520tumor%2520phenotype%2520and%2520tumorigenicity%2520of%2520lung%2520carcinoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D13005%26epage%3D13008%26doi%3D10.1074%2Fjbc.C600012200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yoo, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladyshev, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, D. L.</span><span> </span><span class="NLM_article-title">Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1112</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0001112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1371%2Fjournal.pone.0001112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=17971875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A280%3ADC%252BD2snkslWlug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=e1112&author=M.+H.+Yooauthor=X.+M.+Xuauthor=B.+A.+Carlsonauthor=A.+D.+Pattersonauthor=V.+N.+Gladyshevauthor=D.+L.+Hatfield&title=Targeting+thioredoxin+reductase+1+reduction+in+cancer+cells+inhibits+self-sufficient+growth+and+DNA+replication&doi=10.1371%2Fjournal.pone.0001112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication</span></div><div class="casAuthors">Yoo Min-Hyuk; Xu Xue-Ming; Carlson Bradley A; Patterson Andrew D; Gladyshev Vadim N; Hatfield Dolph L</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1112</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Thioredoxin reductase 1 (TR1) is a major redox regulator in mammalian cells.  As an important antioxidant selenoprotein, TR1 is thought to participate in cancer prevention, but is also known to be over-expressed in many cancer cells.  Numerous cancer drugs inhibit TR1, and this protein has been proposed as a target for cancer therapy.  We previously reported that reduction of TR1 levels in cancer cells reversed many malignant characteristics suggesting that deficiency in TR1 function is antitumorigenic.  The molecular basis for TR1's role in cancer development, however, is not understood.  Herein, we found that, among selenoproteins, TR1 is uniquely overexpressed in cancer cells and its knockdown in a mouse cancer cell line driven by oncogenic k-ras resulted in morphological changes characteristic of parental (normal) cells, without significant effect on cell growth under normal growth conditions.  When grown in serum-deficient medium, TR1 deficient cancer cells lose self-sufficiency of growth, manifest a defective progression in their S phase and a decreased expression of DNA polymerase alpha, an enzyme important in DNA replication.  These observations provide evidence that TR1 is critical for self-sufficiency in growth signals of malignant cells, that TR1 acts largely as a pro-cancer protein and it is indeed a primary target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqpqQICSqJPxBrI9DTGjC0fW6udTcc2eahyG8XcyEu3bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snkslWlug%253D%253D&md5=d2fd949e1f8182e351c81253f447ed76</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0001112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0001112%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DM.%2BH.%26aulast%3DXu%26aufirst%3DX.%2BM.%26aulast%3DCarlson%26aufirst%3DB.%2BA.%26aulast%3DPatterson%26aufirst%3DA.%2BD.%26aulast%3DGladyshev%26aufirst%3DV.%2BN.%26aulast%3DHatfield%26aufirst%3DD.%2BL.%26atitle%3DTargeting%2520thioredoxin%2520reductase%25201%2520reduction%2520in%2520cancer%2520cells%2520inhibits%2520self-sufficient%2520growth%2520and%2520DNA%2520replication%26jtitle%3DPLoS%2520One%26date%3D2007%26volume%3D2%26spage%3De1112%26doi%3D10.1371%2Fjournal.pone.0001112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Papp, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, K. K.</span><span> </span><span class="NLM_article-title">From selenium to selenoproteins: synthesis, identity, and their role in human health</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">â</span> <span class="NLM_lpage">806</span><span class="refDoi">Â DOI: 10.1089/ars.2007.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2007.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=17508906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlOiurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=775-806&author=L.+V.+Pappauthor=J.+Luauthor=A.+Holmgrenauthor=K.+K.+Khanna&title=From+selenium+to+selenoproteins%3A+synthesis%2C+identity%2C+and+their+role+in+human+health&doi=10.1089%2Fars.2007.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">From Selenium to Selenoproteins: Synthesis, Identity, and Their Role in Human Health</span></div><div class="casAuthors">Papp, Laura Vanda; Lu, Jun; Holmgren, Arne; Khanna, Kum Kum</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">775-806</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  The requirement of the trace element selenium for life and its beneficial role in human health has been known for several decades.  This is attributed to low mol. wt. selenium compds., as well as to its presence within at least 25 proteins, named selenoproteins, in the form of the amino acid selenocysteine (Sec).  Incorporation of Sec into selenoproteins employs a unique mechanism that involves decoding of the UGA codon.  This process requires multiple features such as the selenocysteine insertion sequence (SECIS) element and several protein factors including a specific elongation factor EFSec and the SECIS binding protein 2, SBP2.  The function of most selenoproteins is currently unknown; however, thioredoxin reductases (TrxR), glutathione peroxidases (GPx) and thyroid hormone deiodinases (DIO) are well characterized selenoproteins involved in redox regulation of intracellular signaling, redox homeostasis and thyroid hormone metab.  Recent evidence points to a role for selenium compds. as well as selenoproteins in the prevention of some forms of cancer.  A no. of clin. trials are either underway or being planned to examine the effects of selenium on cancer incidence.  In this review we describe some of the recent progress in our understanding of the mechanism of selenoprotein synthesis, the role of selenoproteins in human health and disease and the therapeutic potential of some of these proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJFvjzN_YPHLVg90H21EOLACvtfcHk0lhDuXc1nbZgcA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlOiurw%253D&md5=44b83993922e803499bd408e82452ccc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1528%26sid%3Dliteratum%253Aachs%26aulast%3DPapp%26aufirst%3DL.%2BV.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26atitle%3DFrom%2520selenium%2520to%2520selenoproteins%253A%2520synthesis%252C%2520identity%252C%2520and%2520their%2520role%2520in%2520human%2520health%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D775%26epage%3D806%26doi%3D10.1089%2Fars.2007.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, A.</span><span> </span><span class="NLM_article-title">Thioredoxin system in cell death progression</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1738</span><span class="NLM_x">â</span> <span class="NLM_lpage">1747</span><span class="refDoi">Â DOI: 10.1089/ars.2012.4650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2012.4650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=22530689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1738-1747&author=J.+Luauthor=A.+Holmgren&title=Thioredoxin+system+in+cell+death+progression&doi=10.1089%2Fars.2012.4650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin System in Cell Death Progression</span></div><div class="casAuthors">Lu, Jun; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1738-1747</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: The thioredoxin (Trx) system, comprising NADP, Trx reductase (TrxR), and Trx, is crit. for maintaining cellular redox balance and antioxidant function, including control of oxidative stress and cell death.  Recent Advances: Here, we focus on the research progress that is involved in the regulation of apoptosis by Trx systems.  In mammalian cells, cytosolic Trx1 and mitochondrial Trx2 systems are the major disulfide reductases supplying electrons to enzymes for cell proliferation and viability.  The reduced/dithiol form of Trxs binds to apoptosis signal-regulating kinase 1 (ASK1) and inhibits its activity to prevent stress- and cytokine-induced apoptosis.  When Trx is oxidized, it dissocs. from ASK1 and apoptosis is stimulated.  The binding of Trx by its inhibitor Trx interacting protein (TXNIP) also contributes to the apoptosis process by removing Trx from ASK1.  TrxRs are large homodimeric selenoproteins with an overall structure which is similar to that of glutathione reductase, and contain an active site GCUG in the C-terminus.  Crit. Issues and Future Directions: In the regulation of cell death processes, Trx redox state and TrxR activities are key factors that det. the cell fate.  The high reactivity of Sec in TrxRs and its accessible location make TrxR enzymes emerge as targets for pharmaceutic drugs.  TrxR inactivation by covalent modification does not only change the redox state and activity of Trx, but may also convert TrxR into a reactive oxygen species generator.  Numerous electrophilic compds. including some environmental toxins and pharmaceutical drugs inhibit TrxR.  We have classified these compds. into four types and propose some useful principles to understand the reaction mechanism of the TrxR inhibition by these compds.  Antioxid. Redox Signal. 17, 1738-1747.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG24Fxk1bz_7Vg90H21EOLACvtfcHk0lgHASW6ZMAodg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagtb%252FK&md5=7287bfc98f2c31e5bcb787f06088b344</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4650%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520system%2520in%2520cell%2520death%2520progression%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D17%26spage%3D1738%26epage%3D1747%26doi%3D10.1089%2Fars.2012.4650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ducki, S.</span><span> </span><span class="NLM_article-title">Antimitotic chalcones and related compounds as inhibitors of tubulin assembly</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">â</span> <span class="NLM_lpage">347</span><span class="refDoi">Â DOI: 10.2174/1871520610909030336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.2174%2F1871520610909030336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=19275525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Cgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=336-347&author=S.+Ducki&title=Antimitotic+chalcones+and+related+compounds+as+inhibitors+of+tubulin+assembly&doi=10.2174%2F1871520610909030336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antimitotic chalcones and related compounds as inhibitors of tubulin assembly</span></div><div class="casAuthors">Ducki, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">336-347</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of chalcones as antimitotic agents has led to the design of other analogs able to interact with tubulin and inhibit its assembly into microtubules.  This activity has also been assocd. with their anti-vascular activity.  This review focuses on the development of chalcones and related analogs as antimitotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4udbevzeoA7Vg90H21EOLACvtfcHk0lgHASW6ZMAodg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Cgu7c%253D&md5=de9d119eedd2f60dc9f3f9783b3d6495</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1871520610909030336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520610909030336%26sid%3Dliteratum%253Aachs%26aulast%3DDucki%26aufirst%3DS.%26atitle%3DAntimitotic%2520chalcones%2520and%2520related%2520compounds%2520as%2520inhibitors%2520of%2520tubulin%2520assembly%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D336%26epage%3D347%26doi%3D10.2174%2F1871520610909030336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Srinivasan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span> </span><span class="NLM_article-title">Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3â²,4â²,5â²- tetramethoxychalcone and its analogues as potent nuclear factor ÎºB inhibitors and their anticancer activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7228</span><span class="NLM_x">â</span> <span class="NLM_lpage">7235</span><span class="refDoi">Â DOI: 10.1021/jm901278z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901278z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7228-7235&author=B.+Srinivasanauthor=T.+E.+Johnsonauthor=R.+Ladauthor=C.+Xing&title=Structure-activity+relationship+studies+of+chalcone+leading+to+3-hydroxy-4%2C3%E2%80%B2%2C4%E2%80%B2%2C5%E2%80%B2-+tetramethoxychalcone+and+its+analogues+as+potent+nuclear+factor+%CE%BAB+inhibitors+and+their+anticancer+activities&doi=10.1021%2Fjm901278z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm901278z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901278z%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DT.%2BE.%26aulast%3DLad%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DC.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520chalcone%2520leading%2520to%25203-hydroxy-4%252C3%25E2%2580%25B2%252C4%25E2%2580%25B2%252C5%25E2%2580%25B2-%2520tetramethoxychalcone%2520and%2520its%2520analogues%2520as%2520potent%2520nuclear%2520factor%2520%25CE%25BAB%2520inhibitors%2520and%2520their%2520anticancer%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7228%26epage%3D7235%26doi%3D10.1021%2Fjm901278z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yang, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, P.</span><span> </span><span class="NLM_article-title">Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1550</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">â</span> <span class="NLM_lpage">152</span><span class="refDoi">Â DOI: 10.1016/S0167-4838(01)00276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2FS0167-4838%2801%2900276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11755203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWn" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1550&publication_year=2001&pages=144-152&author=E.+B.+Yangauthor=Y.+J.+Guoauthor=K.+Zhangauthor=Y.+Z.+Chenauthor=P.+Mack&title=Inhibition+of+epidermal+growth+factor+receptor+tyrosine+kinase+by+chalcone+derivatives&doi=10.1016%2FS0167-4838%2801%2900276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives</span></div><div class="casAuthors">Yang, Er Bin; Guo, Yong Jian; Zhang, Kai; Chen, Yu Zong; Mack, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1550</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In our previous study, butein, a chalcone deriv., was found to be an inhibitor of tyrosine kinases and the inhibition was ATP-competitive.  In this work, chalcone and seven chalcone derivs. were used to analyze the relationship between the structure of these compds. and their inhibition of tyrosine kinase activity.  Three of chalcone derivs., including butein, marein and phloretin, were found to have an ability to inhibit the tyrosine kinase activity of epidermal growth factor receptor (EGFR) in vitro.  IC50 was 8 Î¼M for butein, 19 Î¼M for marein and 25 Î¼M for phloretin.  The structural characterizations of these inhibitors suggest that the hydroxylations at C4 and C4' of these mols. may be required for them to act as EGFR tyrosine kinase inhibitors.  The inhibition of EGF-induced EGFR tyrosine phosphorylation by butein was also obsd. in human hepatocellular carcinoma HepG2 cells, while marein and phloretin were inactive at the doses tested.  Mol. modeling suggests that butein, marein and phloretin can be docked into the ATP binding pocket of EGFR.  Hydrogen bonds and hydrophobic interaction appear to be important in the binding of these inhibitors to EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89d_JO0pHFrVg90H21EOLACvtfcHk0ljutiaJQRAXBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWn&md5=d39a563357fef4312c025d2d24e958e9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2801%2900276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252801%252900276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DE.%2BB.%26aulast%3DGuo%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%2BZ.%26aulast%3DMack%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520by%2520chalcone%2520derivatives%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2001%26volume%3D1550%26spage%3D144%26epage%3D152%26doi%3D10.1016%2FS0167-4838%2801%2900276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rizvi, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, I.</span><span> </span><span class="NLM_article-title">Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">â</span> <span class="NLM_lpage">944</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.bmcl.2011.12.017" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=942-944&author=S.+U.+Rizviauthor=H.+L.+Siddiquiauthor=M.+Nisarauthor=N.+Khanauthor=I.+Khan&title=Discovery+and+molecular+docking+of+quinolyl-thienyl+chalcones+as+anti-angiogenic+agents+targeting+VEGFR-2+tyrosine+kinase&doi=10.1016%2Fj.bmcl.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRizvi%26aufirst%3DS.%2BU.%26aulast%3DSiddiqui%26aufirst%3DH.%2BL.%26aulast%3DNisar%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DI.%26atitle%3DDiscovery%2520and%2520molecular%2520docking%2520of%2520quinolyl-thienyl%2520chalcones%2520as%2520anti-angiogenic%2520agents%2520targeting%2520VEGFR-2%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D942%26epage%3D944%26doi%3D10.1016%2Fj.bmcl.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gan, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminska, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leow, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, E. H.</span><span> </span><span class="NLM_article-title">Identification of Michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activity</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">â</span> <span class="NLM_lpage">1165</span><span class="refDoi">Â DOI: 10.1089/ars.2012.4909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1089%2Fars.2012.4909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=23311917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWnt7jM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1149-1165&author=F.+F.+Ganauthor=K.+K.+Kaminskaauthor=H.+Yangauthor=C.+Y.+Liewauthor=P.+C.+Leowauthor=C.+L.+Soauthor=L.+N.+Tuauthor=A.+Royauthor=C.+W.+Yapauthor=T.+S.+Kangauthor=W.+K.+Chuiauthor=E.+H.+Chew&title=Identification+of+Michael+acceptor-centric+pharmacophores+with+substituents+that+yield+strong+thioredoxin+reductase+inhibitory+character+correlated+to+antiproliferative+activity&doi=10.1089%2Fars.2012.4909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Michael Acceptor-Centric Pharmacophores with Substituents That Yield Strong Thioredoxin Reductase Inhibitory Character Correlated to Antiproliferative Activity</span></div><div class="casAuthors">Gan, Fei-Fei; Kaminska, Kamila K.; Yang, Hong; Liew, Chin-Yee; Leow, Pay-Chin; So, Choon-Leng; Tu, Lan N. L.; Roy, Amrita; Yap, Chun-Wei; Kang, Tse-Siang; Chui, Wai-Keung; Chew, Eng-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1149-1165</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The role of thioredoxin reductase (TrxR) in tumorigenesis has made it an attractive anticancer target.  A systematic approach for development of novel compds. as TrxR inhibitors is currently lacking.  Structurally diversified TrxR inhibitors share in common electrophilic propensities for the sulfhydryl groups, among which include the Michael reaction acceptors contg. an Î±,Î²-unsatd. carbonyl moiety.  We aimed to identify features among structurally diversified Michael acceptor-based compds. that would yield a strong TrxR inhibitory character.  Results: Structurally dissimilar Michael acceptor-based natural compds. such as isobutylamides, zerumbone, and shogaols (SGs) were found to possess a poor TrxR inhibitory activity, indicating that a sole Michael acceptor moiety was insufficient to produce TrxR inhibition.  The 1,7-diphenyl-hept-3-en-5-one pharmacophore in 3-phenyl-3-SG, a novel SG analog that possessed comparable TrxR inhibitory and antiproliferative potencies as 6-SG, was modified to yield 1,5-diphenyl-pent-1-en-3-one (DPPen) and 1,3-diphenyl-pro-1-en-3-one (DPPro, also known as chalcone) pharmacophores.  These Michael acceptor-centric pharmacophores, when substituted with the hydroxyl and fluorine groups, gave rise to analogs displaying a TrxR inhibitory character pos. correlated to their antiproliferative potencies.  Lead analogs 2,2'-diOH-5,5'-diF-DPPen and 2-OH-5-F-DPPro yielded a half-maximal TrxR inhibitory concn. of 9.1 and 10.5 Î¼M, resp., after 1-h incubation with recombinant rat TrxR, with the C-terminal selenocysteine residue found to be targeted.  Innovation: Identification of Michael acceptor-centric pharmacophores among diversified compds. demonstrates that a systematic approach to discover and develop Michael acceptor-based TrxR inhibitors is feasible.  Conclusion: A strong TrxR inhibitory character correlated to the antiproliferative potency is attributed to structural features that include an Î±,Î²-unsatd. carbonyl moiety centered in a DPPen or DPPro pharmacophore bearing hydroxyl and fluorine substitutions.  Antioxid. Redox Signal. 19, 1149-1165.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMUhOi4aQFrbVg90H21EOLACvtfcHk0ljutiaJQRAXBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWnt7jM&md5=8944147ca550e5c618f77898b65791b4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4909%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DF.%2BF.%26aulast%3DKaminska%26aufirst%3DK.%2BK.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiew%26aufirst%3DC.%2BY.%26aulast%3DLeow%26aufirst%3DP.%2BC.%26aulast%3DSo%26aufirst%3DC.%2BL.%26aulast%3DTu%26aufirst%3DL.%2BN.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DYap%26aufirst%3DC.%2BW.%26aulast%3DKang%26aufirst%3DT.%2BS.%26aulast%3DChui%26aufirst%3DW.%2BK.%26aulast%3DChew%26aufirst%3DE.%2BH.%26atitle%3DIdentification%2520of%2520Michael%2520acceptor-centric%2520pharmacophores%2520with%2520substituents%2520that%2520yield%2520strong%2520thioredoxin%2520reductase%2520inhibitory%2520character%2520correlated%2520to%2520antiproliferative%2520activity%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2013%26volume%3D19%26spage%3D1149%26epage%3D1165%26doi%3D10.1089%2Fars.2012.4909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span> </span><span class="NLM_article-title">Synthesis of xanthohumol analogues and discovery of potent thioredoxin reductase inhibitor as potential anticancer agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1795</span><span class="NLM_x">â</span> <span class="NLM_lpage">1805</span><span class="refDoi">Â DOI: 10.1021/jm5016507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5016507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2nsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1795-1805&author=B.+Zhangauthor=D.+Duanauthor=C.+Geauthor=J.+Yaoauthor=Y.+Liuauthor=X.+Liauthor=J.+Fang&title=Synthesis+of+xanthohumol+analogues+and+discovery+of+potent+thioredoxin+reductase+inhibitor+as+potential+anticancer+agent&doi=10.1021%2Fjm5016507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Xanthohumol Analogues and Discovery of Potent Thioredoxin Reductase Inhibitor as Potential Anticancer Agent</span></div><div class="casAuthors">Zhang, Baoxin; Duan, Dongzhu; Ge, Chunpo; Yao, Juan; Liu, Yaping; Li, Xinming; Fang, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1795-1805</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The selenoprotein thioredoxin reductases (TrxRs) are attractive targets for anticancer drugs development.  Xanthohumol (Xn), a naturally occurring polyphenol chalcone from hops, has received increasing attention because of its multiple pharmacol. activities.  We synthesized Xn and 43 analogs and discovered that compd. I displayed the highest cytotoxicity toward HeLa cells (IC50 = 1.4 Î¼M).  Structure-activity relationship study indicates that the prenyl group is not necessary for cytotoxicity, and introducing electron-withdrawing group, esp. on the meta-position, is favored.  In addn., methylation of the phenoxyl groups generally improves the potency.  Mechanistic study revealed that I selectively inhibits TrxR and induces reactive oxygen species and apoptosis in HeLa cells.  Cells overexpressing TrxR are resistant to I insult, while knockdown of TrxR sensitizes cells to I treatment, highlighting the physiol. significance of targeting TrxR by I.  The clarification of the structural determinants for the potency would guide the design of novel potent mols. for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwf_JKL9qk0bVg90H21EOLACvtfcHk0liyTfqETfVFBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2nsLo%253D&md5=87716d4991e9d31cb00189d02b4ad19b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm5016507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5016507%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DDuan%26aufirst%3DD.%26aulast%3DGe%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520xanthohumol%2520analogues%2520and%2520discovery%2520of%2520potent%2520thioredoxin%2520reductase%2520inhibitor%2520as%2520potential%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1795%26epage%3D1805%26doi%3D10.1021%2Fjm5016507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ng, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chui, W. K.</span><span> </span><span class="NLM_article-title">Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">74</span><span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1016%2Fj.ejmech.2016.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=26994844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFKlu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=63-74&author=H.+L.+Ngauthor=S.+Chenauthor=E.+H.+Chewauthor=W.+K.+Chui&title=Applying+the+designed+multiple+ligands+approach+to+inhibit+dihydrofolate+reductase+and+thioredoxin+reductase+for+anti-proliferative+activity&doi=10.1016%2Fj.ejmech.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity</span></div><div class="casAuthors">Ng, Hui-Li; Chen, Shangying; Chew, Eng-Hui; Chui, Wai-Keung</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-74</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of multi-targeting drugs is currently being explored as an attractive alternative to combination therapy, esp. for the treatment of complex diseases such as cancer.  Dihydrofolate reductase (DHFR) and thioredoxin reductase (TrxR) are enzymes belonging to two unrelated cellular pathways that are known to contribute towards cancer cell growth and survival.  In order to evaluate whether simultaneous inhibition of DHFR and TrxR by dihydrotriazines (DHFR-targeting) and chalcones (TrxR-targeting) may be beneficial, breast MCF-7 and colorectal HCT116 carcinoma cells were treated with combinations of selected dihydrotriazines and chalcones at a 1:1 M ratio.  Two combinations demonstrated synergy at low-to-moderate concns.  Based on this result, four merged dihydrotriazine-chalcone compds. were designed and synthesized.  Two compds., 11a [DHFR IC50 = 56.4 Î¼M, TrxR IC50 (60 min) = 12.6 Î¼M] and 11b [DHFR IC50 = 2.4 Î¼M, TrxR IC50 (60 min) = 10.1 Î¼M], demonstrated in vitro inhibition of DHFR and TrxR.  The compds. showed growth inhibitory activity against MCF-7 and HCT116 cells, but lacked cytotoxicity.  Mol. docking expts. showed 11b to possess rational binding modes to both the enzymes.  In conclusion, this study has not only identified the dihydrotriazine and chalcone scaffolds as good starting points for the development of dual inhibitors of DHFR and TrxR, but also demonstrated the synthetic feasibility of producing a chem. entity that could result in simultaneous inhibition of DHFR and TrxR.  Future efforts to improve the antiproliferative profiles of such compds. will look at alternative ways of integrating the two pharmacophoric scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTfuawRog-FrVg90H21EOLACvtfcHk0liyTfqETfVFBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFKlu7Y%253D&md5=db0eda82fcec1659f32400c6c64c4b0f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DH.%2BL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChew%26aufirst%3DE.%2BH.%26aulast%3DChui%26aufirst%3DW.%2BK.%26atitle%3DApplying%2520the%2520designed%2520multiple%2520ligands%2520approach%2520to%2520inhibit%2520dihydrofolate%2520reductase%2520and%2520thioredoxin%2520reductase%2520for%2520anti-proliferative%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D63%26epage%3D74%26doi%3D10.1016%2Fj.ejmech.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Mamalis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outred, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, M.</span><span> </span><span class="NLM_article-title">770. Amino-oxy-derivatives. Part III. Dihydrotriazines and related heterocycles</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_fpage">3915</span><span class="NLM_x">â</span> <span class="NLM_lpage">3926</span><span class="refDoi">Â DOI: 10.1039/jr9620003915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1039%2Fjr9620003915" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1962&pages=3915-3926&author=P.+Mamalisauthor=J.+Greenauthor=D.+J.+Outredauthor=M.+Rix&title=770.+Amino-oxy-derivatives.+Part+III.+Dihydrotriazines+and+related+heterocycles&doi=10.1039%2Fjr9620003915"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fjr9620003915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9620003915%26sid%3Dliteratum%253Aachs%26aulast%3DMamalis%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DOutred%26aufirst%3DD.%2BJ.%26aulast%3DRix%26aufirst%3DM.%26atitle%3D770.%2520Amino-oxy-derivatives.%2520Part%2520III.%2520Dihydrotriazines%2520and%2520related%2520heterocycles%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1962%26spage%3D3915%26epage%3D3926%26doi%3D10.1039%2Fjr9620003915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sodani, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhary, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, B. L.</span><span> </span><span class="NLM_article-title">Syntheses and Reactions of 4 â²-[(omega-Bromoalkyl)oxy]- and 4 â²,4 â´-(Polymethylenedoxy)-bis Substituted Chalcones</span> <span class="citation_source-journal">E-J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">â</span> <span class="NLM_lpage">769</span><span class="refDoi">Â DOI: 10.1155/2010/807059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1155%2F2010%2F807059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVCis7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=763-769&author=R.+S.+Sodaniauthor=P.+C.+Choudharyauthor=H.+O.+Sharmaauthor=B.+L.+Verma&title=Syntheses+and+Reactions+of+4+%E2%80%B2-%5B%28omega-Bromoalkyl%29oxy%5D-+and+4+%E2%80%B2%2C4+%E2%80%B4-%28Polymethylenedoxy%29-bis+Substituted+Chalcones&doi=10.1155%2F2010%2F807059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and reactions of 4'-[(Ï-bromoalkyl)oxy]- and 4',4'''-(polymethylenedioxy)-bis substituted chalcones</span></div><div class="casAuthors">Sodani, R. S.; Choudhary, Prakash C.; Sharma, Hari Om; Verma, B. L.</div><div class="citationInfo"><span class="NLM_cas:title">E-Journal of Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">763-769</span>CODEN:
                <span class="NLM_cas:coden">ECJHAO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">WWW Publications</span>)
        </div><div class="casAbstract">Base-catalyzed condensation of 4-HOC6H4Ac with appropriate aldehydes gave 4'-hydroxychalcone and its 4-methoxy and 4-chloro deriv.  Subsequent reaction with 1 equiv. Î±,Ï-dibromoethane, -butane, or -hexane resulted in a mixt. of 4'-[(Ï-bromoalkyl)oxy]chalcones (sol. in EtOH) and 4',4'''-(polymethylenedioxy)bischalcones (insol. in EtOH).  The latter compds. were also synthesized by another route.  Thus, on treatment with Î±,Ï-dibromo alkanes in 2:1 molar ratio, 4-HOC6H4Ac was converted to 4',4'''-(polymethylenedioxy)diacetophenones, which on base-catalyzed condensation gave the target compds.  Reaction of 4d with phenols and thiophenols gave corresponding phenoxy- and thiophenoxy chalcones, whereas the bis-chalcones on treatment with N2H4Â·H2O furnished the corresponding bis-2-pyrazolines.  The structures of the compds. were confirmed by elemental anal. and spectra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaQ7etIhM8CLVg90H21EOLACvtfcHk0lg9qe0eSLlBow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVCis7Y%253D&md5=b325bdf151569d1808dc06bd8ee2a6c1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1155%2F2010%2F807059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2010%252F807059%26sid%3Dliteratum%253Aachs%26aulast%3DSodani%26aufirst%3DR.%2BS.%26aulast%3DChoudhary%26aufirst%3DP.%2BC.%26aulast%3DSharma%26aufirst%3DH.%2BO.%26aulast%3DVerma%26aufirst%3DB.%2BL.%26atitle%3DSyntheses%2520and%2520Reactions%2520of%25204%2520%25E2%2580%25B2-%255B%2528omega-Bromoalkyl%2529oxy%255D-%2520and%25204%2520%25E2%2580%25B2%252C4%2520%25E2%2580%25B4-%2528Polymethylenedoxy%2529-bis%2520Substituted%2520Chalcones%26jtitle%3DE-J.%2520Chem.%26date%3D2010%26volume%3D7%26spage%3D763%26epage%3D769%26doi%3D10.1155%2F2010%2F807059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span> </span><span class="NLM_article-title">The impact of p53 status on cellular sensitivity to antifolate drugs</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2114</span><span class="NLM_x">â</span> <span class="NLM_lpage">2123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=11448931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslaksr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=2114-2123&author=X.+Luauthor=J.+Erringtonauthor=N.+J.+Curtinauthor=J.+Lunecauthor=D.+R.+Newell&title=The+impact+of+p53+status+on+cellular+sensitivity+to+antifolate+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of p53 status on cellular sensitivity to antifolate drugs</span></div><div class="casAuthors">Lu, Xiaohong; Errington, Julie; Curtin, Nicola J.; Lunec, John; Newell, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2114-2123</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The impact of p53 status on cellular sensitivity to antifolate drugs has been examd. in seven human cell lines (A549, MCF7, T-47D, CCRF-CEM, COR-L23, A2780, and HCT-116) and p53 nonfunctional counterparts of two of the cell lines (HCT-116/N7 and A2780/CP70).  P53 status was detd. by sequencing and functional assays.  The sensitivities of the cell lines to growth inhibition (sulforhodamine B assay) produced by four antifolate drugs (Alimta, methotrexate, raltitrexed, and lometrexol) were studied.  There was no clear relationship between functional p53 status and sensitivity to methotrexate or lometrexol, whereas a functional p53 status was possibly assocd. with resistance to Alimta- and raltitrexed-induced growth inhibition.  In contrast, in the two pairs of related human tumor cell lines (HCT-116 and HCT-116/N7 and A2780 and A2780/CP70) cells with functional p53 were more sensitive to Alimta- and raltitrexed-induced growth inhibition (P = 0.002).  Detailed studies were performed with the A2780 cell lines, and in the parental cells sensitivity to Alimta- and raltitrexed-induced cytotoxicity (clonogenic assay) was similar to the sensitivity detd. in the sulforhodamine B assay.  However, in A2780/CP70 cells, 1 Î¼M of drug resulted in only 40-60% growth inhibition yet â¥85% cytotoxicity.  After Alimta and raltitrexed exposure for â¤72 h, there were no differences between the A2780 and A278/CP70 cell lines in cell cycle phase distribution, abs. cell no., or the induction of apoptosis.  However, the cellular protein content of the A2780/CP70 cells was 3-6-fold higher than in A2780 cells after Alimta and raltitrexed treatment, suggesting that cells without functional p53 can maintain protein synthesis in the absence of cell division (unbalanced cell growth).  In conclusion, the apparent impact of functional p53 status on sensitivity to antifolate drugs may depend upon the phenotypic/genotypic background as well as the assay used to measure cellular sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1VUq3zl8vPbVg90H21EOLACvtfcHk0lg9qe0eSLlBow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslaksr8%253D&md5=b4ac9eb5f2da16ddde0748d80a7d874a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DErrington%26aufirst%3DJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DLunec%26aufirst%3DJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26atitle%3DThe%2520impact%2520of%2520p53%2520status%2520on%2520cellular%2520sensitivity%2520to%2520antifolate%2520drugs%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D2114%26epage%3D2123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>Dihydrofolate reductase assay kit: technical bulletin. <a href="http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Bulletin/cs0340bul.pdf" class="extLink">http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Bulletin/cs0340bul.pdf</a> (accessed July 6,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dihydrofolate+reductase+assay+kit%3A+technical+bulletin.+http%3A%2F%2Fwww.sigmaaldrich.com%2Fcontent%2Fdam%2Fsigma-aldrich%2Fdocs%2FSigma%2FBulletin%2Fcs0340bul.pdf+%28accessed+July+6%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">ArnÃ©r, E. S.; Holmgren, A.</span><span> </span><span class="NLM_article-title">Measurement of thioredoxin and thioredoxin reductase</span>.  <span class="citation_source-book">Current Protocols in Toxicology</span>; <span class="NLM_publisher-name">Wiley</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>Chapter 7, Unit 7.4, DOI: <span class="refDoi">Â DOI: 10.1002/0471140856.tx0704s05</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;key=10.1002%2F0471140856.tx0704s05" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=E.+S.+Arn%C3%A9r&author=A.+Holmgren&title=Current+Protocols+in+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2F0471140856.tx0704s05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471140856.tx0704s05%26sid%3Dliteratum%253Aachs%26aulast%3DArn%25C3%25A9r%26aufirst%3DE.%2BS.%26atitle%3DMeasurement%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%26btitle%3DCurrent%2520Protocols%2520in%2520Toxicology%26pub%3DWiley%26date%3D2003%26doi%3D10.1002%2F0471140856.tx0704s05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01253">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87715"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01253">10.1021/acs.jmedchem.6b01253</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis and characterization of <b>18</b>, <b>16</b>, and <b>6h</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_001.pdf">jm6b01253_si_001.pdf (169.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01253/suppl_file/jm6b01253_si_002.csv">jm6b01253_si_002.csv (2.8 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01253&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01253" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01253" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b3425cac53da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
